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“The kind of control you’re attempting is not possible. If there’s one thing the history of
evolution has taught us, it is that life will not be contained. Life breaks free, expands to new
territories, crashes through barriers, painfully, maybe even dangerously [...]
I’m simply saying that life [pause] finds a way”.
Dr. Ian Malcom (played by Je↵ Goldblum) - Jurassic Park
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Impact Statement
The steady development of powerful biotechnological tools for engineering living organ-
isms represent a promising source of new candidate molecules for discovery of drugs for
clinical use. Among the compounds that can be accessed by biological systems are the Thi-
azole/Oxazole Modified Microcins (TOMMs), a family of molecules produced by diverse
microorganisms, with known molecules displaying antimicrobial and anticancer activities,
both highly-relevant for clinical applications. Synthesis of these molecules by traditional
organic chemistry methods is di cult and their biological production route starts from a
genetically-encoded peptide, making it attractive for engineering with the tools of molecular
biology.
Despite the potential application of synthetic TOMM molecules for compound discovery,
this class of molecules has not yet been widely engineered due to limited understanding
of the functioning of the enzyme complex involved in TOMM biosynthesis. This was the
motivation behind the development a strategy to improve the characterisation of these
enzymes, exploiting publicly-available sequence data from a wide range of microorganisms
to select sites in the proteins likely to contribute to their function in TOMM biosynthesis.
Beyond improving characterisation of the processes involved in TOMM biosynthesis, the
prediction strategy developed here is generalisable and can be applied to many other poorly-
understood families of proteins, accelerating the identification of functional residues.
Improved understanding of TOMM biosynthetic mechanisms will also be of use in future
e↵orts to engineer the enzyme complex with the aim of establishing a generic platform
for production of synthetic TOMMs. As demonstrated here in the attempts to reconsti-
tute purified TOMM synthase complexes in vitro, the task was not trivial, with multiple
expression and detection issues left unsolved.
The currently known enzyme complexes are not robust enough for production of repertoires
of novel synthetic molecules. New engineered — or as-yet unknown natural — enzymes
are needed with robust activity outside their native organisms and with su cient tolerance
towards modified substrate peptides.
In the absence of an adequate set of enzymes for development of novel TOMMs, a framework
was developed here to enable e cient engineering of TOMM substrate peptides and any
other protein (or region of a protein) that can have the length of its sequence changed and
still function. The previously-available methods for the production of genetic diversity with
variable sequence lengths were either ine cient or too costly, putting this type of diversity
beyond the reach of most research groups. InDel Assembly — the method developed here
— can produce sequences with targeted diversity in both length and composition through a
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simple experimental protocol, enabling easier exploration of length variation as a parameter
in protein engineering. In addition to being used for TOMM substrates, this framework
can be adapted to engineer a wide range of biological systems such as antibodies, enzymes
and entire metabolic pathways.
A generalised strategy for the production of synthetic TOMMs is still not within reach, but
the tools developed as part of this thesis represent useful contributions to many distinct
topics within biological research, including the development of novel molecules for clinical
and any other applications.
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Introduction
The biosynthetic repertoire available in the Earth’s biosphere by far outstrips the ca-
pacity for traditional isolation and characterisation of natural products for clinically- or
industrially-relevant bioactive compounds. However, some of the biosynthetic pathways
for naturally-ocurring products can be exploited to e ciently generate and select novel
compounds, using recent molecular biology techniques.
One poorly-sampled region of natural product space that can be explored in this man-
ner is comprised of the Thiazole/Oxazole-Modified Microcins (TOMMs). These are post-
translationally modified peptides containing heterocyclic thiazole and/or oxazole moieties,
identified in bacterial and archaeal species. Their genomically-encoded substrate peptides
are modified by sets of enzymes known to tolerate altered substrates, which makes the
biosynthetic pathway amenable to engineering with directed evolution techniques towards
the production of new biological activities.
1.1 Thiazole/Oxazole-Modified Microcins
1.1.1 Nomenclature and structure
TOMMs are part of a much larger category of natural products, the Ribosomally synthesised
and Post-translationally modified Peptides (RiPPs). This class of compounds was the
subject of a large collaborative review (Arnison et al., 2013) with the aim of standardising
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the nomenclature and classifying the diverse known products into smaller groups with
shared biosynthetic pathways and structural elements.
In this thesis, TOMMs will be defined as ribosomal peptide-derived molecules con-
taining heterocycles generated by post-translational modification of serine, threonine or
cysteine residues. This definition encompasses three of the classes proposed in the RiPP
nomenclature: the Linear Azol(in)e-containing Peptides (LAPs), the cyanobactins and the
thiopeptides (Arnison et al., 2013). Despite the large structural and functional divergences
between all the TOMMs (See Fig. 1.1 for examples), their heterocyclic modifications share
a homologous biosynthetic enzyme system, which will be the main focus of this thesis. The
flat heterocycles installed in the peptides constrain the conformational flexibility of the
backbone and this constraint is crucial for making TOMMs into very specific ligands for
biologically-relevant structures.
In addition to the heterocycles, TOMM substrate peptides can undergo several other
modifications leading to their final, active forms. Cyanobactins and thiopeptides have all
or most of their peptide backbone converted into a macrocycle, while the LAPs remain
in a linear form. The side chains of non-heterocyclised residues can also receive other
modifications such as methylation, dehydration, and prenylation (Wipf and Uto, 1999;
Kalyon et al., 2011). These additional modifications are specific to each molecule and are
performed by enzymes that are usually not involved in the heterocyclisation reactions.
1.1.2 Naturally-ocurring TOMMs
TOMM products and their homologous biosynthetic machinery have been identified in sev-
eral major groups of prokaryotes: Proteobacteria (E. coli (Yorgey et al., 1993)), Firmicutes
(Bacillus (Scholz et al., 2011), Clostridium (Gonzalez et al., 2010a), Streptococcus (Lee
et al., 2008)), Actinobacteria (Streptomyces (Kelly et al., 2009)), Cyanobacteria (Prochloron
21
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Figure 1.1: TOMMs and other thiazole containing natural products. Inside the green
boxes are representative molecules in the classes of RiPPs (sensu Arnison et al 2013),
that are included within TOMMs as defined in this thesis (red box). Outside the red box
are azole-containing compounds not defined as TOMMs. Yersiniabactin is synthesised by
a non-ribosomal peptide synthase system and the biosynthetic route to telomestatin is
unknown.
(Schmidt et al., 2005)) and Archaea (Pyrococcus (Lee et al., 2008)). The widespread oc-
currence and maintenance of these compounds suggests they must provide the producing
organisms with some selective advantage, however the natural biological function of many
natural TOMMs has not yet been identified.
All the TOMMs which have a known function for their producing organism are involved
in ecological interactions at some level. Streptolysin S was likely the first TOMM to be
isolated (Weld, 1934; Czarnetzky et al., 1938), though its chemical identity and biosynthesis
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were only elucidated over 70 years later (Lee et al., 2008), and it is a haemolytic toxin
against the vertebrate hosts of Streptococcus pyogenes. Clostridiolysin S, from Clostridium
botulinum, is also a TOMM virulence factor with a similar activity to streptomycin S
(Gonzalez et al., 2010a).
Anti-microbial activity is the other major natural function that has been identified for
TOMMs. The first compound in this class to have its biosynthetic pathway described was
microcin B17 from E. coli, an antimicrobial compound that acts by inhibiting DNA gyrase
of closely-related bacteria (Li et al., 1996). More recently, Bacillus amyloliquefaciens was
shown to produce a TOMM antibiotic with strong activity only against other species in
the same genus (Scholz et al., 2011). Activity against phylogenetically close species can be
indicative of a role in competition for similar ecological niches.
In contrast, the thiopeptide antibiotic GE37468 from Streptomyces sp. ATCC 55365,
a member of the phylum Actinobacteria, has strong activity against Methicillin-Resistant
Staphylococcus aureus (MRSA) which is in the phylum Firmicutes (Young andWalsh, 2011).
Streptomyces are typically soil-associated bacteria, while MRSA and other Staphylococcus
species are found in vertebrate skin and mucous membranes, with some being opportunistic
pathogens. Since these bacteria are not likely to compete for the same resources, this
activity suggests that TOMMS are involved in ecological interactions that are still largely
uncharacterised.
However, most other TOMMs have no known function for the producing organism yet
have been studied in detail for their clinically-relevant activities. This is the case for the
patellamides and trunkamides, macrocyclic modified peptides with anti-tumour activities.
These molecules are produced by Prochloron sp. uncultivated cyanobacterial symbionts of
the colonial ascidian Lissoclinum patella (Schmidt et al., 2005). The cytotoxicity of some
of the patellamides suggest a possible function as a deterrent against predation by other
animals, but this has never been demonstrated. Experiments with extracts obtained from
23
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other species of ascidians showed strong anti-diatom activity for some of the extracts, which
suggests that some compound contained in these animal’s tissues could be responsible for
preventing fouling of the colony’s surface by diatoms (Koplovitz et al., 2011). It is possible
to speculate that a cytotoxic TOMM synthesised by a cyanobacterial symbiont would be
responsible for this function.
1.1.3 TOMM Biosynthesis
All biosynthetic pathways for TOMM synthesis characterised to date are encoded in ge-
nomic clusters containing the genes needed to produce the final molecule and ensure its
correct function, including the sequence for the substrate peptide itself (reviewed in Arni-
son et al. (2013)). The core enzymatic complex needed to install the heterocycles in the
peptides is composed of three components, an ATP-dependent cyclodehydratase activity,
a docking domain and an FMN-dependent dehydrogenase activity (biosynthetic steps in
Fig. 1.2). In vitro, these components have been shown to associate into a heterotrimeric
TOMM synthase complex (Li et al., 1996).
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Figure 1.2: Biosynthetic steps catalysed by the TOMM synthase complex to generate
azolines and azoles by post-translational modification of peptides. Heterocycles are in-
stalled by the cyclodehydratase activity and the resulting azolines can be oxidised by the
FMN-dependent dehydrogenase activity into azoles.
The cyclodehydratase and the docking domain together catalyse the heterocyclisation
of Cys/Ser/Thr side chains into reduced thiazoline or (methyl-)oxazoline moieties. In most
bacteria, these two components are produced as two separate proteins, however in cyanobac-
teria these two domains are usually fused in a single bifunctional polypeptide (See subsection
1.3.2).
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The dehydrogenase activity oxidises some (or all) of the reduced heterocycles to generate
thiazole or (methyl-)oxazole rings. In most bacteria, monofunctional proteins catalyse
this reaction. Some cyanobacteria have this activity as part of a bifunctional protein,
together with a protease that is involved in post-heterocyclisation TOMM maturation (See
subsection 1.3.3).
TOMM substrate peptides are composed of an N-terminal leader sequence, followed by
a core region which contains the residues to be modified and in some cases a C-terminal
recognition sequence (Fig. 1.3). The leader sequence is needed for recognition by the syn-
thase complex and also contains sites for further modifications and a protease cleavage site
to remove it from the modified peptide. At the C-terminus, the recognition sequence directs
macrocyclisation activity in cyanobacterial products.
Core peptide Recognition sequenceLeader sequence
Figure 1.3: Generalised structure of a TOMM substrate peptide. In black is the leader
sequence needed to direct TOMM synthase activity, in red is the region containing the
heterocyclisable residues and in blue is an optional region containing signals to direct
other post-translational modification enzymes (nomenclature from Arnison et al. (2013)).
In addition to the substrate peptide (A) and the genes encoding the heterocyclase com-
plex (B, C and D), TOMM biosynthesis clusters usually code for one or more proteins
that are needed for further modifications or to ensure proper TOMM function. Among
the additional proteins that are needed by these pathways are transporters to export the
products, other post-translational modification enzymes (prenylases or dehydratases, for
instance) and also proteins that are needed for immunity to the final TOMM product.
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1.1.4 Other -azole containing natural products
The TOMM synthase complex is not the only known pathway by which thiazole and
(methyl)-oxazoles can be introduced into natural products. Yersinia pestis produces yersini-
abactin a heterocycle-containing compound that is very similar to peptides, but is produced
by a non-ribosomal peptide synthetase/polyketide synthase hybrid system from small-
molecule precursors, without requiring a substrate peptide for modification (Miller et al.,
2002). This compound is a siderophore with a high a nity for iron, which makes it an
important virulence factor to allow Y. pestis colonisation of its hosts (Miller et al., 2006).
There are also other heterocycle-containing molecules which still have not had their
biosynthetic mechanism elucidated, but are likely to be produced by a homologue of the
TOMM biosynthetic machinery. One such molecule is telomestatin (Fig. 1.1), which was
isolated from the marine bacterium Streptomyces annulatus and is the most specific natural
product inhibitor of telomerase (Shin-ya et al., 2001). This activity makes it a potential
candidate for drug development as a treatment for telomerase positive tumours (Tauchi
et al., 2003). Telomestatin is a macrocyclic molecule consisting solely of five oxazoles, two
methyloxazoles and one thiazoline. The total synthesis of this molecule has been done by
more than one group but the final yields obtained were very low (<2%), which makes further
development of the compound very costly (Doi et al., 2006; Marson and Saadi, 2006; Linder
et al., 2011). The structure of telomestatin is very similar to some of the cyanobactins,
which suggests a possible homologous biosynthetic pathway and that it could be synthesised
in vitro by heterologous expression of a suitable TOMM synthase complex and substrate
peptide combination.
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1.2 TOMM Product Engineering
1.2.1 In vitro Production
Many of the TOMM-producing species are non-model organisms that are not genetically
tractable or, in some cases, even culturable in the laboratory. Therefore, in order to better
understand the biosynthetic pathways for future engineering, in vitro production and assay
systems needed to be developed.
The first successful report of in vitro reconstitution of a TOMM biosynthetic pathway
was for the E. coli microcin B17, by over-expression of cyclodehydratase (McbD), docking
(McbB), dehydrogenase (McbC) and substrate (McbA) proteins (Li et al., 1996). This
system enabled the early characterisation of the TOMM synthase complex and development
of methods for activity detection. Other synthase pathways that have since been studied
in vitro are the ones that synthesise patellamides in Prochloron sp. (Schmidt et al., 2005),
streptolysin S in S. pyogenes (Lee et al., 2008), plantazolicin in B. amyloliquefaciens (Scholz
et al., 2011) and BalhA in Bacillus sp. Al-Hakam (Melby et al., 2012). In addition, the
trimeric synthase complex from the archaeon P. furiosus was heterologously expressed and
shown to have activity on the S. pyogenes substrate peptide, converting it into the active
form of streptolysin S (Lee et al., 2008).
Cell-free systems allow for easier introduction of non-proteinogenic amino acids into
the substrate peptide, as well as avoiding product toxicity issues which can hinder in vivo
TOMM production. One such system was developed for in vitro translation and hetero-
cyclisation of substrate peptides, using the patellamide heterocyclase patD and increasing
the chemical space accessible to engineered TOMMs (Goto et al., 2014) by allowing the
introduction of non-proteinogenic amino acids into synthetic TOMMs.
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1.2.2 Production of modified TOMMs by genetic engineering
The heterologously expressed TOMM synthase complexes were an important step in facili-
tating e↵orts to generate new TOMM products, while also allowing exploration of the limits
of synthase activity (See Section 1.3 for characterisation of TOMM synthase enzymes). Af-
ter the initial description of E. coli microcin B17 biosynthesis, site-directed mutagenesis
was used to generate substrate peptide variants that were heterocyclised and screened for
antibiotic activity (Sinha Roy et al., 1999). Some of the mutants led to new compounds
but all the new TOMMs that were successfully produced in these experiments had lower
antibiotic activity than the wild-type microcin. However, mutations at di↵erent hetero-
cyclisation sites did not have equal e↵ects. There was a significantly stronger decrease in
activity when the C-terminal bisheterocyclic moiety was mutated than when similar mu-
tations were introduced into the N-terminal bisheterocycle (See Fig. 1.1 for MicrocinB17
structure) (Sinha Roy et al., 1999), which suggests di↵erent roles for each region in the
interaction with the DNA gyrase target.
Substitutions of cyclised residues for non-cyclisable ones or S-C/C-S mutations (replac-
ing a thiazole with an oxazole and vice-versa) have been shown to generally reduce the
antibacterial activity of variants against E. coli and the inhibitory e↵ect on DNA gyrase
(Sinha Roy et al., 1999; Zamble et al., 2001). Interestingly, Sinha Roy et al. (1999) also
detected in extracts from producing cultures a minor form of the Microcin B17 product in
which Ser26 is heterocyclised — bringing the total number of heterocycles in the molecule
to nine (compared with the eight heterocycles in the accepted structure of Microcin B17) —
and this compound was shown to have higher antimicrobial activity against E. coli (Zamble
et al., 2001).
Terminal truncations of this TOMM have also been produced, both by in vivo biosyn-
thesis of truncated precursor genes and by organic synthesis of variants(Collin et al., 2013;
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Thompson et al., 2014; Shkundina et al., 2014). Most of these variants also reduced over-
all activity, but a synthetic variant without the N-terminal “tail” containing a stretch of
nine glycines was a stronger inhibitor of DNA gyrase than Microcin B17 (Thompson et al.,
2014). Despite this increased activity against the known in vivo target, this compound had
lower antimicrobial activity against E. coli independently of the reduced cellular uptake of
variants without this “tail” (Shkundina et al., 2014). Surprisingly, substitution of Ser26
with an oxazole (which increases the antimicrobial activity of the full-length version) in
the“tail”-less variant, led to decreases in both gyrase inhibition and activity against E. coli
(Thompson et al., 2014).
Other TOMM synthase complexes proved to be more tractable to novel TOMM pro-
duction than the E. coli system, especially the cyanobactin synthase from Prochloron sp.
The whole pathway was introduced into E. coli for in vivo production and saturation
mutagenesis was performed at selected sites. Mutations at five out of seven sites within
the trunkamide macrocycle resulted in detectable products, showing that the enzymes will
tolerate substitutions to most amino acids at positions that are not crucial to the macro-
cyclisation process (Ru↵ner et al., 2014). One notable exception that is not tolerated at
these five sites is cysteine, which is likely to interfere with the macrocyclisation process
when it is converted into a heterocycle. The chemical space that can be accessed by this
pathway was further expanded by the incorporation of non-proteinogenic amino acids into
novel TOMMs (Ru↵ner et al., 2014). The catalytic promiscuity of the cyclodehydratase
activity in Prochloron sp. was independently demonstrated by the cell-free translation sys-
tem developed by Goto et al. (2014), which produced linear TOMMs containing up to 18
heterocyclised residues, compared to only four modified residues in the wild-type product.
While not possessing the wide substrate tolerance that was demonstrated for Prochloron
sp. enzymes, mutagenesis was carried out for TOMMs of other organisms and the novel
29
Chapter 1. Introduction
products had their activities compared against their wild-type forms. An engineered Strep-
tomyces coelicolor strain was transformed with the production pathway for the antibiotic
GE37468 from Streptomyces sp. ATCC 55365 and 133 variants of the substrate peptide
(Young et al., 2012). Out of this repertoire of mutant peptides, 29 led to succesful produc-
tion and export of a TOMM product. These were purified for detection of antimicrobial
activity against B. subtilis and MRSA, which was retained by 12 of the mutants, including
one with a 2-fold increase in activity compared to the wild-type (Young et al., 2012).
A similar experiment with Plantazolicin A production in E. coli also produced novel
processed TOMMs, but none had improved activity over the wild-type antibiotic (Deane
et al., 2013). Of special interest is the fact that the strongest negative e↵ects in the
plantazolicin were observed for mutations in the heterocyclised sites, demonstrating that
these post-translational modifications are directly related to the function of this compound.
In the published literature to date, there are no reports of novel synthetic TOMMs
being generated by directed evolution. However, the TOMM biosynthesis pathway meets
all the requirements for directed evolution to be possible (See Section 1.5 for an overview
of directed evolution). The fact that the substrate peptides are genetically encoded enables
the generation of diversity by well-established molecular biology techniques and in vivo
production of variants can exploit whole cells as a genotype-phenotype linkage. All that
is needed to perform a directed evolution experiment is the development of a system in
which the synthetic TOMM libraries are synthesised and selected for an activity of interest
while maintaining a genotype-phenotype linkage — by physical compartmentalisation or
localisation of modified peptides to the interior or surface of cells.
Directed evolution has been successfully employed to develop novel thioether-macrocyclic
compounds — similar to TOMMS in being natural products derived from post-translationally
modified peptides — for use as kinase inhibitors (Hayashi et al., 2012). These molecules
contain only a single post-translational modification, which is a macrocyclisation between
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the N-terminal non-proteinogenic amino acid N-(2-chloroacetyl)-tyrosine and a cysteine
residue near the C-terminus. Libraries of mRNAs coding for short peptides were translated
in an in vitro system that resulted in the mRNA being linked to the peptide C-terminus,
providing the genotype-phenotype linkage. The target kinase was immobilised on magnetic
beads, which allowed the capture of positive clones while washing out the non-binders.
The selected sequences could then be amplified by PCR to start a new round of selection
(Hayashi et al., 2012).
1.3 TOMM biosynthetic machinery
1.3.1 Organisation and Occurrence
All characterised TOMM biosynthesis pathways are genetically encoded in clusters con-
taining all genes needed for correct production and function of their respective compounds.
Though the order of the genes within the cluster may vary, the most common organisation
for TOMM clusters is depicted in Fig. 1.4A. The substrate peptide-encoding gene is usu-
ally located immediately upstream of the heterocyclisation genes. The gene coding for the
dehydrogenase is followed by the two genes responsible for the cyclodehydratase activity
and these two activities represent the common core of TOMM biosynthesis. Downstream
of these genes are the sequences coding for auxiliary functions needed for biosynthesis, such
as proteases to cleave the leader peptide, transport proteins to export products from the
cell, other post-translational modification enzymes and proteins needed for self-immunity
to toxic products.
Out of all studied TOMM synthase systems, the cyanobactin synthesis pathways from
Prochloron sp. are the ones which have been more thoroughly explored, especially the genes
involved in functions other than heterocyclisation. The patellamide cluster in Prochloron
sp. is composed of seven co-directional genes, patA through patG. The first gene in this
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TOMM cluster
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PatD                                
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PatA                            
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PatG
Heterocyclisation Leader cleavage Azoline oxidation/
Macrocyclisation
Figure 1.4: Comparison between TOMM and patellamide clusters and mechanism. A -
top - Generalised TOMM synthase gene cluster with genes labeled according to Arnison
et al. (2013). Components found in all such clusters are a substrate peptide (black) a
dehydrogenase (red), a docking domain (yellow) and a cyclodehydratase (green). The
remaining genes encode genes responsible for modifications specific to each cluster (blue).
Bottom - the Patellamide A biosynthesis cluster from Prochloron sp.: The first gene is a
protease responsible for leader peptide cleavage, followed by two short proteins of unknown
function (grey), a bifunctional protein containing docking and cyclodehydratase domains,
the substrate peptide, a protein of unknown function with homology to prenylases (grey)
and a bifunctional protein containing dehydrogenase and macrocyclase activities. B - Steps
in patellamide maturation. Substrate peptides containing leader peptides (L), core peptide
region (C) and recognition sequences (R) are initially heterocyclised on the core region the
PatD, generating azolines in the region (green). Then, the leader peptide is cleaved by the
action of PatA, followed by oxidation and macrocyclisation by PatG, which leads to the
removal of the C-terminal region past the core peptide. The final product is macrocyclic
and containing azoles or azolines.
cluster codes for a protease which is responsible for cleaving the leader peptide after hete-
rocyclisation has been carried out (Agarwal et al., 2012; Sardar et al., 2014). Immediately
downstream are two short genes, patB and patC, which have no known function. PatD is
a bifunctional enzyme containing the full cyclodehydratase activity in a single polypeptide,
equivalent to the C and D proteins present in other species (Schmidt et al., 2005). PatE
is the substrate peptide, composed of a leader peptide with recognition elements for PatA
cleavage and PatD heterocyclisation, the core sequence that is modified by PatD and a
C-terminal recognition sequence for PatG macrocyclisation (Sardar et al., 2014). The next
gene, patF is also of unknown function, but the structure of its protein product has been
determined and it is homologous to prenylating enzymes. However, the patellamides are
not prenylated, the putative active site residues are mutated in this gene and no enzymatic
activity could be detected from the expressed protein, so it does not have a prenylating
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function in this cluster (Bent et al., 2013). Finally, patG also encodes a bifunctional en-
zyme encompassing the TOMM dehydrogenase function and the macrocyclisation activity
(Agarwal et al., 2012; Koehnke et al., 2012). There are no known transport or immunity
mechanisms for the patellamide system.
The genes responsible for TOMM export and immunity in E. coli were discovered by
deletion analyses. mcbE and mcbF code for the proteins that export Microcin B17 from cells
and also prevent the TOMM from interacting with its DNA gyrase target in the producing
cell (Garrido et al., 1988). The third immunity related gene, McbG is uncharacterised
but its paralogue Qnr has been shown to prevent quinolone inhibition of DNA gyrase by
directly binding the enzyme (Tran et al., 2005). This interaction reduces gyrase a nity for
DNA, which may prevent the formation of the gyrase-drug-DNA complex that is needed
for quinolone activity (Tran et al., 2005). This model of drug resistance fits the observation
that McbG complements the resistance provided by the exporters McbE and McbF (Garrido
et al., 1988), with only the strains that possess all three genes being highly resistant to the
toxicity of their own antimicrobial compound.
1.3.2 Cyclodehydratase/Heterocyclase
Heterocycles are installed in substrate peptides by the cyclodehydratase activity, converting
side chain free alcohol or thiol groups into oxazolines or thiazolines by reaction with the
main chain carbonyl from the preceding residue. This reaction is ATP-dependent and
results in the loss of the mass equivalent of one water molecule per heterocyclised residue
(Milne et al., 1998). However, the mechanism by which this reaction occurs is still unclear
and the cyclodehydratase activity has not been assigned an EC number.
There are two contradicting mechanisms which have been proposed for the TOMM cy-
clodehydration reaction, using two distinct enzymes as experimental models: BalhD from
Bacillus sp. Al-Hakam and the bifunctional cyclodehydratase/docking protein TruD from
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Prochloron sp.. Experiments with BalhD detected ADP formation during cyclodehydration
reactions, which led the authors to propose a mechanism in which ATP directly phospho-
rylates the amide carbonyl in the substrate backbone, activating it to drive the reaction to
heterocyclisation (Fig. 1.5 A, Dunbar et al. (2012)). Activity assays with the TruD enzymes
led only to AMP formation and the mechanism proposed for this system is the adenylation
of the carbonyl, releasing pyrophosphate rather than free phosphate (Fig. 1.5 B) (Koehnke
et al., 2013).
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Figure 1.5: Simplified comparison of proposed mechanisms for the cyclodehydration
reaction in TOMM synthesis. A - Phosphorylation mechanism proposed by Dunbar et al.
(2012) and leading to ADP production. B - Adenylation mechanism proposed by Koehnke
et al. (2013) and leading to pyrophosphate production.
A crystal structure of a TOMM D homologue from E. coli, YcaO, was obtained in the
apo form and also as a complex with AMP (Dunbar et al., 2014), which could be evidence in
favour of the proposed adenylation mechanism, since that model predicts an AMP complex
as an intermediate in the reaction. However, this homolog does not have cyclodehydration
activity and no AMP-bound TOMM cyclodehydratase structure has been obtained yet.
Apart from the proposed reaction mechanisms, there are still several poorly charac-
terised aspects of cyclodehydratase function, such as the role of the C docking domain for
the activity, how the leader peptide is recognised before cyclodehydration and the drastic
di↵erences in regioselectivity of heterocyclised residues between enzyme complexes from
di↵erent species.
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1.3.2.1 C docking domain
Most of the cyclodehydratases that have been studied so far are active only in the presence
of a C docking protein, or are directly fused to a C domain as in the cyanobactin enzymes (Li
et al., 1996; Schmidt et al., 2005; Lee et al., 2008; Scholz et al., 2011). However, the BalhD
protein still possesses a reduced cyclodehydration activity in the absence of BalhC (Dunbar
et al., 2012). Interestingly, in the absence of BalhC there is deregulated consumption of
ATP, with more than one molecule being converted to ADP per heterocyclised residue
(Dunbar et al., 2012), which suggests that the C domain is somehow involved in regulating
cyclodehydratase activity.
There is also evidence of a role for the C domain in binding both the leader region of the
substrate and the cyclodehydratase activity of the D domain, bringing them together for
catalysis. Fluorescence polarisation experiments demonstrated that BalhD alone has low
a nity for the substrate peptide, but free BalhC was shown to interact with a high a nity
towards the substrate BalhA (Dunbar et al., 2014). The interaction between BalhD and
BalhC is mediated by a conserved proline-rich motif PXPXP found at the C terminus of
cyclodehydratases. Any mutations within this motif led to both decreased heterocyclisation
activity and reduced a nity towards BalhC (Dunbar et al., 2014), further demonstrating
the importance of the C domain for overall heterocyclisation activity.
1.3.2.2 Leader peptide sequence
While it is clear that the leader peptide region of the TOMM substrate has an impor-
tant role in substrate recognition, some of the known TOMM cyclodehydratases can carry
out heterocyclisations on peptides lacking leader sequences, albeit at lower activities and
a nities. In the Prochloron sp. cell-free translation and heterocyclisation system devel-
oped by Goto et al. (2014), a leader-free substrate peptide was heterocyclised at half of its
modifiable residues. Interestingly, expression of two peptides containing an isolated leader
35
Chapter 1. Introduction
peptide and leader-free substrate sequence led to modification of the core peptide with a
higher e ciency than when the leader-free substrate was expressed alone, which indicates
that the leader can perform part of its function in trans (Goto et al., 2014).
Similar results were observed with leader-free substrate peptides for the Bacillus sp. Al-
Hakam system, heterocyclisations can be observed but the a nity of the substrate towards
the modifying enzymes is much lower than that observed for the wild-type peptide. (Dunbar
and Mitchell, 2013). Additionally, the removal of the leader peptide negatively a↵ected the
subsequent dehydrogenation step, as a complex mixture of oxidation products was observed
when the B dehydrogenase was added to reaction mixtures (Dunbar and Mitchell, 2013).
While there is a clear recognition function for the leader sequence in TOMM biosynthesis,
the complex e↵ects on the dehydrogenase reaction and the trans-activating evidence point
toward as-yet unexplained functions for this region in the overall modification process.
1.3.2.3 Sequence specificity in the core peptide
One aspect of the cyclodehydratases which has not yet been well characterised is the mech-
anistic basis for the wide variability that can be observed in modified sequence selectivity
between the known TOMM synthase systems. Natural TOMM products di↵er widely in
the number of consecutive heterocycles found in the final product; patellamides have only
isolated heterocyclic moieties, microcin B17 and BalhA have bisheterocycles and planta-
zolicin A has five consecutive modified residues (See Fig. 1.1 for structures). The tolerance
of the respective biosynthetic enzymes towards changes in the substrates were probed by
mutagenesis studies, revealing di↵erences in cyclisation site selectivity in enzymes from
di↵erent species.
Both bisheterocyclic sites in the Microcin B17 product are flanked by glycines, but
expression of substrate variants containing mutations at these residues demonstrated that
only the N-terminal glycine is absolutely required for processing while the downstream
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position is more flexible (Belshaw et al., 1998; Sinha Roy et al., 1998). This was interpreted
by the authors as a possible steric or conformational requirement for a small group at the
position where the first heterocycle is installed, however this condition is not observed in
TOMMs produced by other organisms. The BalhA2 peptide from Bacillus sp. Al-Hakam
has heterocyclisations preceded by aspartate, lysine, proline and glycine, which shows that
charge, size of side chain and conformational flexibility are not absolute requirements for
heterocyclisation by this system.
The tolerance for variability at the heterocyclised sites similarly varies between species.
The PatD heterocyclase has a very high substrate flexibility in vitro, generating linear
products containing up to 18 heterocyclised residues and also variants of its wild-type
product having all heterocyclisation sites mutated to cysteines, serines or threonines (Goto
et al., 2014). Meanwhile, an in vivo screen of 40 plantazolicin A mutants at heterocyclised
sites only led to 8 detectable products, 2 of which were produced at a high enough titer for
antimicrobial activity assays (Deane et al., 2013). The low success rate in the plantazolicin
mutants may reflect a lower tolerance for non-native sequences in the core peptide, but it
could also be a failure of the in vivo system to process and export at a step downstream of
cyclodehydration.
1.3.3 Dehydrogenase
The TOMM dehydrogenase is an FMN-dependent enzyme and is responsible for the oxi-
dation of azolines into their respective azoles. In most organisms it is expressed a separate
polypeptide, except for Prochloron sp., which has this activity as part of a bifunctional pro-
tein (PatG) which also possesses macrocyclase activity. The E. coli Microcin B17 synthase
complex is inactive in the absence of this protein (Milne et al., 1999), but other complexes
have been shown to stably produce the reduced heterocyclised product in the presence of
only the cyclodehydratase activity.
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Attempts at expressing the BalhB protein from Bacillus sp. Al-Hakam only led to in-
active forms of the protein, probably due to a lack of the required FMN cofactor. To
circumvent this issue, the highly similar BcerB from B. cereus 172560W was expressed
and it was capable of substituting for the BalhB protein in oxidising the BalhA hetero-
cyclised peptides (Melby et al., 2012). To further support the validity of assembling this
cross-species system, assays were performed using a dehydrogenase from an actinobacterial
species and even in this cross-phylum hybrid system, the results obtained were equivalent
(Melby et al., 2014).
A conserved Lys-Tyr motif located near the FMN cofactor was identified by alignment
of dehydrogenase sequences to a nitroreductase with a known structure and mutants were
generated to prove its catalytic importance (Melby et al., 2014). BcerB and homologues
from E. coli and the archaeon Sulfolobus acidocaldarius all lost catalytic activity when both
residues in the motif were mutated. However, the BcerB double mutant was still able to
interact with BalhC and BalhD, further supporting the catalytic importance of these two
residues for dehydrogenase activity (Melby et al., 2014).
1.4 Computational tools for protein characterisation and en-
gineering
Despite the recent advances in the characterisation of the TOMM biosynthetic enzymes, lit-
tle is still known about mechanistic aspects of enzyme function and this knowledge would be
of great use in engineering TOMM production. There are a variety of computational tools
to predict functional sites within protein sequences, which can then be experimentally val-
idated and later used in e↵orts to improve the enzymes themselves. The choice of methods
to be employed in the engineering of any specific system depends on the depth of knowl-
edge that is already available, especially structural and mechanistic information. Here, a
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functional residue will be defined as any residue that, when mutated, has an impact on a
known function of a protein, including catalytic activity, substrate recognition, allosteric
e↵ects, conformational changes, protein-protein interactions and structural integrity.
1.4.1 Structure-based methods
Structural data, including structures of enzyme-substrate and enzyme-inhibitor complexes,
is a valuable source of information to guide protein engineering e↵orts. For systems in
which such data is available, a diverse array of tools can be used to infer residues involved
in catalysis, substrate recognition and overall protein stability.
Methods based on predicting the e↵ect of mutations on known structures are especially
relevant for reducing the experimental e↵ort in the engineering of existing proteins. Among
the strategies developed for this goal are approaches that extract rules from sets of known
mutation e↵ects (Sunyaev et al., 2001; Hurst et al., 2009), calculate the energetic impact of
given mutations and search through conformation space to determine the overall impact on
a protein (Lilien et al., 2005; Schymkowitz et al., 2005), and also approaches that integrate
multiple sources of information to improve prediction accuracy (Karchin et al., 2005). These
tools have many applications, including the engineering of protein active sites to create
a nity towards non-cognate substrates (Chen et al., 2009a) and predicting the e↵ect of a
mutation on the stability of a protein (Guerois et al., 2002).
Beyond the e↵ects of single mutations, molecular dynamics can be used to simulate
interactions of every atom in a protein to provide insights into its functional mechanisms
Kiss et al. (2013). However, the computational complexity involved in these simulations
often requires the use of powerful clusters to produce simulations at timescales relevant for
biological processes (Hospital et al., 2015) and ab initio predictions of protein folding are
so far only possible for short proteins (Dill and MacCallum, 2012).
Alternative strategies have been developed to circumvent the need to calculate all in-
teractions in a protein by employing knowledge from known protein structures to predict
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structure and function, such as the Rosetta package (Kaufmann et al., 2010). This tool has
been successfully used for de novo design of synthetic proteins with desired structures (Lin
et al., 2015) and even novel enzymatic activities that do not exist in any natural enzyme
(Siegel et al., 2010).
Computational tools also exist to evaluate the ability of small molecules to interact with
proteins by docking (Morris et al., 2009). This strategy enables the detection of binding
pockets for small molecules (Fukunishi and Nakamura, 2011; Heo et al., 2014), information
which can be used to predict the binding site of a protein that could not be crystallised
in complex with a known ligand (Singh et al., 2011). In addition, these tools also enable
the design of novel inhibitors for proteins of clinical relevance, by in silico screening of
candidates and selecting for the strongest interactions (Velmurugan et al., 2014; Singh
et al., 2016).
Methods such as the ones cited above can produce accurate predictions and, therefore,
require a relatively small experimental validation e↵ort to obtain the desired characteri-
sation or engineering results (Bommarius et al., 2011). However, as mentioned, they can
also require extensive structural and mechanistic information that is not available for many
proteins. Of the known TOMM synthases, no structure has yet been determined of an
enzyme in complex with its substrate or a substrate analog. The closest equivalent to this
is the YcaO domain of unknown function, which is homologous to the cyclodehydratase
proteins, and has been crystallised in complex with AMP and an ATP analog (Dunbar
et al., 2014). This complex is of limited value for engineering of a cyclodehydratase, since
there is no information regarding the binding site for the heterocyclised substrate or the
native activity of the YcaO domain.
1.4.2 Sequence-based methods
For systems with not enough structural information to employ the strategies mentioned
in Section 1.4.1, purely sequence-based methods can be an alternative to obtain candidate
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functional residues for characterisation and later engineering (Bommarius et al., 2011).
These methods invariably require the construction of multiple sequence alignments (MSAs)
containing the sequence of interest and a diverse set of homologous sequences. The con-
stantly expanding genomic (Benson et al., 2013) and metagenomic (Mitchell et al., 2016)
sequence databases are an invaluable resource in the construction of these alignments, as
they cover a much greater portion of the tree of life than could be achieved a decade ago,
before the availability of Next-Generation Sequencing technologies (NGS) (Metzker, 2010).
Extant functional proteins that share a common ancestor sequence represent a subset
of the possible sequence space that has been explored over evolutionary time starting from
the ancestral sequence. Any highly deleterious variant that arose would be eliminated
by the process of natural selection and functional variants would be maintained, to be
sampled in the genomes of living organisms. Homologous proteins with a common function
are also likely to have closely-related structures and are classified in families (Mulder and
Apweiler, 2002). Once the a sequence dataset is constructed for a chosen family, two main
evolutionary signals — yielding complementary information about the sequence-function
relationship in the family — can be extracted from MSAs using metrics: conservation (or
its opposite, diversity) and coevolution of columns (Fig. 1.6).
1.4.2.1 Conservation detection metrics
The first aspect that can be investigated through large MSAs is the overall conservation of
each column in the alignment (See Fig. 1.6 for an example of a conserved MSA column),
which can be valuable in identifying residues that have been evolutionarily constrained by
purifying selection, due to a required function for that residue in the function shared by
the family (Echave et al., 2016). Conserved residues have been shown to play important
roles in catalytic activity, protein-protein interfaces and directing the correct folding of
proteins (Bharatham et al., 2011). A variety of di↵erent strategies have been proposed to
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Figure 1.6: Evolutionary signals that can be detected in an MSA - Two homologous
subfamilies are depicted, with a conserved column highlighted in dark green and a col-
umn showing signs of coevolution highlighted in orange. The column highlighted in light
green for subfamily A represents a determinant residue for this subfamily, with no signs of
conservation in subfamily B.
detect evolutionary conservation of an MSA column, calculating scores based on compar-
isons between the physicochemical characteristics of the residues, the use of metrics from
information theory to estimate the degree of variability, or reconstruction of the evolution-
ary history of the family to infer evolutionary rates as a measure of conservation (Valdar
and Thornton, 2001; Valdar, 2002).
When sequencing technologies started to become accessible and sequence databases large
enough to construct alignments of homologous protein sequences appeared, comparisons
based on physicochemical characteristics of amino acids were an early attempt to highlight
column conservation (Valdar, 2002). One such strategy was based on Venn Diagrams
showing the relations between several properties — among them, side chain size, polarity,
charge, and aromaticity — and visual highlighting in MSAs or textual descriptions of
the conservation within a column based on the shared characteristics identified for the
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observed residues (Taylor, 1986). Another method produced a numerical descriptor for
conservation calculated from the number of shared physicochemical characteristics in a
column, arbitrarily assigning an equal weight to every di↵erence or similarity (Livingstone
and Barton, 1993). However, the subjective nature of the textual descriptions and the
arbitrary nature of the quantification led to the development and more widespread adoption
of computational metrics that take into account evolutionary processes that can be inferred
from alignments and, ultimately, are more e cient at detecting conserved residues (Capra
and Singh, 2007).
The simplest procedures to incorporate evolutionary processes into MSA conservation
measures are based on comparisons of residue frequency distributions in MSA columns to
“background” distributions, which are representative of the frequency of all amino acids
in sites not under selection pressure. These distributions are computed from substitutions
matrices used in sequence alignment, such as BLOSUM62, that encode the probability of
mutations from any residue to all other residues (Heniko↵ and Heniko↵, 1992). Metrics
based on information theory can then be used to quantify the degree of conservation within
a column by measuring the divergence between the observed residue distributions in the
MSA columns to the background distribution — a high divergence from a background
distribution indicates a high degree of conservation. Among these are Relative Entropy
(Wang and Samudrala, 2006) and Jensen-Shannon Divergence (JSD) (Capra and Singh,
2007). Capra and Singh (2007) compared the performance of these two metrics along with
others and found that JSD robustly detected known conserved residues from benchmark
MSAs.
Since the background distributions used for the information theory-based were computed
from a large set of proteins, they will not necessarily be an accurate representation of the
frequency distributions found in neutral sites of a specific protein family. For instance,
transmembrane regions of proteins are known to contain higher frequencies of hydrophobic
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residues than cytosolic regions of the same proteins, due to the di↵erent environments to
which these regions are exposed (Bordner, 2009). Therefore, methods were developed to
quantify conservation by comparison to column evolutionary rates calculated for the MSA,
such as Rate4Sites (Pupko et al., 2002) and ConSurf (Ashkenazy et al., 2016). However,
construction of phylogenetic trees for the calculation of these evolutionary rates can be
computationally di cult for large sequence sets and the computationally-simple JSD metric
was shown to perform similarly to Rate4Site by Capra and Singh (2007).
In diverse protein families composed of two (or more) subfamilies that have diverged in
function, residues that are required for the function of one group but not for the remain-
ing ones can be referred to as determinant residues (Bharatham et al., 2011) and are only
expected to be conserved in the first group (See Fig. 1.6 for an example of a determinant
residues within an MSA). These can also be referred to as Specificity-Determining Posi-
tions and methods such as SDPPred have been proposed for their detection, by identifying
conserved columns that are conserved within one functional group and divergent between
groups (Kalinina et al., 2004). Since this predictor requires an MSA with an explicit sub-
division between functional groups, its applicability is limited to families with su cient
annotation for the confident assignment of sequences to each group.
1.4.2.2 Coevolution detection metrics
The other evolutionary pattern that is commonly detected through MSA analysis is co-
evolution (See Fig. 1.6 for an example of a pair of coevolving MSA columns), yielding
information that is complementary to what is obtained from conservation measures. By
locating columns in the MSA that present covariation with one or more other positions, it
is possible to detect residues that are free to vary but only when there are compensatory
mutations at other positions in the sequence. Algorithms to detect coevolution perform
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pairwise comparisons of amino acid frequencies at columns and measure how the composi-
tion of one column influences the distribution of frequencies of the second column (de Juan
et al., 2013). These comparisons can reveal global networks of interactions, direct or me-
diated through intervening residues (de Juan et al., 2013). Coevolutionary interactions
often correspond to physical proximity between residues — indicating a shared function for
coevolving residues, such as maintaining structural interactions or shaping the active site
for diverse substrates within a family — but coevolutionary interactions between physically
distant residues can also be involved in allosteric e↵ects (Lockless and Ranganathan, 1999;
Su¨el et al., 2003).
As was described for conservation measurements, metrics from information theory —
have been employed for the detection of networks of coevolving pairs in MSAs, successfully
predicting the position of catalytic sites (Marino Buslje et al., 2010). An alternative strat-
egy, based on modelling the exploration of sequence space during protein evolution as a
particle in statistical mechanics — named Statistical Coupling Analysis — has been shown
to detect indirect interactions between residues, coinciding with know allosteric interactions
in proteins (Lockless and Ranganathan, 1999; Su¨el et al., 2003).
Alternatively, methods have been devised to reduce the influence of indirect interactions
on the covariation signal, with the aim of predicting physical interactions between residues.
Direct Coupling Analysis (DCA) measures correlations between all possible residue pairs
to measure the fraction of MI that is produced by physically-interacting residues and can
predict protein-protein interactions (Weigt et al., 2009), as well as direct contacts within a
single protein (Morcos et al., 2011). Further improvements to direct contact detection were
achieved by a procedure named MetaPSICOV, which combines DCA with other coevolution
calculations along with other alignment metrics and secondary structure prediction into a
neural network, generating more accurate contact predictions than any of the metrics in
isolation (Jones et al., 2015)
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1.5 Directed Evolution for the engineering of proteins and
other biological systems
Traditionally, two routes were recognised as viable paths for the engineering of biological
systems towards phenotypes of interest: rational design — in which multiple sources of
knowledge (biochemical annotation, structural information, computational predictions) are
combined to generate mutations of predictable e↵ect — and directed evolution — in which
superior phenotypes are screened or selected from a diverse pool (Nixon and Firestine, 2000;
Chen, 2001). However, these two extreme views are oversimplifications and neither pure
option is the ideal strategy for engineering most biological systems (Lutz, 2010).
For well-characterised systems, with known functional mechanisms and structural infor-
mation to guide design, the prediction and design strategies described in Section 1.4.1 have
been successfully applied to produce the desired phenotypes (Siegel et al., 2010; Lin et al.,
2015). However, for any system without extensive characterisation, the available prediction
strategies can only direct attention towards regions of sequences likely to be involved in
function, requiring further experimental data to enable precise prediction of the functional
impact of mutations or the use of directed evolution approaches to reduce the number of
variants to be tested.
Directed evolution is a widely-adopted strategy for the engineering of biological systems
that is analogous to natural selection because they share the same pre-requisites: a heritable
phenotype, genetic diversity encoding diversity in the phenotype, and a process that biases
the chance of a genotype being present as a function of the encoded phenotype (Lane and
Seelig, 2014; Packer and Liu, 2015; Tizei et al., 2016). The phenotype can be a single
macromolecule such as a protein encoded by DNA, a functional nucleic acid that can be
both phenotype and genotype, a metabolic pathway encoded by a set of genes, or even
an entire cell encoded by its genome. Genetic diversity can be generated experimentally
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or arise spontaneously as a result of cell division, with the population of variants used in
an experiment being called a library. The final element is any mechanism that can ensure
an uneven partitioning of the diversity present in the population, such that the desired
phenotype is enriched relative to the bulk of the population.
In natural selection, the partitioning mechanism is di↵erential survival and reproduction
of the organisms which posses the phenotypes most adapted to their environment. The
o↵spring will carry the genotype which encodes the selected phenotype, propagating it
into the next generation. In directed evolution, partitioning strategies must be designed
with a connection between the desired phenotype and the genotype which encoded it — a
genotype-phenotype linkage — to ensure recovery of the genotype for subsequent cycles of
evolution (Tizei et al., 2016; Leemhuis et al., 2005). The nature of these mechanisms can
vary greatly depending on the phenotype being selected and will be covered in Section 1.5.2.
In order for a phenotype to be carried forward in a round of directed evolution, it must
be present in the diversity pool at the start of the cycle and this requirement creates an
upper limit on the size of library which can be used. Biological sequence space — for
nucleic acids and proteins alike — is vastly larger than what can be covered in any feasible
experiment. For a relatively small protein with 200 residues in its sequence, the number
of possible combinations of all 20 amino acids is 20200, which vastly dwarfs the estimated
number of atoms in the observable universe — around 1080. This means that it is physically
impossible to produce every single possible variant of such a target molecule, let alone select
a library of that size. Therefore, diversity generation strategies for directed evolution must
restrict their exploration of sequence space to reduce the experimental e↵ort in selection
and increase the likelihood that the desired phenotype can be isolated.
The simplest solution to this problem is to reduce the sequence length until all possible
variations of the sequence can be completely covered by existing selection strategies, which
range from roughly 108 for in vivo methods (Tee and Wong, 2013) up to 1014 for in vitro
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selection (Hoinka et al., 2015a). This can be done for nucleic acid aptamer selections,
since a fully-randomised stretch of 20 nucleotides — with about 1012 (420) possible variants
— can be covered by SELEX starting from 1 nmol (>1014 molecules) of a commercially-
synthesised pool of oligonucleotides containing 20 N incorporations. However, not all the
desired functions for aptamers can be produced by such short sequences and this restriction
is even more severe for proteins with their alphabet consisting of the 20 proteinogenic
amino acids — a sequence of 12 residues already has over 1015 possible variants, while
the shortest known functional domains are at least 30 residues long (Jones et al., 1998).
Since exhaustive searches of sequence space are impossible for most phenotypes of interest,
rational approaches are frequently employed to restrict diversity to shorter regions within
a larger sequence, reducing the number of possible variants, and increasing the probability
of obtaining the desired phenotype.
In most cases, one or more known natural molecules already possessing the desired
function to some degree are already known and can be used as starting points to restrict the
search space for a directed evolution experiment (Arnold, 1998; Crameri et al., 1998). This
approach has permitted the isolation of highly active enzymes starting from promiscuous
natural enzymes with poor activity on the desired substrate (Aharoni et al., 2005) and
recently led to the engineering of the first known protein able to catalyse the formation
of a carbon-silicon bond (Kan et al., 2016a). Some of the computations tools mentioned
in Section 1.4 have achieved a degree of success in designing entirely novel proteins with
desired activities (Siegel et al., 2010), but the use of natural proteins as starting points in
directed evolution experiments is still by far the most common approach.
The field of Synthetic Biology often uses a cycle comprised of Design-Build-Test-Learn
steps to illustrate the process of engineering biological systems, which can be seen as anal-
ogous to the processes involved in carrying out directed evolution and will be used to guide
the explanation of these processes here (Fig. 1.7) (Baldwin et al., 2015; Tizei et al., 2016).
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“Design” encompasses the decisions made in targeting diversity in the genotype, with the
aim of producing a library containing the desired phenotype. “Build” represents the experi-
mental procedures to generate the library. “Test” is the partitioning step, in which variants
are screened or selected to enrich for the phenotype of interest. Finally, the enriched pop-
ulation is analysed in the “Learn” phase to identify successful variants and direct further
rounds of evolution. The description will start with the Build phase, which will be given
additional emphasis due to development of a library assembly strategy for engineering of
synthetic TOMM products.
Figure 1.7: Steps involved in a round of directed evolution compared to the synthetic
biology cycle for engineering biological systems.
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1.5.1 Build: Diversity generation for directed evolution
As described above, a pool of variants is an integral part of directed evolution but the vast
size of biological sequence space is an impediment to the complete exploration of possible
sequences for most relevant targets. This conflict is resolved by employing strategies to
target diversity towards subsets of the possible sequence space for a given target. Such
approaches are possible due to great heterogeneity that can be observed when comparing
the e↵ects of mutations throughout a sequence. Not all possible mutations to a given
biological sequence will have a positive impact on the phenotype of interest. In fact, most
mutations to a given sequence are expected to have a deleterious or at least neutral e↵ect
on any given phenotype and only a small fraction are expected to contribute positively
(Ohta, 1992). Prior knowledge about the relation between genotype and phenotype in the
system of interest can be of great use in targeting relevant sites and, therefore, reducing the
size of the search space. This knowledge can come from a variety of di↵erent sources such
as structures, phylogeny (using methods such as the functional predictions in Section 1.4),
functional annotation, biochemical characterisation coupled to site-directed mutagenesis,
and results from previous engineering e↵orts for similar phenotypes.
If the available knowledge about the targeted system cannot yield any relevant insight
into the genotypic contributions to the phenotype — or if the goal is to obtain more infor-
mation about the system to then inform future targeted rounds of diversification — “blind”
exploration of the sequence space can be employed. In this strategy, diversity is introduced
without any intentional bias at any point of the chosen sequence, submitted to selection,
and any positive variants obtained are carried on to further rounds of diversification and
selection. Mutations that produced positive phenotypes in separate clones can be combined
in a single variant, which would be expected to produce a superior phenotype if the e↵ects
of all the mutations are additive. However, this is frequently not the case and many sites
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will have epistatic interactions with other regions, producing greater and smaller e↵ects
than would be expected by simple addition of the e↵ects of the single mutations.
The strategies outlined above represent extreme cases of available knowledge about the
target system, with either enough information to direct mutations to a small set of specific
functional residues or a complete lack of useful information that forces experimenters to
apply untargeted diversification methods to the entire sequence. However, real directed
evolution e↵orts tend to fall somewhere in between the two extremes. Even for relatively
uncharacterised systems, there often is enough public information available to direct di-
versification to only a region of the whole sequence representing a functional domain or
to predict a repertoire of candidate mutants that can be validated by selection. In the
cases where these approaches do not yield reliable candidates, the results of a first round of
untargeted diversification followed by selection can be used to focus deeper exploration of
the sequence space on the regions around the positive hits. Whichever higher-level strategy
is selected for introducing diversity into a directed evolution experiment, the repertoire of
methods used for physically producing the desired variants is, in itself, extremely diverse
and constantly being supplemented with novel techniques.
1.5.1.1 Overview of commonly-used diversity generation methods
The techniques which can be employed to produce the sequence diversity vary greatly in
terms of experimental complexity, cost, range of selection platforms to which they can be
adapted, and the degree of control over the exploration of sequence space. The choice of
a method (or combination or methods) for the directed evolution of a system depends on
the time and resources available for the project, the size of the sequence that is targeted,
and the complexity of the desired phenotype.
The simplest way to obtain diversity for selection is by exploiting the variation that
naturally arises as cells divide and — with varying degrees of fidelity — replicate their
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DNA, accumulating mutations throughout the genome. This requires no input other than
cells that express the phenotype to be engineered and means for the population to expand,
such as sequential batch cultures or continuous growth in bacteriostats. In these conditions,
mutations should be fairly spread over the entire genome, which makes this method suitable
for engineering complex multi-factorial phenotypes which are not completely understood.
This approach is referred to as “Evolutionary Engineering” when used to produce microbial
strains with phenotypes such as resistance to challenging environmental conditions — such
as oxidative stress (Cakar et al., 2005), freezing (Teunissen et al., 2002), solvent tolerance
(Stanley et al., 2010) — and more e cient metabolism of novel substrates for growth
and production of useful metabolites (e.g. sugars derived from hydrolysis of lignocellulosic
biomass (Wisselink et al., 2007; Lee et al., 2016)).
Furthermore, the natural mutation rate can be increased by certain environmental con-
ditions — UV (Fiedurek and Gromada, 1997) and chemical mutagens (Sandana Mala et al.,
2001) — or by introducing mechanisms to increase the error rate of DNA replication —
such as deleting DNA repair mechanisms (Muteeb and Sen, 2010). However, these ex-
ogenous factors to increase mutation rate must be carefully controlled, both to prevent
collapse of the population due to accumulation of multiple deleterious mutations (Trindade
et al., 2010) and due to the potential personal hazards involved in growing microbes under
mutagenic conditions.
Populations of model organisms such as the bacterium E. coli and the yeast Saccha-
romyces cerevisiae generate point mutations at relatively low rates in standard culture
conditions without any external mutagens, approximately 1.8  2.4⇥ 10 9 per bp per cell
division in E. coli (Lee et al., 2012) and 3.3⇥ 10 9 per bp per cell division in yeast (Lynch
et al., 2008). This makes in vivo directed evolution ine↵ective for engineering single pro-
teins or phenotypes encoded by a small set of genes, since the vast majority of mutations
would not be in functionally-relevant regions. This would require large culture volumes to
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increase the likelihood of obtaining enough mutations in the targeted regions and could
still be susceptible to noisy selection results due to the relatively large number of o↵-target
mutations that could generate unpredictable selection parasites. Therefore, more targeted
approaches are often employed when the phenotype is encoded by regions much smaller
than a whole microbial genome.
Much as the in vivo DNA replication machinery can be forced to increase its error rate,
the DNA polymerases routinely used in PCR amplification can be made to have lower
fidelity for diversity generation in the process known as error-prone PCR (epPCR). This
is most easily done by spiking reaction bu↵ers with Mn2+, with increasing concentrations
of this ion producing greater error rates which can be tuned in the range of 1-5 mutations
per kb (Cirino et al. (2003) roughly, 106-fold higher mutation rate than obtained in vivo).
However, there is a detectable bias towards A/T to G/C in the mutations generated by
epPCR (Cirino et al., 2003) and the single base-pair mutations produced restrict the range
of accessible amino acids in each site of a protein, since a single point mutation in any
codon cannot produce codons for the other 19 amino acids. The mutational bias can be
reduced using modified nucleotides (Tee and Wong, 2013) or commercial kits which claim to
generate even distributions of mutations (i.e. GeneMorph II from Agilent), but the codon
accessibility is an intrinsic limitation of epPCR and any other technique which produces
only point mutations. Libraries produced by epPCR can also su↵er from amplification
bias, when some sequences become over-represented in the final library due to di↵erential
amplification e ciency caused by variations in GC content or secondary structure (Polz and
Cavanaugh, 1998), or due to the stochastic nature of PCR leading to over-representation
of sequences that were amplified in the initial PCR cycles (Kebschull and Zador, 2015).
These e↵ects can be mitigated by ensuring that the number of initial template molecules
is greater than the final number of variants which will be present in the library used in the
selection or screening processes (Firth and Patrick, 2005).
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In vitro processes can also emulate the role of sexual reproduction in directed evolution,
by allowing recombination between variants within a library. The process of DNA shu✏ing,
developed by Stemmer (1994), consists of a DNA fragmentation step and reassembly by
a DNA polymerase extending cross-primed fragments. This versatile technique quickly
became widely adopted for its use in recombining mutations present in multiple variants
obtained in rounds of selection and also for exploiting natural diversity in homologous
natural sequences as starting points for directed evolution (Arnold, 1998; Crameri et al.,
1998; Aharoni et al., 2005).
PCR can also be exploited to produce targeted mutations by carrying out amplifications
with primers containing single mutations or degenerate oligos synthesised with defined mix-
tures of nucleotides at chosen positions, known as site-directed mutagenesis (Carrigan et al.,
2011) (SDM). This strategy avoids the biases and single base-pair mutation disadvantages
of epPCR by explicitly picking which mutations will be targeted in a library, which can be
in a size range one to tens of base pairs, depending on oligo synthesis limitations, cloning
strategy, and the size of the non-mutated priming region that is needed. Commercial syn-
thesis of oligos containing degeneracies can also be exploited to allow multiple possible
mutations at one site to be encoded by a single oligo. A fully degenerate codon (NNN) can
encode all 20 proteinogenic amino acids in 64 combinations with three of those being stop
codons (4.7% of the possible codons), but NNS or NNK (where S = C or G and K = G
or T) also cover the full codon repertoire and only one possible stop codon (UAG, 3.1% of
the possible codons), so the latter are more frequently used. However, the approximately
equimolar amounts of each base incorporated at each degeneracy mean that amino acids
encoded by multiple codons will be over-represented, so strategies such as “Small Intel-
ligent” libraries have been developed to ensure more uniform sampling without requiring
a full set of 20 oligos to produce an unbiased randomised site in a protein (Tang et al.,
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2012). Other degeneracy options can be made if the library design does not require full
randomisation at a specific site, reducing library size and selection e↵ort.
While PCR-based SDM allows a great deal of control over the sequence that is integrated
at each site, traditional methods are limited in only being able to target a single small region
of a gene at a time. If another region of a gene needs to be targeted or if a single target
is larger than the maximum practical size for an oligo, multiple rounds of SDM need to
be carried out sequentially, which can become very labour-intensive and time-consuming.
Alternative methods have been developed to multiplex the SDM process, with varying
degrees of e ciency and experimental (Seyfang and Jin, 2004; Tian et al., 2010).
With recent developments in oligo synthesis technologies, companies have started to
o↵er custom synthesis of gene libraries. These services allow diversity to be targeted to any
position within a gene and fully specified according to the desired library design. While
this option can produce high-quality libraries with minimal sequence redundancy and zero
experimental e↵ort, their costs are frequently too high for routine use in most academic
laboratories.
Advances in in vivo genome manipulation from the past decade have also proved use-
ful in library generation, by allowing diversity to be targeted to specific genomic regions.
Multiplex Automated Genome Engineering (MAGE) adapts a phage-derived recombinase
to replace genomic sequences in E. coli with homologous single-stranded oligos containing
the desired mutations (Wang et al., 2009). The endlessly-versatile CRISPR-Cas9 is another
system that has been adapted to produce targeted point mutations by fusing a catalyti-
cally inactive form of the enzyme (dCas9) to the cytidine deaminase enzyme responsible for
somatic hypermutation in antibody-producing cells, resulting in a fusion protein that pro-
duces point mutations around a region of interest that is targeted by single-stranded RNA
(Hess et al., 2016). Using techniques such as these, it is possible to conduct directed evolu-
tion rounds fully in vivo, with no intermediate cloning steps and a greatly reduced library
55
Chapter 1. Introduction
size when compared to spontaneously-occurring mutations, reducing overall experimental
complexity.
Most uses of these technologies have one crucial characteristic in common, which is
that the libraries produced by them are designed to contain only compositional variation
or substitutions in sequences all having the same length. The term homometric library
is proposed to represent these libraries, in contrast to heterometric libraries in which se-
quences di↵er in length and may or may not also contain compositional variation. There
are two main reasons why substitutions are favoured over insertions and deletions (indels)
for directed evolution: the methods needed to explore variation simultaneously in length
and composition in the laboratory are not as versatile as the ones described above and
indels have a greater chance of being deleterious, on average, than substitutions. However,
by not considering length variations in library design, most protein engineering e↵orts are
implicitly stating that the main chain length of the starting protein is the optimal one
for the function of interest. In fact, for most cases there is no evidence to support this
assumption and there are published examples where the opposite is true — i.e. a length
variation is essential for a new or altered function.
1.5.1.2 Length diversity in natural and laboratory evolution
Indels are a very broad class of mutations, in both size and potential phenotypic e↵ect.
At the smallest end of the scale, single base-pair indels can be e↵ectively neutral when
occurring in repetitive intergenic regions with no detectable function, but they can also be
highly deleterious in protein-coding regions by causing frameshifts. This is reflected in the
lower frequency of indels compared to substitutions when comparing pairs of genomes of
closely-related species across widely divergent groups such as primates and bacteria (Khan
et al., 2015; Chen et al., 2009b). The ratio between substitutions and indels (S/I) also
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varies widely according to genomic region, being generally higher in protein coding regions
(Khan et al., 2015; Chen et al., 2009b).
However, as the size of indels in protein coding regions increases, multiple-of-3 bp lengths
have a greater likelihood of being selectively neutral or even positive, since they become
indels of one or more whole codons that maintain reading frames. The e↵ect of multiple-
of-3 bp indels is still widely variable, because changes in the backbone of crucial secondary
structure elements can disrupt multiple interactions, while indels within a structurally-
flexible loop tend to be more tolerated and can contribute to function. These di↵erences
can also be observed in genome evolution, by comparing the frequency of full-codon length
indels in sequences coding for functional protein domains to the indels of the same size
in regions of DNA that code for non-regular structural parts of proteins, the latter being
measurably higher due to the higher likelihood of such indels being selectively neutral or
even positive (Khan et al., 2015). At even larger scales of whole protein domains or genes,
this class of mutation represents an important source of novel material for selection to act
upon, creating combinations of elements that did not exist before, generating redundant
copies of elements that loosen purifying selection pressure upon one of the copies or even
introducing new sets of genes into a species by horizontal gene transfer (Borneman et al.,
2011).
Comparative sequence analysis can also yield insights into how indels in genetic se-
quences correspond to phenotypic di↵erences. The phosphotriesterase (PTE) enzyme,
which is thought to have evolved recently to degrade the organophosphate insecticide
paraoxon, is a clear example of this. The sequence of PTE is homologous to the bacterial
quorum sensing-related enzyme family called PTE-Like Lactonases (PLL) — so named for
their initial description as proteins related to PTE, only later having their function char-
acterized — and their main di↵erence lies in a longer active-site loop in the structure of
PTE (Afriat et al., 2006). Each family has strong activity on its own preferred substrate
57
Chapter 1. Introduction
and very low residual activity on the substrate of the other family. However, deletion of
the longer loop in PTE, followed by a single point mutation, produced a variant that is
active on both substrates — an apparent intermediate in the evolution of PTE from PLL
(Afriat-Jurnou et al., 2012).
Comparative genome studies can reconstruct evolutionary events that took place since
the divergence of the species or strains under study, which generally takes place in time
scales much longer than what can be recreated in a laboratory. However, relatively short
laboratory evolution experiments with fast-growing microbes have also produced evidence
to support the importance of indels in the evolution of novel phenotypes. One notable
example is the Long Term Evolution Experiment by Richard Lenski’s group that obtained
E. coli strains capable of metabolising citrate after nearly 20 years ( 50,000 generations) of
continuous growth. Genome sequencing of the adapted strains detected indels at frequencies
greater than 10% that of point mutations (Tenaillon et al., 2016). Moreover, experiments
conducted in much shorter timescales also corroborate this observation. Selection of pop-
ulations of E. coli and Pseudomonas under carbon source or antibiotic selection produced
the desired phenotypes in experiments ranging from 8 to 44 days and all selected strains
were shown to have indels in their genomes, ranging in size from a few codons to amplifi-
cations of whole genes (Toprak et al., 2011; Wong et al., 2012; Herring et al., 2006). These
examples of indels obtained under laboratory conditions were the result of spontaneous in
vivo mutations with no deliberate interference in the natural mutation rates of the organ-
isms. However, there are methods developed to intentionally produce diversity containing
length variations and these have been successfully deployed to engineer function.
1.5.1.3 Experimental strategies to produce heterometric libraries
Though not as broad as the repertoire of techniques available for producing homometric
libraries, a range of methods from the toolset of molecular biology have been adapted to
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produce heterometric diversity. These tools can produce indels in diverse scales and with
varying degrees of control over the composition of the output sequence, also di↵ering in
terms of experimental complexity and cost. Another important limitation that must be
addressed when engineering protein coding sequences is that most indels in protein coding
sequences of sizes that are not multiples of three will produce deleterious frameshifts, so
methods that can restrict indels to these multiples are inherently more e cient.
As was mentioned for compositional variation earlier, commercial synthesis of libraries
represents the least labour-intensive path to obtain length diversity, but comes at a cost
that makes it inaccessible to many academic projects. These synthetic libraries can be
produced by high-throughput oligonucleotide synthesis in arrays such as the ones sold by
Twist Biosciences or generated by combinatorial assembly of a smaller number of oligonu-
cleotides using restriction endonucleases and ligases (Ashraf et al., 2013; Van den Brulle
et al., 2008). Synthetic libraries allow the desired diversity to be fully specified and reduce
the occurrence of redundant sequences, consequently also reducing the experimental e↵ort
needed for screening or selection of positive clones (Osuna et al., 2004).
Adaptations to chemical synthesis methods have been made to create libraries of se-
quences with their length as a distribution of values rather than a single length per synthe-
sis. One such method, COBARDE, is based on synthesizing trinucleotide building blocks
with orthogonal protecting groups that are added to only part of the population after each
cycle and then reset, leading to failed incorporations in some cycles for a fraction of the pop-
ulation that produce a distribution of di↵erent lengths at the end of the synthesis (Osuna
et al., 2004). Changes in reaction conditions can be exploited to tailor the length distribu-
tion of the final products. However, this synthetic strategy requires specialized equipment
and organic synthesis expertise that is beyond the reach of many academic oligonucleotide
synthesis facilities.
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Library synthesis requires a degree of information about the targeted system to inform
the diversification strategy and reduce the search space. This limitation becomes more
relevant when length diversity is included, since each amino acid indel in a position creates
a new set of possible variants for the targeted region that contains 20n-1 or 20n+1 new
variants, which quickly grows to intractable numbers as the numbers of indels or positions is
increased. Therefore, untargeted methods can be employed to probe the tolerance to indels
of an entire protein coding sequence and direct deeper diversification by other methods.
Randomized Tandem Repeat Insertions (TRINS) (Kipnis et al., 2012) produces short
duplications in coding sequences by fragmenting a template DNA into smaller fragments,
followed by circular ligation of single-stranded fragments and a mixture of PCR and rolling-
circle amplification, which produces double-stranded variants of the original sequences con-
taining short tandem repeats. This method was validated by producing a library of TEM-1
b-lactamase variants and selecting for activity on the non-cognate substrate ceftazidime
(Kipnis et al., 2012). These duplications can be of any length, so it is expected that
two-thirds of them will be function-disrupting frameshifts.
The occurrence of frameshifts can be avoided by strategies that only produce fixed-
length indels, such as in vitro transposons that insert randomly into target DNA and delete
exactly 3 bp when excised by a restriction endonuclease (Jones, 2005). This produces either
a deletion of a single codon — when the excision event removes an entire codon — or a
deletion and a substitution — when the excision event removes part of two adjacent codons
and a new codon is formed by joining the remainders of the original codons. This strategy
has been used to isolate a GFP variant with faster folding kinetics, containing a deletion
in an N-terminal a-helix (Arpino et al., 2014).
The strategies described until now have focused on the ones that produce indels at scales
that are useful for protein engineering, since this was the focus of this work. However, the
development of robust genome engineering techniques in the past decade has also produced
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methods that can generate large indels for the in vivo engineering of complex phenotypes.
At the moment, CRISPR-Cas9 (Jinek et al., 2012; Chu et al., 2015) is the most used
system for producing targeted indels, but other targeted nucleases such as Zinc Finger
Nucleases (Bibikova et al., 2003) (ZFNs) and Transcriptional Activator-Like E↵ector Nu-
cleases (Christian et al., 2010) (TALENs) can also perform the same functions. Insertions
are produced by creating a double-stranded break (DSB) at a specific genomic location
and introducing the desired DNA fragment containing ends which are complementary to
the regions surrounding the DSB, leading to its repair by homology directed repair (HDR).
Deletions can be generated by creating a pair of DSBs surrounding the targeted region,
which can be repaired by non-homologous end-joining (NHEJ)(Su et al., 2016) or by HDR
if a deletion cassette is provided with complementarity to both ends.
1.5.2 Test: Selection and screening strategies for directed evolution
As mentioned earlier, directed evolution requires a partitioning process by which diverse
variants within a population are compared and the ones harbouring the desired phenotype
can be isolated. A wide range of partitioning frameworks have been developed for directed
evolution, but they can be broadly divided into two categories: screening and selection
methods (Lane and Seelig, 2014; Packer and Liu, 2015). In screening, properties of each
variant in the library are individually quantified and these measurements are used by exper-
imenters to decide which variants will be subjected to further characterisation or be used as
templates in a subsequent round of diversification (Packer and Liu, 2015). Conversely, se-
lection methods probe the entire population in parallel by a physical separation mechanism
or di↵erential survival of cells carrying the phenotype of interest and experimenters do not
have direct control over the individual variants that are carried to the next round (Packer
and Liu, 2015). In vivo selection processes in directed evolution can also be seen as anal-
ogous to the complementation experiments used in genetics for discovery of gene function
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and some authors adopt the term “complementation” to refer to the partitioning of desired
variants in directed evolution (Baker et al., 2002), but the more common “Selection” will
be used here for clarity.
Screening and selection processes each have distinct advantages and disadvantages. Since
variants are probed individually in a screen, the observed phenotype can be directly con-
nected to its encoding genotype, which is impossible in a bulk selection experiment in which
all genotypes are pooled for sequencing at the end of a round. Conversely, the bulk nature
of selection processes allows for a much higher throughput per round than is achievable in
screening strategies that require physical separation of variants. Here, a greater emphasis
will be placed on selection processes, since it was the strategy used in Chapter 6.
Screening vs selection
Any selection strategy can be be visualised as the intersection of two key processes: the
degree to which library variants possess the function of interest and the stringency of the
method in removing variants that do not have the required function (Fig. 1.8, (Tizei et al.,
2016)). A successful selection should e ciently recover functional variants, while rejecting
the bulk of the diversity that does not possess the phenotype.
However, this visualisation also illustrates the failure modes that can occur in any selec-
tion process as a result of problems with the genotype-phenotype linkage (Fig. 1.8, blue and
yellow regions). Functional variants that fail to be recovered by selection are considered
false negative results and a high proportion of these can impair the e ciency of the entire
directed evolution strategy. False negatives can occur when a functional variant is poorly
expressed or the partitioning cuto↵ point for the desired function has high variability.
Recovery of false positives without the phenotype of interest, on the other hand, can have
two distinct origins. The first, named background, is random recovery from the population
bulk due to non-specific interactions in the partitioning process. For instance, in selection
for a nity towards a target molecule supported on a matrix, insu cient washing can lead
62
Chapter 1. Introduction
Figure 1.8: Possible outcomes in selection experiments. Recovered true positives are
represented in green and selection failure modes are represented in relation to recovery
and function. False negatives are functional variants that failed to be recovered by selec-
tion (yellow). In blue are the recovered false positives, including non-specific background
variants and harmful parasites that are actively recovered by unexpected interactions with
the selection mechanism. According to (Tizei et al., 2016).
to retention of non-functional molecules due to non-specific interactions with the system
(Vant-Hull et al., 2000). Due to the random nature of these interactions, background
negatives can be removed by further cycles of selection or changes to selection conditions.
Conversely, parasites are a class of false negative variants that are recovered due to
specific interactions with the partitioning mechanism, while not harbouring the targeted
phenotype. Following the example given above, a parasite would be a variant that has high
a nity for a component of the matrix used to support the target molecule and, therefore,
would not be eliminated by washes to remove variants interacting non-specifically. Parasites
can be harmful to the selection process if recovered in high proportions relative to the
true positives, leading to wasted characterisation e↵ort in determining the phenotype of
recovered variants. Possible sources of parasites must be evaluated while the selection
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strategy is being designed and steps taken to reduce their probability of emergence, but it
is impossible to predict all possible sources of parasites and changes to the selection strategy
may be needed if parasites do emerge during selection.
The wide diversity of selection and screening strategies that have been established for di-
rected evolution can be divided into four categories, according to the nature of the genotype-
linkage: in vivo, ex vivo, or in vitro systems. Each will be described in a separate section.
1.5.2.1 In vivo selection systems
In vivo selection systems are closest to natural biological evolution, using living cells as the
genotype-phenotype linkage. This enables the engineering of complex phenotypes such as
tolerance to environmental conditions or growth using non-natural substrates, with contri-
butions from the entire cellular genome. Selection for growth under specific environmental
conditions is the simplest strategy employed in in vivo directed evolution and has been
used to isolate complex phenotypes. Hoesl et al. (2015) isolated a strain of E. coli capable
of replacing L-tryptophan in its proteome with the synthetic analogue L-b-(thieno[3,2-
b]pyrrolyl)alanine, using serial batch cultures in media containing the synthetic analogue.
Using a turbidostat for fine control of cell growth rates and gradual changes to medium
composition, Marliere et al. (2011) obtained E. coli that incorporate chlorouracil instead
of thymine into their genetic material.
However, growth-based selections are restricted to phenotypes that are required for basic
cell processes — such as the protein or nucleic acid synthesis examples mentioned above —
or at least closely correlated with cell growth, such as metabolic pathways. If the desired
phenotype is production of a metabolite that is not needed for cell survival, parasites may
arise that are able to successfully grow under selection but do not produce the desired
metabolite. A xylose-fermenting Saccharomyces cerevisiae strain was engineered with a
metabolic pathway for fermentation of the sugar arabinose into ethanol and grown in the
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presence of this sugar in repeated batch cultures, leading to the isolation of a strain that
was able to ferment arabinose but lost the ability to ferment xylose (Wisselink et al., 2007).
This example illustrates a warning often repeated in the field of directed evolution that
“You get what you select for” (Zhao and Arnold, 1997), i.e. selection conditions must be
carefully selected to recover the desired phenotype.
Recently, methods for engineering biosensors for target small molecules have been estab-
lished, allowing their use in logic circuits to allow for selection of phenotypes not naturally
correlated with growth. Such a biosensor for progesterone was coupled to a fluorescent out-
put, enabling the use of Fluorescence Assisted Cell Sorting (FACS) to screen for variants
capable of producing higher titres of the hormone (Feng et al., 2015a). Chou and Keasling
(2013) coupled an engineered biosensor for lycopene to expression of an error-prone DNA
polymerase, leading to high initial mutation rates and a gradual decrease as variants capa-
ble of high lycopene yields appeared in the population. Continued development of biosensor
technology will expand the range of functions which can be targeted by in vivo selection
systems.
1.5.2.2 Ex vivo selection systems
Ex vivo selection — also known as surface display — platforms also employ whole cells
or bacteriophage particles as their genotype-phenotype linkage, but do not exploit growth
or metabolic processes for the selection mechanism. Instead, the protein to be engineered
is exposed on the surface of the organism, for interaction with the chosen partitioning
mechanism. The protein of interest must be fused to a protein naturally present on the
outer surface of the host organism, such as a phage capsid subunit (Smith, 1985) or bacterial
membrane protein (van Bloois et al., 2011), which also restricts the use of this strategy to
proteins that do not disturb the export process of the fusion partner and retain their
function upon fusion.
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The ease of selection for high-a nity variants using solid-supported antigens led to
widespread use of ex vivo directed evolution for the engineering of a nity reagents, en-
abling the development of synthetic antibodies for clinical applications (Huse et al., 1989).
Although limited to few activities, enzymes displayed on the surface of phage have been en-
gineered by capturing active variants with high-a nity transition state analogue inhibitors
or “suicide substrates” that create an irreversible covalent link to the active site of ac-
tive variants (Fernandez-Gacio et al., 2003). Peroxide-generating enzymes (lipases and
esterases) have been selected by yeast cell surface display by coupling their activity to
peroxidase-mediated production of highly-reactive tyramide radicals, which create a cova-
lent link to cell-surface proteins for activity detection (Lipovsek et al., 2007).
1.5.2.3 In vitro selection systems
In in vitro selection strategies, cells are not used as the genotype-phenotype linkage and,
consequently, other mechanisms must be designed to ensure the selected phenotypes can be
linked to their encoding genotypes. The methods to establish this linkage can be broadly di-
vided into two groups: mechanisms which physically link genotype and phenotype molecules
and compartmentalisation of the population to avoid mixing of variants.
In this first category are methods for engineering functional nucleic acids, employing the
same molecule as both genotype and phenotype. These have been used for the generation of
a nity reagents known as aptamers (Blind and Blank, 2015) and molecules with enzymatic
activity (Robertson and Joyce, 1990). Adaptations of this strategy for the directed evolution
of proteins is possible by creating a physical link between between the mRNA genotype
and the protein responsible for the phenotype, either via a covalent linkage to a puromycin
modification on the mRNA (mRNA display, Liu et al. (2000)) or maintaining the translation
complex by stalling the ribosome (ribosome display, Hanes and Pluckthun (1997)). For all
of these methods, genotypes can be recovered directly by PCR if information is encoded in
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DNA or by reverse transcription if encoded in RNA or synthetic nucleic acids. Since these
strategies do not require intermediate steps in whole cells, faster turnaround times and
higher throughputs can be achieved than with in vivo and ex vivo strategies — libraries
containing up to 1014 variants are routinely selected for the isolation of aptamers (Blind
and Blank, 2015), compared to limits of approximately 108 CFU for high-e ciency E. coli
transformation processes (You and Percival Zhang, 2012). However, RNA-based display
strategies can be hindered by ubiquitous contaminations with RNA-degrading enzymes, a
problem that can be mitigated by the use of nuclease-free translation extracts (Barendt
et al., 2013) or conversion of mRNA to cDNA prior to selection (Yamaguchi et al., 2009).
The second category of in vitro selection and screening frameworks relies on individual
compartmentalisation of each variant in a library, to prevent variants from coming into
contact with each other due to the lack of a physical link between genotype and phenotype.
Two distinct strategies are used to achieve this compartmentalisation: screening assays in
individual wells of microplates or encapsulation of genotype and phenotype molecules inside
a cell-like water-in-oil emulsion compartment.
In microplate-based screening strategies, the link between genotype — usually a micro-
bial strain expressing a single library variant — and phenotype — proteins secreted into
culture medium or lysates of cultures — is the ability to recover the library variant respon-
sible for the phenotype observed in an assay well. Throughput of these systems is limited
by the resources — either from human experimenters or automated liquid handling plat-
forms — available for the project, due to the space and experimental e↵ort requirements
required for screening large numbers of microplate assays. Ambitious directed evolution
experiments, such as metabolic engineering of microbial strains for biofuel production using
multi-step pathways require screening of vast libraries containing over 105 combinations of
elements: relative copy number of genes in the pathway, promoter strength, terminators,
ribosome binding sites and mRNA stability (Peralta-Yahya et al., 2012). To circumvent
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extensive (and costly) screens, information-rich library design strategies allow the e cient
engineering of novel phenotypes, such as the recent engineering of the first carbon-silicon
bond forming enzymes from sequential site-saturation mutagenesis of only three sites (60
possible variants) within a cytochrome c (Kan et al., 2016b).
Emulsion-based selection methods link their genotypes and phenotypes with the same
physical separation principle as microplate screening, but using much smaller compartment
volumes — with droplet diameters around the single micrometre range — containing a
single cell expressing a protein variant from the library. The greatly-reduced volume of
these emulsion droplets allows for higher throughputs than is possible with microplates
and at a lower cost, enabling libraries of 109 to be selected in a total emulsion volume
of 1 ml (Pinheiro et al., 2012a). Selection platforms have been developed for engineering
of nucleic acid-active enzymes by capture of plasmids encoding active variants (Ghadessy
and Holliger, 2007; Pinheiro et al., 2012a), allowing the development of the first synthetic
genetic information storage system (Pinheiro et al., 2012a). Precise control over droplet
dimensions using microfluidics devices enabled the establishment of a very high throughput
screening system using fluorescent enzyme substrates and FACS, capable of screening over
107 variants in under 2 hours (Zinchenko et al., 2014). Though this system was only
demonstrated on a model enzyme system, it was shown to capable of recovering active
variants from a population of inactive variants that was 100,000-fold larger, showing the
potential of such systems for enzyme engineering.
1.5.3 Learn: Analysis of directed evolution results
The results obtained from the Test step of the cycle are crucial to inform the decisions
that will direct the subsequent steps of a directed evolution project. The first decision is
whether to continue carrying out cycles of directed evolution and it depends on how close
the phenotypes of the variants obtained in the current cycle are to the aims set for the
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project. If the goals have not yet been met and the decision to start a new cycle is made,
the results obtained in the current cycle can be exploited to inform the subsequent Design
phase.
If the project employs direct screening for a single phenotype of interest to partition the
population in the Test step, the results of the screen can be used directly to decide whether
the desired phenotype is present in any of the variants or whether a library will be designed
for a new round of selection (Kan et al., 2016c). However, this is not a frequent scenario
for many biological systems, in which multiple phenotypes are evolutionarily correlated
due to being encoded by overlapping networks of residues (Pires et al., 2016). In many
cases this leads to the observation of trade-o↵s between a phenotype of interest — such
as catalytic activity — and secondary but still essential phenotypes — such as enzyme
stability (Dellus-Gur et al., 2013).
Whenever such trade-o↵s exist, any important phenotypes correlated to the one being
targeted must also be measured for the chosen variants, to prevent the isolation of undesired
variants such as a highly-active enzyme that is not stable at the conditions in which it will
be used (Li et al., 2016). Once a set of “hits” comprised of the most improved variants is
found, these can be used to inform the design of any subsequent cycles of directed evolution
that are deemed necessary. Commonly, the sequences of these variants are compared by
MSAs and clustered, allowing the detection of positions or motifs that contribute to function
(Breaker and Joyce, 1994).
For projects that employ selection as a partition strategy, the traditional approach
is to isolate a fraction of the selected population, use Sanger sequencing to recover the
genotypes and measure the phenotype of interest in these isolated variants. This sampling
is needed because the number of variants recovered from selection is frequently greater than
throughput of screening assays (See Section 1.5.2.3 for a discussion of screening throughput).
The results of these screens can then be used to select the most improved variants for input
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into the design (See Section 1.5.4) step of the next cycle. This approach is commonly
employed for the engineering of nucleic acid aptamers with a nity for a wide range of
targets (Stoltenburg et al., 2007).
However, the development and widespread adoption of NGS within the last decade
has made it possible to extract information from a much greater proportion of a selected
population. If the selection strategy enriches variants proportionally to the strength of
the phenotype they encode, read counts can be used as a measure of the phenotype —
reducing the need for laborious screening of variants. This approach is being increasingly
employed for directed evolution experiments and also as a way to increase the throughput
of biochemical characterisation assays, such as binding a nities of nuclear factors for large
panels of post-translational modifications of histones (Nguyen et al., 2014).
Due to the importance of phage display as a platform for the generation of antibod-
ies, NGS was adopted to identify enriched variants in earlier rounds of selection, in which
diversity is still too large to reliably isolate the best clones for Sanger sequencing. Early
e↵orts only extracted the most frequent variants from the obtained sequences, not making
attempts to identify shared motifs that could be responsible for the observed enrichment
(Ravn et al., 2010). These were followed by methods that incorporated clustering of se-
quences for motif detection but only characterising the phenotype of a single enriched motif
(Christiansen et al., 2015) or stratifying the list of identified motifs into groups of equal
length (Ravn et al., 2013), overlooking any possible motifs that spanned more than a single
length. Since variations in sequence length are known to be important for the function of
high-a nity antibodies (Krause et al., 2011), this parameter should be incorporated into
enrichment analyses to more closely reflect the natural mechanisms involved in natural
antibody selection and maturation.
Employment of NGS for directed evolution has not been restricted to antibody engineer-
ing, though. Sequencing of phage display-based selections of viral proteases for activity in
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the presence of inhibitors enabled the detection of enriched point mutations with frequen-
cies varying between 1% and 50% (Dickinson et al., 2014), which would have required
extensive and laborious isolation of clones for similar discrimination by Sanger sequencing
— and likely at a higher total cost than is possible with multiplexed sequencing of multiple
populations using relatively low-throughput NGS systems such as Illumina MiSeq. Work-
flows for aptamer selection with analysis of enrichment in the populations have also been
established, employing clustering algorithms capable of handling datasets of over 20 million
sequences (Hoinka et al., 2015b) or identifying the most enriched sequences and calculating
their fitness from their relative frequencies (Jimenez et al., 2013). The additional infor-
mation recovered by these approaches can, then, be employed to inform library design for
further rounds of directed evolution, accelerating the progress of engineering compared to
traditional workflows based on characterisation of small numbers of variants per cycle.
1.5.4 Design: Integrating multiple sources of information to increase the
e ciency of directed evolution rounds
The methods employed to target diversity within a sequence in a directed evolution exper-
iment depend on the information that is available at that stage of the experiment. The
possible sources of information to direct diversification are: functional annotation on the
phenotype of interest from the literature, bioinformatic predictions (such as the ones de-
scribed in Section 1.4), enrichment patterns observed in a prior round of directed evolution,
or results from initial experiments to map positions which contribute to the phenotype of
interest. The latter option can be carried out e ciently using the technique known as deep
mutational scanning, in which each site within a protein is mutated to all possible residues
and the phenotype of all variants is measured by an assay using NGS as its output, allow-
ing simultaneous quantitation of the e↵ect of all single point mutations for the sequence
(Fowler and Fields, 2014).
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The results obtained in previous rounds of a directed evolution experiment can be a
valuable source of information for design of a diversification strategy for subsequent rounds.
In these cases, the simplest option is to apply the same diversification strategy used in the
previous round onto the best variant isolated from that round — if multiple positive variants
were isolated, all can be diversified and pooled — to become the library for the next round
of selection or screening. However, more sophisticated strategies have been developed to
more e ciently explore the sequence space around selected variants.
Whenever multiple functional variants with mutations at di↵erent sites in the sequence
exist, these can be combined to determine whether there is additivity in their phenotypes
or any form of epistasis. While it is practical to produce combinations of a small number of
mutations by traditional site-directed mutagenesis (SDM) methods, this becomes impracti-
cal for large numbers of mutations — there are 1013 possible combinations for ten separate
mutations in a sequence. Therefore, techniques such as DNA shu✏ing were developed to
quickly generate such libraries in a process that is analogous to the production of combina-
torial diversity in sexual reproduction of organisms (Stemmer, 1994). Additional diversity
can be generated by spontaneous mutations caused by the enzymes used in the shu✏ing
method, but these will not be restricted to the sites of the original variants. Deeper ex-
ploration of the sequence space at these sites can be achieved by a strategy called iterative
saturation mutagenesis, in which selected positions in a variant are mutated to the other
nineteen amino acids, followed by selection and further saturation mutagenesis at the same
positions (Reetz and Carballeira, 2007).
While the approaches mentioned above are e cient for generating libraries specifically
towards engineering a single phenotype in a target system, generalised libraries can be pro-
duced as an common starting point for engineering multiple divergent phenotypes in a same
system. Such libraries have been produced for antibodies (Prassler et al., 2011) and a -
bodies (Woldring et al., 2015, 2017) — small proteins used as a nity reagents analogously
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to antibodies, but based on Protein A as a sca↵old — for use in isolation of binders to
any target, with a reduced frequency of misfolded variants and residue compositions biased
towards sequences more likely to produce more e↵ective binders.
1.6 Thesis aim and overview
The aim of this thesis was to develop methods to enable the engineering of TOMM synthases
and their products by directed evolution. Towards this aim, the following specific objectives
were pursued:
1) Establishment of a sequence-based functional residue prediction strategy for the pro-
teins of the TOMM synthase complex, including a novel metric for detection of determinant
residues for TOMM biosynthesis.
2) Validation of candidate functional residues selected for E. coli McbC dehydrogenase,
involved in biosynthesis of microcin B17.
3) Establishment of a robust in vitro assay system for TOMM synthase complexes, to
aid in characterisation of proteins in the complex and form the basis for a directed evolution
strategy for their engineering.
4) Development and validation of a framework for directed evolution of proteins that
enables e cient exploration of length diversity, including methods for targeted library syn-
thesis and detection of motifs enriched by selection in mixed-length datasets.
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2.1 Genetic constructs
Oligonucleotides described in this section are listed in Appendix B.
2.1.1 TOMM Synthase enzyme constructs
Amino acid sequences for BamB (CBJ61639.1), BamC (CBJ61637.1) and BamD (CBJ61638.1)
were obtained from NCBI. Coding sequences for Bacillus amyloliquefaciens TOMM syn-
thase complex enzymes were codon optimised for expression in E. coli and comercially
synthesised (GeneWiz, USA).
N-terminal Maltose Binding Protein fusions of each enzyme were made by cloning into
the multiple cloning site of pMAL-c2x (New England Biolabs, USA). BamB and BamC were
cloned into the 50-EcoRI-SalI-30 sites and BamD was cloned into the 50-EcoRI-HindIII-30
sites.
Inserts were generated by PCR using Q5 Hot Start DNA Polymerase (New England
Biolabs, USA) and primer pairs containing the appropriate restriction sites for each fusion
construct (See Section 2.2.1). Primers MBP BL B F and MBP BL B R were used to clone
BamB, MBP BL C F and BL C R to clone BamC and MBP BL D F and BL D R to clone
BamD. PCR products and vector were digested with the appropriate restriction enzymes
for each construct, followed by ligation and transformation. (See Section 2.2.6).
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Expression constructs for the E. coli and Bacillus sp. Al-Hakam TOMM synthase
complexes were kindly provided by Douglas A Mitchell. All constructs consist of the coding
sequence of each enzyme with an N-terminal fusion to MBP and a TEV protease clevage
site, in pET29b vector (Melby et al., 2012, 2014). All plasmids were transformed into
cloning and expression strains of E. coli (see Section 2.3.3) and constructs were confirmed
by sequencing before expression (see Section 2.2.9). Proteins were expressed and purified
as per Sections 2.4.1 and 2.4.5.
2.1.2 Synthetic substrate constructs
Synthetic substrate constructs for the B. amyloliquefaciens TOMM Synthase complex were
built by a combinatorial strategy, annealing and ligating short single-stranded oligonu-
cleotides with complementary ends to generate peptide substrate variants (see construction
strategy in Fig. 2.1), followed by IPCR to generate short deletions/insertions. All constructs
were made in vector pTWIN1 (New England Biolabs, USA) and inserted into the 50-NdeI-
SapI-30 sites, in frame with the C-terminal Mxe intein-Chitin Binding Domain purification
tag (intein-CBD).
The peptide elements contained in the final constructs are in Table 2.1. All substrate
constructs contained the B. amyloliquefaciens leader sequence and a streptavidin-binding
tag (Strep-tag) for purification, with the core peptide region being variable. The four core
peptide regions used in these constructs are named 0C, 1C, 2C and 3C, according to the
number of heterocyclisable cysteine residues contained in each. The 0-cysteine construct is
illustrated in Fig. 2.1 as an example.
The XCYS (X being 0 or 3) and BACA LEADER oligos contained complementary
overhangs to allow their ligation into a single double-stranded fragment.
The inserts for 0C and 3C substrate constructs were generated in two separate annealing
and ligation steps, followed by PCR amplification of the ligated products. The substrate
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Annealing and Ligation Annealing
PCR to add
restriction site 
overhangs
PCR to add 
restriction site 
overhangs
Digestion with NdeI 
and BsaI
Digestion with BsaI and 
SapI
Ligation into NdeI/SapI 
digested pTWIN1
Bacillus amyloliquefaciens 
leader sequence Core Peptide Streptavidin-binding tag
Figure 2.1: Substrate construct design. Top - Strategy used for the assembly of the
synthetic substrate constructs. Initially, oligonucleotides coding for the leader and core
sequences were annealed and ligated, while the oligonucleotides coding for the streptavidin-
binding tag were simply annealed. This step was followed by PCR amplification the two
resulting double-stranded fragments with primers containing restriction enzyme sites in
their overhangs. The PCR products were then digested with the appropriate restriction
enzymes to enable their insertion and ligation into pTWIN1 for cloning. Bottom - map of
the B0SIC construct generated by this strategy for the 0-cysteine substrate peptide.
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Peptide ele-
ment
Sequence
Leader MTQIKVPTALIASVHGEGQHLFEPMAA
New-
Leader
MEEVTIMTQIKVPTALIASVHGEGQHLFEPMAA
0C YDGGK
1C CDGGK
2C CCDGGK
3C CCCDGGK
PznA CTCTTIISSSSTF
Strep-tag MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP
MMSGGCKLGS
Strep-tag-C MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP
Table 2.1: Amino acid sequences of peptide elements contained in substrate constructs.
Initially, all constructs contained Leader and Strep-tag regions, along with 0C, 1C, 2C or
3C. Deletion to generate Strep-tag-C produced BXSIC-C constructs. Leader and Strep-tag
were present in all of the first round of constructs and each construct contained 0C, 1C,
2C or 3C.
single-stranded oligos XCYS F and XCYS R (X being 0 or 3) were annealed along with
the leader oligos BACA LEADER F and BACA LEADER R (see Section 2.2.5) and the
Strep-tag oligos (SB19C4 F and SB19C4 R) were annealed in a separate reaction. The
annealed products containing the XCYS and BACA LEADER oligos were ligated according
to Section 2.2.6. Since the SB19C4 fragment was only composed of two complementary
oligos, no ligation was necessary.
The double-stranded products of the annealing and ligation steps were then amplified by
PCR with primers containing restriction enzyme recognition sites as overhangs, to enable
insertion of the fragments into pTWIN1. Primers BacL-F-NdeI and XCys-R-BsaI (X being
0 or 3) were used to amplify the leader-core fragment with 50-NdeI-BsaI-30 restriction sites
and primers Strep-F-BsaI-Cterm and Strep-R-SapI-Cterm were used to amplify the strep-
tag fragment with 50-BsaI-SapI-30 restriction sites, according to the PCR protocols in section
2.2.1. Inserts were digested with the appropriate restriction enzymes for the respective
overhangs and pTWIN1 vector was digested with NdeI and SapI, followed by simultaneous
ligation of all three products and transformation according to the protocols in section 2.2.6.
77
Chapter 2. Materials and Methods
Once the 0- and 3-Cysteine constructs clones were confirmed by sequencing (see Section
2.2.9), the 1- and 2-Cysteine variants were generated by PCR deletions of, respectively, 2
and 1 cysteine codons using the 3-Cysteine construct as a template. Primers XCys-IPCR-F
(X being 1 or 2) and Cys-IPCR-R were used to amplify the 3-Cysteine construct with the
appropriate deletions (see Section 2.2.1), followed by blunt-ended cloning as described in
Section 2.2.7. These clones were also confirmed by sequencing (Section 2.2.9)
The cysteine residue present in the Strep-tag sequence was removed from all substrate
constructs by an additional round of PCR deletions (see Section 2.2.1), removing the
MMSGGCKLGS sequence that is not essential for streptavidin-binding function and pro-
ducing Strep-tag-C (see Table 2.1). All four substrate constructs were used as templates
for these PCR deletions followed by cloning (see Section 2.2.7), generating the BXSIC-C
(X being 0, 1, 2 or 3) constructs which were sequenced (Section 2.2.9) and later expressed
and purified for use in assay development (see Sections 2.4.3 and 2.4.6).
Expression constructs for the E. coli and Bacillus sp. Al-Hakam TOMM substrates were
kindly provided by Douglas A Mitchell. All constructs consist of the coding sequence for
each substrate, consisting of leader and core regions, fused at its N-terminus to MBP and a
TEV protease cleavage site, in pET29b vector (Melby et al., 2012, 2014). All plasmids were
transformed into cloning and expression strains of E. coli (see Section 2.3.3) and constructs
were confirmed by sequencing before expression (see Section 2.2.9). Proteins were expressed
and purified as per Sections 2.4.1 and 2.4.5.
In addition to the wild-type BalhA1 substrate from Bacillus sp. Al-Hakam containing
10 ciclysation sites (WT), there is a negative control construct where all the cyclisable
residues were converted into alanines (NC for non-cyclisable) and also single cyclisation
variants of NC where one of the alanines is converted to a cyclisable residue (NC-A40C and
NC-A40T).
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2.1.3 Substrate construct variants
To produce synthetic substrate constructs with the New-Leader element and the native
Plantazolicin A core peptide (see Table 2.1), PCR was carried out (See Section 2.2.1) with
primers BamLeadFix-0C-F and BamLeadFix-R or BamLeadFix-PznA-F and BamLead-
Fix-R, with B0SIC-C as template. These primers contain SapI restriction enzyme sites,
to create compatible overhangs for the insertion of the fragments generated by the an-
nealing and digestion of the oligos B1-WT-T and B1-WT-B or BP-WT-T and B1-WT-B.
(See Sections 2.2.5 and 2.2.6). These inserts produced substrate peptides containing the
New-Leader region and, respectively, the 1C and PznA core regions (See Table 2.1). The
constructs were named B1SIC-WT and BPSIC-WT.
Once a correct clone was obtained for B1SIC-WT, this construct was used as template
for PCR with primers B1-WT-CmutX-F (X being 0, 2 or 3) and B1-WT-Cmut-R. The
products of these amplifications were blunt-end cloned (See Section 2.2.7) to produce the
B0SIC-WT, B2SIC-WT and B3SIC-WT constructs. These substrate constructs containing
the altered leader peptide were expressed and purified by the same methods used for the
earlier constructs (See Sections 2.4.3 and 2.4.6).
Modified McbA substrate peptides were constructed following the SDM procedure (Sec-
tion 2.2.8) to insert codons for the QMQ and KKD insertions, using oligo pairs McbA-1-46-
QMQ-AarIF/McbA-1-46-AarI-R and McbA-1-46-KKD-AarIF/McbA-1-46-AarI-R. However,
these were cloned by digestion with the restriction endonuclease AarI and ligation of the
overhangs generated by digestion (Section 2.2.6).
2.1.4 Constructs for validation of McbC dehydrogenase mutants
Mutations were inserted into vector pCID909 containing the entire Mcb17 biosynthetic
operon following the SDM procedure described in Section 2.2.8, with oligo pairs McbC-
XXXX-F/R-Blunt-, where XXXX is the position of each mutation.
79
Chapter 2. Materials and Methods
2.1.5 Constructs for TEM-1 directed evolution
The TEM-1 gene was cloned into pBAD30 by amplifying the gene in two parts to remove
an internal BsaI site present in its sequence with a silent mutation, using oligo pairs TEM1-
Nter-F/R and TEM1-Cter-F/R. The vector was amplified using the oligo pair Vec-TEM1-
F/R and gene insertion was carried out through the BsaI sites added to the 50 of each
oligo. The M182T stabilising mutation and the 165YYG167 triple mutation were created in
this vector by SDM, using the oligo pairs TEM1-M182T-F/R and TEM1-YYG-F/TEM1-
MutLoop-R, respectively.
Temp-Opt oligos were used for optimisation of the InDel assembly process, exploiting
the internal fluorescent label for sensitive detection of assembly products. Temp-TEM1-XG
oligos were the template oligos used to start assembly of the libraries for both rounds of
directed evolution. Similary, Cap-Opt oligos were used as capping oligos during library
design and Cap-TEM1 oligos were adopted for the TEM-1 libraries. Finally, AB-X-T/B
oligo pairs form the assembly blocks for each codon used in the assembly mixtures for each
step of the Indel protocol.
Oligos TEM1-Seq(1-7) were used to fully sequence the vectors of selection parasite vari-
ants PTX7S and PTX8S, by overlapping Sanger sequencing reactions.
2.2 Molecular Biology
Unless otherwise mentioned (See Appendix A for list of reagents), all enzymes used in
cloning procedures were purchased from New England Biolabs, USA. dNTPs were pur-
chased from Bioline, UK.
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2.2.1 PCR
Polymerase Chain Reaction (PCR) was used to amplify DNA fragments with the high fi-
delity enzyme Q5 Hot Start DNA Polymerase, in Peqstar (Peqlab, Germany) and C1000
Touch (BioRad, USA) thermocyclers. Primers used for each reaction are listed in Ap-
pendix B and annealing temperatures were selected according to the Melting Temperature
calculator available on the NEB website (http://tmcalculator.neb.com/).
Amplifications were tipically carried out in 50 ml reactions containing 1X Q5 Reaction
Bu↵er, 200 mM dNTPs, 0.5 mM each primer, 1 ng template DNA, 0.02 U/ml Q5 Hot Start
DNA Polymerase. Reaction conditions were as follows: initial denaturation at 98°C for 30
seconds; 25-30 cycles of 98°C for 10 seconds, 50-72°C for 20 seconds and 72°C for 20 seconds
per kilobase of the target DNA; final extension at 72°C for 2 minutes and storage at 4°C
once the reaction is completed. For amplification of DNA bound to streptavidin-coated
paramagnetic beads, 1 µl resuspended bead slurry replaced the purified templated DNA in
the reaction.
MyTaq HS Dna Polymerase was used for reactions where initial template was limited
and Q5 polymerase did not yield robust amplification. Reactions for this enzyme contained
1x MyTaq Reaction bu↵er, 0.1U/µl My Taq HS DNA Polymerase, 0.4 µM each primer, 1 ng
template (or less) and a total reaction volume of 50 µl. Reaction conditions were as follows:
initial denaturation at 95°C for 1 minute; 25-30 cycles of 95°C for 15 seconds, 50-72°C for
20 seconds and 72°C for 30 seconds per kilobase of the target DNA; final extension at 72°C
for 2 minutes and storage at 4°C once the reaction is completed.
For reactions that yielded non-specific products, the CES enhancer solution (Ralser
et al., 2006) was made as a 5x stock (2.7 M betaine, 6.7 mM DTT, 6.7% (v/v)DMSO, 55
µg/ml BSA, stored at -20°C) and added to reactions at a 1x final concentration.
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2.2.2 Agarose gel electrophoresis
PCR and restriction digest products were analysed in agarose gels using a horizontal elec-
trophoresis system (AlphaLabs, UK). Gels were prepared in 0.5X TBE bu↵er (45 mM Tris
base, 45 mM Boric acid, 0.125 mM EDTA pH 8.3) or 10 mM Lithium Acetate with varying
concentrations of agarose (0.8-2% (w/v)), according to the fragment size to be analysed.
SYBR Safe stain was added to gels at a final concentration of 0.5X from 10,000X com-
mercial stock. Samples were diluted in 6X DNA loading dye (40% (v/v)Glycerol, 0.025%
(w/v)Bromophenol blue) before loading onto gels. Gels were run in 1X TBE or 10 mM
lithium acetate DNA bands were visualised by transillumination with blue or UV light.
2.2.3 Measurement of DNA concentration by spectrophotometry
Concentration of all DNA solutions was measured by absorbance at 260 nm and purity
was evaluated by measuring ratios of absorbance at 260 nm to 280 nm to detect protein
contamination and 260 nm to 230 nm to detect solvent or guanidine contamination. All
measurements were conducted using the SpectroStar Nano (BMG Labtech, UK) instru-
ment, with the LVis Plate accessory, which enables the measurement of absorbance in 1.5
mL droplets.
2.2.4 Measurement of DNA concentration by Qubit fluorometry
High-precision quantitation of DNA concentration for NGS library preparation (see Section
2.2.12) was carried out using a Qubit 3.0 fluorometer (Thermo Fisher Scientific) with a
dsDNA HS assay kit. The working solution of the dye was prepared by a 200-fold dilution
of the dsDNA HS reagent in the dilution bu↵er provided by the manufacturer. Only 0.5
ml microcentrifuge tubes recommended by the manufacturer were used to ensure accurate
measurements. Standards were prepared by adding 190 µl of the working solution to tubes,
followed by 10 µl of the provided concentrated standards. Samples were prepared by adding
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199 µl of the working solution to 1 µl of each sample. All tubes were vortexed for 2-3 s,
incubated at room temperature for 2 min and measured in the Qubit instrument.
2.2.5 Single-stranded oligonucleotide annealing
Double-stranded fragments were generated from complementary single-stranded oligonu-
cleotides by combining the oligos to be ligated in TE (10 mM Tris-Cl pH 8.0, 1 mM EDTA)
at a final concentration of 10 mM. The solution was heated to 95°C for 5 minutes, then
cooled to 4°C at a rate of 0.1°C per second.
2.2.6 Cloning of fragments with complementary overhangs
Amplified PCR products were purified using the GeneJet PCR Purification Kit (Thermo
Scientific) according to manufacturer’s instructions. Vector and inserts were digested in
separate 20 mL reactions containing 2 mL Cutsmart Bu↵er, 1 mg DNA and 10 U each of
the enzymes need for the specific construct. Digestions of PCR products amplified from
plasmid templates also contained 10 U DpnI to remove the methylated plasmid DNA and
reduce false positives in the transformation. Digestions were carried out at 37°C for 2 hours
and subsequently purified using the GeneJet PCR Purification Kit.
Ligations were carried out in 20 mL volume, containing 1X T4 DNA Ligase bu↵er (50
mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM ATP, 10 mM DTT) and 40 U T4 DNA Ligase.
Vector and insert DNA were added to a total of approximately 100 ng per reaction, in a
ratio of 1 molecule of the vector to 3 molecules of the insert. Reactions were incubated for
2 hours at 25°C.
Before transformation, ligation products needed to be purified by phenol/chloroform
extraction and ethanol precipitation (see Section 2.2.10) to remove salts and other ions
that interfere with transformation by electroporation.
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2.2.7 Blunt-ended single fragment cloning
Purified PCR products to be used for blunt-ended cloning of a single fragment by in-
tramolecular ligation were phosphorylated by incubation of 1 mg DNA with 10U NEB T4
Polynucleotide Kinase (PNK) and 10 U DpnI in 1x T4 DNA Ligase bu↵er for 1 hour at
37 °C. Phosphorylated products were purified using the GeneJet PCR Purification Kit and
20 mL ligation reactions were assembled in 1X T4 DNA Ligase Bu↵er with 40 U T4 DNA
ligase and approximately 100 ng DNA. These reactions were incubated at 16°C for 16 hours
before phenol/chloroform extraction and ethanol precipitation (see Section 2.2.10), followed
by transformation (See Section 2.3.5).
2.2.8 Site-directed mutagenesis
Site-directed mutagenesis was carried out on plasmid templates containing the target se-
quence by amplification of the entire vector sequence with pairs of primers annealing imme-
diately adjacent to the site where mutations were introduced. The desired mutations were
added as 50 non-annealing sequence to only one of the oligos and PCR was done using Q5
DNA polymerase (see Section 2.2.1) for a maximum of 25 cycles to reduce the likelihood
of mutations. Purified products were recircularised by blunt-ligation (see Section 2.2.7).
2.2.9 Sanger sequencing of plasmids
Aliquots of each construct to be sequenced were sent to GATC Biotech AG, Germany for
Sanger sequencing, according to the service provider’s instructions. Sequencing results were
aligned by BLAST to the expected sequences of each construct to detect possible mutations
from the cloning process. If a clone presented mutations, another colony isolated from the
same transformation was submitted for sequencing.
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2.2.10 Phenol/Chloroform extraction and ethanol precipitation of nu-
cleic acids
Phenol/Chloroform/Isoamyl Alcohol (25:24:1) was added to the DNA to be purified in a 1:1
ratio, mixed by vortexing and centrifuged at 17,000 g for 5 minutes at room temperature.
The aqueous phase was transferred to a new tube and precipitation was carried out with
100 mM ammonium acetate, 70% (v/v) ethanol and 10 mg glycogen azure. Ammonium
acetate was used in the precipitation as it sublimates during pellet drying and glycogen
azure was used to facilitate visual detection of the nucleic acid pellet by staining it blue.
After vortexing, tubes were kept at -20°C for at least 1 hour, followed by centrifugation
at 17,000 g for 30 minutes at room temperature. The supernatant was discarded and the
pellets were washed by adding 500 mL ice-cold 70% ethanol and repeating the centrifugation
step for 10 minutes. The supernatant was discarded again and pellets were air-dried at room
temperature, then resuspended in dH2O.
2.2.11 InDel Assembly
Oligos used in InDel Assembly reactions were commercially synthesised as single-stranded
DNA oligos and purified by desalting (Integrated DNA Technologies). One strand of the
template oligos contained a 50 Biotin-TEG modification for capture on streptavidin beads
and were purified by HPLC. Double-stranded fragments were obtained by diluting oli-
gos in annealing bu↵er (10 mM Tris-HCl pH 8.0, 20 mM NaCl, 1 mM MgCl2, 0.01%
(v/v)Tween20), followed by freezing at -20°C for 1 hour, thawing at room temperature and
heat annealing following the steps in Section 2.2.5.
Prior to annealing, the oligos corresponding to the strands providing 50 ends for liga-
tions were phosphorylated in 100 µl reactions containing 1x T4 DNA ligase bu↵er, 10 U T4
PNK and 1 nmol oligo. Reactions were incubated at 37°C for 3 h, followed by inactivation
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at 80°C for 20 min. Oligos were phenol-chloroform extracted, ethanol precipitated, resus-
pended in 90 µl annealing bu↵er and annealed (as above) to 1 nmol of the corresponding
complementary block. Building blocks containing codons for each amino acid were mixed
after annealing in the selected ratios for each assembly step.
To prepare for oligo capture, 60 µl of paramagnetic Dynabeads MyOne Streptavidin C1
(Invitrogen) beads were added to 1.5 mL microcentrifuge tubes. During all bead handling
steps, any solution changes were carried out by capturing beads from slurry on a magnetic
rack, removing supernatant with a pipette and resuspending in the desired solution. Fresh
beads were washed twice in 500 µl BWBS (5 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 1 M
NaCl, 0.05% (v/v)Tween20) and incubated with rotation at room temperature in 500 µl
BWBS for 30 min in a rotating incubator. After washing, 10 pmol biotinylated dsDNA
template oligos were added to the bead slurry and incubated for 16 h at room temperature
in a rotating incubator. Beads were washed once more in 500 µl BWBS, resuspended in
100 µl BWBS and the slurry was transferred to a 0.5 ml microcentrifuge tube for assembly.
All on-bead digestion steps were carried out with SapI (NEB) in 100 µl reactions (10
µl 10X CutSmart bu↵er, 20 U SapI, 1 µl, 0.01% (v/v)Tween20) for 2 h at 37°C with
vortexing every 15-20 min to keep beads in suspension. After digestion, beads were isolated,
resuspended in 100 µl BWBS and incubated at 37°C for 30 s before recapturing to start
the annealing step. The supernatant containing SapI was retained and stored at 4°C for
use in other assembly cycles carried out within the same day.
The mixture of building blocks selected for the assembly step was added to the washed
beads, incubated at 37°C for 30s, followed by incubation at 4°C for 30 s. The supernatant
containing the unbound building blocks was retained if needed for furtther steps and 100 µl
ligation mixtures were added (10µl 10X T4 DNA ligase bu↵er, 12 µl 1,2-propanediol, 10 µl
30% (v/v)PEG-8000, 400 U T4 DNA ligase, 50 U 50 deadenylase, 1 µl 1% (v/v)Tween20, 65
µl ddH2O). Ligations were incubated at 25°C for 1 h, with vortexing every 15-20 minutes.
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Ligation mixtures were retained and stored at 4°C for use in other assembly cycles carried
out within the same day.
After ligation, beads were washed in BWBS with a 30 s incubation at 37°C and were
then ready to be used in a new assembly cycle, starting from the digestion step. The final
assembly cycle used a modified dsDNA assembly block (called a 30 cap block) containing
a priming site to amplify the assembled library from the beads. After the ligation step of
the final assembly cycle with the capping oligo, beads were resuspended in 50 µl BWBS for
PCR amplification and long-term storage at 4°C.
2.2.12 Preparation of libraries for Illumina sequencing
Libraries for Next-Generation Sequencing (NGS) on an Illumina MiSeq instrument were
prepared by PCR with oligos containing the required 50 and 30 adaptor sequences, along
with distinct indices to allow all pre-and post-selection libraries to be sequenced in a single
lane.
Pre-selection libraries were amplified directly from the assembled bead slurries and post-
selection libraries were amplified from plasmid DNA extracted from a liquid cultures into
which were pooled all selected colonies of one selection round. Amplification was carried
out in 50 µl reactions using Q5 polymerase and a maximum of 20 PCR cycles were used to
avoid polymerase-induced mutations and reduce amplification biases. Reactions contained
1 U Q5 polymerase, 0.2 µM each of oligos XXX-MiSeqF (one oligo for each library, with
varying index sequences for demultiplexing. Oligo names and sequences are in Apendix
B) and TEM1-MiSeq-R, 1 ng plasmid template or 1 µl resuspended bead slurry from the
assembled library, 200 µM dNTPs, 1X Q5 reaction bu↵er and 1X CES enhancer solution.
Entire reaction products were loaded onto agarose gels for verification of product size and
purity, followed by excision of bands for purification using Monarch Gel Extraction kits
(NEB).
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Libraries were quantified by Qubit fluorometry (see Section 2.2.4 and pooled in propor-
tion to the desired number of reads for each sample. Sequencing was done by the UCL
Genomics Facility, using an Illumina MiSeq instrument with a 150 cycle v3 kit.
2.3 Microbiology
2.3.1 E. coli culture
Routine E. coli cultures were carried out in LB medium (1%(w/v) tryptone, 0.5% (w/v)NaCl,
0.5% (w/v)yeast extract. For solid medium, 1.5% (w/v)agar was added). Additional media
used for protein overexpression experiments include LBD (LB with 5% (w/v)D-glucose),
TB (1.2% (w/v)tryptone, 2.4% (w/v)yeast extract, 0.4% (v/v) glycerol), 2xTY (1.6%
(w/v)tryptone, 1% (w/v)yeast extract, 0.5% (w/v)NaCl). Antibiotics used as transfor-
mation controls include ampicillin (100 mg/ml stock solution in 50% (v/v)ethanol store at,
100 µg/ml working concentration), kanamycin (50 mg/ml stock solution in dH2O, 50 µg/ml
working concentration), and chloramphenicol (34 mg/ml stock solution in 100% ethanol,
34 µg/ml working concentration).
Media and glassware used for cultures were sterilised by autoclaving at 121°C for 20
minutes. All antibiotic free-media were kept at room temperature, antibiotic stocks were
kept at -20°C, antibiotic-containing media were kept at 4°C.
2.3.2 Measurement of bacterial growth by spectrophotometry
Cell density of liquid E. coli cultures was estimated by measuring light scattering in spec-
trophotometer cuvettes with 1 cm path length. Absorbance at 600 nm (OD600) of culture
aliquots was measured in the SpectroStar Nano instrument (BMG Labtech, Germany),
compared to a culture medium blank and only measurements lower than an OD600 of 1
were considered reliable due to flattening of the response at higher values. If a culture had
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an absorbance value greater than OD600 of 1, both the culture and blank were diluted
tenfold in dH2O before being measured again and the obtained value was multiplied by 10
to obtain an estimate of the original culture density.
2.3.3 E. coli strains
E. coli NEB 10-B (New England Biolabs, USA) was used for cloning of all constructs de-
scribed in this report and also for the expression of MBP-fused BamB and BamC constructs.
E. coli T7 Express ER 2566 and E. coli T7 Express LysY/Iq (New England Biolabs, USA)
were used for expression of constructs under control of T7 promoter or for improving pro-
tein yield. E. coli strain BL21(DE3) (New England Biolabs, USA) was used solely for in
vivo TOMM biosynthesis assays. Throughout the text, E. coli strains will be referred to
only by their strain names as shown here and these are listed in the Abbreviations table,
before the start of the main text.
2.3.4 Preparation of electrocompetent cells for transformation
An overnight culture of the selected E. coli strain was started from a glycerol stock main-
tained at -80°C in 10 mL LB with no antibiotics and incubated at 37°C with shaking. After
saturation, the culture was used to start a 200 mL culture in a 2 L shake flask at an initial
OD600 of 0.1, incubated at 30°C with shaking. When the cell density in the culture reached
0.4 units, the culture was transferred to pre-chilled 50mL centrifuge tubes and centrifuged
for 10 minutes at 3250 g at 4°C. The supernatant was discarded and the pellets were each
resuspended in 50 mL filter-sterilised ice-cold 1 mM HEPES pH 7.0, then pelleted by cen-
trifugation under the same conditions as before. Once again the supernatant was discarded,
but the pellets pooled in two 50 mL tubes and each resuspended in 50 mL 1 mM HEPES.
Pelleting, pooling and resuspension were repeated, resulting in a single tube with cells in
50 mL 1 mM HEPES, followed by a final pelleting step.
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The final resuspension was carried out with 2 mL 1 mMHEPES containing 10% (v/v)filter-
sterilised glycerol, followed by dividing the competent cell mixture into 50 mL or 100 mL
aliquots and immediately flash-freezing in dry ice. Competent cell aliquots were stored at
-80°C.
2.3.5 Transformation of E. coli by electroporation
Transformation of E. coli was carried out by electroporation in cuvettes with a 0.2 cm gap
between electrodes (BioRad, USA). Before transformation, competent cell aliquots were
removed from storage at -80°C and thawed on ice, while the cuvettes were also placed on
ice. Once thawed, competent cells were added to the cuvettes, along with the DNA to be
transformed. If the original DNA solution contained salts, it was first phenol/chloroform
extracted and ethanol precipitated (see Section 2.2.10) to prevent arcing.
Electroporation was carried out using a Gene Pulser II electroporator (BioRad, USA) at
2.5 kV, 200 W and 25 mF. Immediately after electroporation, 500 mL LB was added to each
cuvette with gentle mixing, followed by a 30-minute incubation at 37°C for recovery. After
incubation, cells were plated in LB-agar containing the appropriate antibiotic for selection
of transformants and incubated at 37°C overnight.
2.3.6 Plasmid purification from E. coli
Colonies obtained on transformation plates were isolated and transferred to liquid media
for plasmid multiplication. Cultures were carriet out in 10 mL LB-Amp and incubated at
37°C with shaking. Before harvesting the cultures for lysis, 500 mL of each culture was
transferred to a a microcentrifuge tube and sterile glycerol was added to a final concentra-
tion of 20% (v/v)for storage of clones at -80°C. The remaining culture volume was lysed
and plasmids were purified using the GeneJET PCR Purification Kit. To increase final
DNA concentration, culture and bu↵er volumes were doubled in relation to the kit man-
ufacturer’s recommendations, while the final elution volume was not altered. Once the
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plasmids were purified, concentration and purity were checked by spectrophotometry as
described in Section 2.2.3.
2.3.7 Large-scale selection for antibiotic resistance
Assembled TEM-1 libraries were transformed by electroporation of freshly-prepared NEB
10-b cells.After recovery in liquid LB medium, cultures were plated onto LB-agar medium
in 24.5 cm x 24.5 cm plates supplemented with the selected ceftazidime concentration for
selection and incubated at 37°C overnight. Resistant colonies were harvested using a cell
scraper, resuspended in 10 ml LB medium containing the same concentration of ceftazidime
used in the solid plates, and incubated at 37°C for 2-3h. Once turbity reached 1-2 OD600
units, the cultures were split into three aliquots. One received an addition of glycerol to a
final 20% (v/v) concentration and was frozen at -80°C for storage. A second aliquot was
diluted to plate approximately 104 CFU on LB agar plates containing higher ceftazidime
concentrations to isolate the most active TEM-1 variants from the pool. The remainder of
the culture was used for plasmid extraction.
2.3.8 Broth microdilution assay for antibiotic resistance
The Minimum Inhibitory Concentration (MIC) of NEB 10-bcells carrying selected TEM-1
variants was estimated by the broth microdilution method (Balouiri et al., 2016). Strains
were grown in liquid media containing varying concentrations of a small panel of antbiotics,
consisting of the penems ampicillin (Amp) and carbenicillin (Cbn), the cephalosporins
ceftazidime (Caz) and cefotaxime (Ctx), and the penem imipenem (Imp).
Approximately 100 CFU of a mid-log growth culture were added to 200 µl LB medium
with varying concentrations of the selected antibiotics in a flat-bottom 96-well microplate
(Greiner), sealed with a gas-permeable plate seal (AeraSeal, Excel Scientific), and incubated
at 37°C for 16 h with shaking. Cells deposited at the bottom of wells were resuspended by
91
Chapter 2. Materials and Methods
mixing with a multichannel pipette and growth was estimated from OD600 measurements.
Each plate contained a full column of no antibiotic control wells to normalise OD600 between
independent experiments and the wells along the outer edge of the plate were not used to
reduce evaporation e↵ects. Each experiment was carried out a minimum of three times and
the MIC of an antibiotic for each strain was defined as the lowest concentration of that
antibiotic that fully inhibited growth of the strain.
2.3.9 Disc-di↵usion assay for antibiotic resistance
Disc-di↵usion assays (Balouiri et al., 2016) were carried out by placing filter paper discs
(Oxoid) containing fixed amounts of antibiotic onto a lawn of the selected strain containing
approximately 107 CFU, plated on antibiotic-free LB medium. Ampicillin discs contained
25 µg, Carbenicillin discs contained 100µg, Ceftazidime discs contained 10 µg, Cefotaxime
discs contined 30 µg, and Imipenem discs contained 10 µg. Susceptibility of a strain to
an antibiotic was measured as the radius of growth inhibition around the antibiotic disc,
measured in four directions around the disc to reduce the e↵ect of any assymetry. A
minimum of three independent experiments were carried out for each strain and up to
three discs were placed on each culture plate.
2.3.10 In vivo Microcin B17 synthesis assay
The agar well di↵usion method (Balouiri et al., 2016) was used to detect in vivo production
and export of Microcin B17, as a measure of the activity of McbC dehydrogenase variants.
E. coli BL21(DE3) cells that did not carry the Microcin B17 resistance genes (sensitive
strains) were grown and approximately 107 CFU were added to 4 ml 0.7% (w/v)agar
and overlaid on antibiotic-free LB agar plates. Plates were left at room temperature for
15 min for agar solidification and four wells were created in each plated using a 9 mm
diameter cork borer. Culture supernatants from overnight cultures of BL21(DE3) producing
92
Chapter 2. Materials and Methods
strains — carrying the Microcin B17 biosynthetic pathway in pCID909 — were obtained
by centrifugation at 17,000 rcf in 1.5 ml microcentrifuge tubes for 15 min and 175 µl
supernatant was added to agar wells.
Plates were incubated for 16h at 37°C with lids facing up to avoid irregularly-shaped
growth inhibition zones caused by supernatant spills. One well was loaded with sterile
LB medium in each plate as a negative control and to be used as a size standard to
compare images taken at di↵erent zoom levels. Each plate was imaged after growth and
the area of growth inhibition zones was measured using ImageJ software (Schindelin et al.,
2012), allowing estimation of an overall radius and calculation of an inhibition radius by
subtracting the radius of the blank well in each plate. Dilution curves of the wild-type
supernatant were made to estimate a relation between observed inhibition radii and the
relative amount of Microcin B17 produced by each strain.
2.4 Macromolecule Expression and Analysis
2.4.1 Induction of Bacillus amyloliquefaciens TOMM synthase constructs
The BamB and BamC constructs were solubly expressed using the E. coli NEB 10-beta
clones obtained from the cloning process and the BamD plasmid was transformed into
the T7 Express strain for expression, according to the the electroporation protocol in Sec-
tion 2.3.5. Each of the clones was grown for 16 h in 10 mL LB-Amp, followed by innoculation
at a cell density of OD600 0.1 into 200 mL fresh LB-Amp in flasks incubated at 37°C with
shaking. Cell growth was monitored until the density reached OD600 values between 0.4-0.6
and IPTG was added to a final concentration of 1 mM for induction.
BamB and BamD were induced for 5 hours at 37°C and BamC was induced for 16
hours at 16°C, with continuous shaking for all constructs. Induced cells were harvested by
centrifugation at 3250 g at 4°C for 10 minutes, washed in 20 mM Tris-Cl pH7.5 with 150
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mM NaCl, pelleted again and stored at -20°C until lysis and purification (See Sections 2.4.4
and 2.4.5).
2.4.2 Induction of Bacillus sp. Al-Hakam and E. coli TOMM synthase
constructs
Balh enzymes and substrates were induced with 1 mM IPTG for 3 hours at 37°C. All
enzymes were induced in LB medium, with the addition of 50 mM riboflavin for BcerB,
50 mM ZnCl2 for BalhC. BalhA1 substrates were induced in 2xTY medium (1.6% (w/v)
tryptone, 1% (w/v) yeast extract, 0.5% (w/v) NaCl).
2.4.3 Induction of pTWIN1 constructs
The pTWIN1 constructs coding for the synthetic substrate constructs were transformed
into the T7 Express ER2566 (New England Biolabs, USA) strain for induction of the T7
promoter used by this vector. Each of the clones was grown for 16 h in 10 mL LB-Amp,
followed by innoculation at a cell density of OD600 0.1 into 200 mL fresh LB-Amp in flasks
incubated at 37°C with shaking. Cell growth was monitored until the density reached
OD600 values between 0.4-0.6 and IPTG was added to a final concentration of 1 mM for
induction.
All substrate constructs were induced for 5 hours at 37°C with shaking. Induced cells
were harvested by centrifugation at 3250 g at 4°C for 10 minutes, washed in 20 mM Tris-Cl
pH7.5 with 150 mM NaCl, pelleted again and stored at -20°C until lysis and purification
(See Sections 2.4.4 and 2.4.6).
2.4.4 Lysis of induced cell pellets
Induced cell pellets were lysed in the Equilibration bu↵er for the column used in subsequent
purification steps (See Sections 2.4.5 and 2.4.6 for bu↵er compositions), with the addition
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of 1 mM PMSF to inhibit expressed protein degradation by cellular proteases. Pellets were
resuspended at a cell density equivalent to an OD600 of 60-90 and transferred to a tube
appropriate for the cell suspension volume for lysis by sonication. When needed, cOmplete
Mini EDTA-free Protease Inhibitor Cocktail tablets were added to lysis bu↵er to prevent
protein degradadation during processing.
Sonication was carried out using a Soniprep 150 (MSE, UK) instrument with a micro-
probe accessory. The probe was immersed into the cell suspension for 9 cycles consisting of
4 seconds of sonication and 5 seconds with no sonication, at a 20 mm amplitude. All sam-
ples were kept on ice throughout sonication to prevent protein denaturation by excessive
heating. This process was carried out once for samples in 1.5 mL microcentrifuge tubes,
twice for samples in 15 mL tubes and three times for samples in 50 mL tubes.
After sonication, lysed samples were centrifuged at 4°C for 30 minutes at 17,000 g. The
supernatant containing the soluble proteins was transferred to a new tube and the insoluble
fraction was resuspended with the same volume of lysis bu↵er as was used for the lysis.
Protein solubility was assessed by electrophoresis in polyacrylamide gels under denaturing
conditions (see Section 2.4.7). Cleared lysates containing soluble protein were used for
purification.
2.4.5 Purification of MBP fusions
MBP-fused enzymes were purified by a nity chromatography on MBPTrap HP (GE Health-
care, Sweden) columns with a 1 mL bed volume, manually operated with syringes and
following the manufacturer’s recommendations. Sample injection, column washing, and
elution phases of the purification process were each collected in separate 15 mL tubes, with
no further fractionation.
Before loading the cleared lysates, the column was equilibrated with 10 mL MBP equi-
libration bu↵er (50 mM Tris-Cl pH 7.5, 125 mM NaCl, 2.5% (v/v) glycerol, 0.1% (v/v)
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Triton X-100, 0.5 mM TCEP). The sample was loaded onto the the column, followed by
another a washing step of 20 mL MBP Wash bu↵er (50 mM Tris-Cl pH 7.5, 125 mM NaCl,
2.5% (v/v) glycerol, 0.5 mM TCEP). Finally, bound proteins were eluted by flushing the
column with 10 volumes MBP Elution bu↵er (50mM Tris-Cl pH 7.5, 150 mM NaCl, 10 mM
Maltose, 2.5% (v/v)glycerol, 0.5 mM TCEP).
Collected fractions were stored at -20°C. The column was regenerated with 5 volumes
MBP equilibration bu↵er and stored at 4°C. Purity of the fractions was assessed by denatur-
ing electrophoresis on polyacrylamide gels using the Tris-Tricine bu↵er system, according
to Section 2.4.7
2.4.6 Purification of intein-fused synthetic substrates
Intein-CBD-fused substrates were purified by a nity chromatography on 0.8 mL bed vol-
ume Micro Bio-Spin Columns (BioRad, USA) hand-packed with 0.2 mL Chitin Resin (New
England Biolabs, USA). Chromatography was conducted by gravity flow, with bu↵ers and
samples loaded by carefully pipetting directly over the resin, according to the manufac-
turer’s recommendations. Sample injection, column washing, and elution phases of the
purification process were each collected in separate 15 mL tubes, with no further fraction-
ation.
The columns were equilibrated with 3 mL Chitin Column Bu↵er (Chitin CB, 20 mM
Tris-Cl pH 8.5, 500 mM NaCl, 0.1% (v/v) Triton X-100) and 2 mL of each lysate was
loaded, collecting the flow-through fraction. The columns were then washed with 4 mL
Chitin CB to remove unbound proteins. In-column self-cleavage of the intein-CBD tag was
initiated by washing the column with 0.6 mL Chitin CB with 50 mM DTT, followed by
capping of the columns and overnight incubation at 4°C for the intein clevage reaction.
Free peptides were eluted by loading 1.2 mL Chitin CB. The columns were regenerated by
loading 0.6 mL Chitin CB with 0.3 M NaOH and capping the columns to incubate for 30
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minutes at room temperature, followed by a wash with 2 mL Chitin CB with 0.3 M NaOH,
5 mL dH2O and 1 mL Chitin CB.
The eluted peptide fractions were then reloaded onto the equilibrated columns to capture
the remaining uncleaved fusion peptides. After the loaded sample was collected as flow-
through, another 1 mL Chitin CB was loaded to increase the peptide yield and collected
as a pool with the first flow-through fraction.
The peptides were then concentrated and bu↵er-exchanged by ultracentrifugation using
Amicon-30K and Amicon-3K spin filters. The 30 kDa cuto↵ filter was used to remove any
traces of the fused peptides and other proteins and the 3 kDa cuto↵ filter was used to con-
centrate the peptide and remove traces of contaminants that could interfere in downstream
analyses. Purity of the concentrated material was assessed by denaturing electrophoresis
on polyacrylamide gels using the Tris-Tricine bu↵er system, according to Section 2.4.7
2.4.7 Protein electrophoresis
All denaturing polyacrylamide gel electrophoresis experiments for protein detection (SDS-
PAGE) were carried out in vertical systems (Peqlab, Germany) and gels were made with
an Acrylamide:Bis-acrylamide 37.5:1 40% (w/v) solution (Alfa Aesar, USA). Two di↵erent
gel and bu↵er compositions were used for the experiments in this report, one for proteins
> 30 kDa and the second for peptides < 20 kDa.
For larger proteins, a two-layered (stacking and resolving gels) system was used. The
stacking gel composition was 5% (w/v) Acrylamide:Bis-acrylamide, 125 mM Tris-Cl pH
6.8, 0.05% (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED. Resolving gel composition
was 8% Acrylamide:Bis-acrylamide, 375 mM Tris-Cl pH 8.8, 0.05% (w/v) SDS, 0.1% (w/v)
APS, 0.1% (v/v) TEMED.
The resolving gel was poured first, followed by an overlay of 2-butanol to remove air
bubbles and ensure a horizontal interface with the stacking gel. Once the first gel was
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polymerised, 2-butanol was washed away with dH2O, the stacking gel was poured and the
wells were cast in it.
Samples are diluted twofold in 2X SDS-PAGE sample bu↵er (100 mM Tris-Cl pH 6.8,
4% (w/v) SDS, 0.02% (w/v) Bromophenol Blue, 20% (v/v) glycerol, 20 mM TCEP) and
incubated at 95°C for 5 minutes before loading into the wells in the stacking gel. The
composition of the SDS-PAGE running bu↵er is 25 mM Tris, 192 mM glycine, 0.1% (w/v)
SDS pH 8.3.
2.4.8 Peptide electrophoresis
For smaller peptides, a three-layered (stacking, spacer and resolving gels) system was
used with a Tris-Tricine bu↵er system (Tricine SDS-PAGE). The stacking gel compo-
sition was 4% (w/v) Acrylamide:Bis-acrylamide, 125 mM Tris-Cl pH 6.8, 0.05% (w/v)
SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED. The spacer gel composition was 10% (w/v)
Acrylamide:Bis-acrylamide, 375 mM Tris-Cl pH 8.8, 0.05% (w/v) SDS, 0.1% (w/v) APS,
0.1% (v/v) TEMED. The resolving gel composition was 16% (w/v) Acrylamide:Bis-acrylamide,
375 mM Tris-Cl pH 8.8, 0.05% (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED.
The resolving gel was poured first, followed by an overlay of 2-butanol to remove air
bubbles and ensure a horizontal interface with the stacking gel. Once the first gel was
polymerised, 2-butanol was washed away with dH2O, the spacer gel was poured to a height
of approximately 1 cm and overlaid with 2-butanol until polymerisation. The organic
solvent was washed away, the stacking gel was poured and the wells were cast in it.
Samples for peptide gels were diluted twofold in 2X non-reducing SDS-PAGE sample
bu↵er (100 mM Tris-Cl pH 6.8, 4% (w/v) SDS, 0.02% (w/v) Bromophenol Blue, 20% (v/v)
glycerol) and incubated at 95°C for 5 minutes before loading into the wells in the stacking
gel. Two di↵erent running bu↵ers are used in this system, Tricine SDS-PAGE cathode
bu↵er (100 mM Tricine, 100 mM Tris, 0.1% (w/v) SDS pH 8.3) and Tricine SDS-PAGE
anode bu↵er (133 mM Tris-Cl pH 8.8).
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2.4.9 Denaturing polyacrylamide gel electrophoresis for nucleic acids
Electrophoresis in denaturing polyacrylamide gels was used for detection of nucleic acid
fragments smaller than 100 bp and single base-pair resolution of fragments (Urea-PAGE).
Gels contained 15% polyacrylamide (19:1 acrylamide:bis-acrylamide) with 8 M urea in 1X
TBE and were cast homogeneously in a single step.
An equal volume of Urea-PAGE loading solution (98% (v/v) formamide, 10 mM EDTA,
0.02% (w/v) Orange G) was added to samples, which were incubated at 95°C for 5 min
before loading onto the gel. Runs were carried out at a constant current of 30 mA for 1.5-2
h. FAM-labeled oligos were detected by imaging on a Typhoon FLA 9500 scanner (GE Life
Sciences).
2.4.10 Cleavage of MBP fusion tag by proteases
Factor Xa and ProTEV plus were used to remove fused MBP from TOMM synthase com-
plex enzymes and substrates and cleavage e ciency was monitored by acrylamide gel elec-
trophoresis. Factor Xa cleavage reactions contained 50 mg MBP fusion proteins, 20 mM
Tris-Cl pH 7.5, 100 mM NaCl, 2 mM CaCl2 and 0.5 mg Factor Xa protease. Reactions were
incubated at at 23°C for 16 h. ProTEV plus reactions were carried out simultaneously with
TOMM synthase activity reactions (Section 2.5.1).
2.4.11 Precipitation of peptides by Acetone/Trichloroacetic acid
Peptides were precipitated in microcentrifuge tubes in 80% (v/v) acetone, 10% (w/v)
trichloroacetic acid, with the addition of 10 m glycogen azure to facilitate visualization
of pellets. Precipitations were incubated at -20°C for at least 16 hours, then centrifuged at
17,000 g for 1 hour. Pellets were washed twice in acetone by discarding the supernatant,
adding 500 mL acetone and centrifuging at the same conditions for 15 minutes. After the
second wash, the pellets were air-dried and resuspended in 50 mM TEAB pH 8.5, MBP
fusion elution bu↵er or acetonitrile for water-insoluble peptides.
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2.4.12 Protein quantitation in solution
Proteins in solution were quantitated using the Pierce 660 nm Protein Assay Reagent
(Thermo Scientific, USA), according to the manufacturer’s instructions. The protocol was
adapted for use in the low-volume LVis accessory for the SpectroStar Nano (BMG Labtech,
UK) instrument, by proportionally scaling down the recommended assay volumes to 20 mL.
2.5 TOMM Synthase activity detection
2.5.1 Activity assay conditions
TOMM Synthase activity assays were conducted according to the methods of Dunbar et al.
(2012). The reaction mixtures contained 100 mM Tris-Cl pH 7.5, 125 mM NaCl, 2 mM
ATP, 20 mM, MgCl2 and 10 mM DTT in a volume of 50 µl. Free Substrate peptides
(100 µM) and FactorXa-cleaved synthase complex enzmyes (10 µM each) were added and
incubated at 25°C for at least 16 hours. For the enzyme fusions that contain TEV protease
cleavage sites, all proteins and peptides were added as MBP fusions and 5U TEV Protease
was added to the reaction to release the free enzymes and substrates for reaction.
After incubation, results were analysed by precipitating the reaction products with ace-
tone/TCA (see Section 2.4.11) and detecting migration shifts in Tricine SDS-PAGE (see
Section 2.4.7), analysing by MALDI-TOF (see Section2.5.2), or thiol labeling with fluores-
cent dyes 2.5.3.
2.5.2 Detection of heterocyclisation by Mass Spectrometry
MALDI-TOF Mass Spectrometry was carried out in a Waters MALDI Micro MX (Waters
Corporation, USA) instrument in linear negative mode for peptide detection, scanning in
a m/z range of 500-10,000. Peptides in 50 mM TEAB were mixed with CHCA matrix
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(See Appendix A) in equal volumes and spotted onto MALDI plates. Spots were air-
dried at room temperature before loading into the instrument. Masses were normalised to
Calibration Mixture 2 of the Sequazyme Peptide Mass Standards Kit (Life Technologies,
USA).
LC-MS was carried out in a Waters Acquity UPLC - Single quadrupole system, using
an Acquity BEH C18 column (Waters) in a gradient from 5% to 95% (v/v) acetonitrile in
5 minutes, containing 0.1% (w/v) formic acid. Samples were dissolved in acetonitrile and
20 µl were injected for each sample. Electrospray was used for ionisation and detection
in the quadrupole was done in positive mode, between 150-2000 m/z and McbA peptides
were detected approximately 1.5 minutes after injection. Spectra were deconvoluted using
Water MassLynx software.
2.5.3 Chemical labeling of cysteine residues in peptides
Prior to chemical labeling of cysteine residues, peptides were bu↵er exchanged into La-
beling Bu↵er (40 mM Tris-Cl pH 7.5, 300 mM KCl, 2 mM EDTA, 0.1% (w/v) Triton
X-100). Iodoacetamide-Fluorescein (IAA-FITC) or Fluorescein-5-Maleimide (FITC-Mal)
were added to the peptides in varying molar ratios and incubated for 2 hours at room
temperature, while protected from light. The reaction was quenched by the addition of a
2-fold excess of L-cysteine to dye and the reaction products were loaded on Tricine SDS-
PAGE gels for analysis. Fluorescent signal from the dye was detected prior to staining for
proteins, using a Typhoon FLA9500 (GE Healthcare, Sweden) scanner. After recording of
the fluorescent signal from the cysteine labeling, the gel was stained with InstantBlue dye
and scanned a second time with the appropriate filters for protein detection.
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2.6 Bioinformatics
2.6.1 Dataset construction for functional predictions
Sequence based methods were used to construct large and diverse Multiple Sequence Align-
ments for functional residue prediction in TOMM Synthase proteins. The methods used in
this process are summarised in Fig. 2.2.
A separate functional residue prediction dataset was created for each of the three en-
zymes in the E. coli TOMM synthase complex, using publicly available sequence databases.
The initial set (referred to as Validated MSA in this thesis) was constructed by perform-
ing blastp searches with the B. amyloliquefaciens protein sequences as queries against the
NCBI nr database with a 10-6 e-value cuto↵. This stringent cuto↵ value was used in the
initial search to recover a number of homologues that was not too large for manual analysis
in the construction of the Validated MSA. Only hits that contained genes for the remaining
two genes in the TOMM synthase complex within a window of no more than 20kb were
included in the initial Curated dataset. Hits retrieved by this method were aligned using
the T-Co↵ee package (Notredame et al., 2000).
The sequences in the Curated dataset were used as queries for a new round of blastp
searches with the same parameters as above (10-6 e-value cuto↵). A computational pipeline
was implemented to produce the input MSAs for functional prediction using the local
pairwise alignments from the blastp output. The tools used were freely available sequence
analysis software (Uclust, exonerate) and a set of perl and MATLAB scripts for conversion
of file formats and construction of the final alignments (see Fig. 2.2 for an overview of the
workflow and Appendix C for the scripts used in this section).
First, the script PWA-reformat.pl (See Appendix C) was used to extract the sequence
IDs of each of the hits in the search, as well as all the pairwise alignments generated by the
query. The sequence IDs were used to recover all the individual target sequences from the
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Figure 2.2: Analysis pipeline implemented for the E. coli TOMM synthase complex
enzymes. The validated dataset was created by manual curation of BLAST hits from
the E. coli query sequences, to include only sequences found within a genomic cluster
that contained homologues for all three enzymes of the TOMM synthase complex. These
sequences were aligned by T-Co↵ee to produce the Validated MSA and also used as queries
for a larger BLAST search. The sequences obtained in the second BLAST search were
clustered to remove duplicate sequences and very close homologues, then an Expanded
MSA was created by realignment of the regions recovered from the BLAST searches and
removal of columns with low alignment quality. Both MSAs were then used as input into
prediction strategies.
local copy of the nr database using the fastafetch script from Exonerate (https://www.
ebi.ac.uk/~guy/exonerate/). The pairwise alignments were used in the construction of
the final MSA, after the filtering steps.
These were clustered (Edgar, 2010) in groups of >95% identity and all but one of the
sequences in each of these groups was removed from the dataset, to reduce any biases due
to overrepresentation of certain taxonomic groups in the sequences deposited in nr. The
clustering package output was then parsed with the clusterParse.pl script (See Appendix C),
extracting a representative sequence for each cluster, to be part of the final MSA. The
sequence ID of each representative cluster was written to another file to be used for selection
of the pairwise alignments added to the final MSA.
Each column in the Validated MSAs was also scored by the Quality values calculated
by the Jalview alignment software (Waterhouse et al., 2009) and any columns with Qual-
ity values below 50 were deleted from the MSAs to focus the analysis on regions that
were more highly conserved in the Curated MSAs. This score is calculated by summing
the BLOSUM62 scores for each pair of mutations in an alignment column and, since sub-
stitutions between similar residues in BLOSUM62 have higher scores, columns with high
Quality scores will have high proportions of similar residues. This filter by the Jalview
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Quality value was used to remove columns containing large proportions of gaps, that could
bias the results produced by prediction strategies that frequently ignore gaps.
The per-column quality values extracted from Jalview and BLAST reports are used as
input for the script hash.pl (See Appendix C). This script detects which of the queries in
the Validated dataset had the best pairwise alignment to each of the target sequences in the
BLAST results and also matches the high-quality positions in the Validated MSA to their
equivalent positions in the selected pairwise alignment. Each of the highest-scoring pairwise
alignments is then printed into a separate FASTA file by the script pairwiseSplitFilter.pl
(See Appendix C).
The MATLAB script MSAMapper.m (See Appendix C) takes as input the selected high-
quality sites in each of the pairwise alignments and builds a single MSA, containing the
residue found at each of these positions for all the pairwise alignments that were selected.
This is done by mapping each column in the pairwise alignments back to the original
Validated MSA, using the pairwise alignment start position and the residue numbering of
the query sequence in each alignment. This final dataset was then exported into a FASTA
format that could be submitted to functional prediction web servers and custom scripts.
2.6.2 Functional residue prediction
The Expanded MSA was submitted to functional residue prediction servers to be analysed
by the Jensen-Shannon Divergence (JSD (Capra and Singh, 2007)) and Cumulative Mutual
Information (CMI (Simonetti et al., 2013)) methods using the default settings. Additionally,
both data sets were scored by the proposed Normalised Shannon Entropy (NoSE) method,
based on the following equation (described in Chapter 3):
NoSEi = PimaxC( 
20P
j=1
PijE ⇤ log2PijE)
where PimaxC is the frequency of the most common residue in the ith column of the Curated
MSA and PijE is the frequency of residue j in the ith column of the Expanded MSA.
NoSE was calculated by running the script freqscores2MSAs.m (See Appendix C) with the
Validated and Expanded MSAs loaded in MATLAB.
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2.6.3 Analysis of functional prediction results
The top 5% of scores for all three methods were selected for further analysis. Homology
models of each enzyme in the B. amyloliquefaciens TOMM synthase complexes were con-
structed by submitting their amino acid sequences to the PHYRE2 homology modelling
server, using the intensive modelling mode (Kelley and Sternberg, 2009). These models
were then structurally aligned with their homologous template structures and candidate
functional residues were plotted onto the aligned structures using PyMOL (The PyMOL
Molecular Graphics System, Version 1.6.0 Schro¨dinger, LLC.)
2.6.4 Simulation of libraries produced by InDel Assembly
In silico library assemblies and selections were carried out using a set of MATLAB scripts
written by Dr. Vitor Pinheiro. Script InDEL assembly3b CsvRead.m simulated library
assembly using assembly e ciency and number of cycles as input values that can be altered
directly in the script and relative frequencies of each codon for each assembly step from the
fred input.csv file. Simulated enrichment and motif detection were then carried out using
scripts InDEL selection3.m and InDel analysis3.m
2.6.5 Treament of MiSeq data for analysis
Reads in fastq format were trimmed to remove the NNN sequence at the 50 and all sequences
past the 100th nucleotide at the 30 end using the script fastx trimmer from the FASTX-
Toolkit (Available at: http://hannonlab.cshl.edu/fastx toolkit/). This step was followed
by a quality control step, keeping only reads with > 30 quality value over > 90% of their
sequence, using the script fastq quality filter (FASTX-Toolkit). Reads were then demulti-
plexed according to the indices used for each library with the script fastx barcode splitter
(FASTX-Toolkit) and trimmed again to remove the indices and ensure that the first nu-
cleotide of each read was the beginning of the variable region of each library and in the +1
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frame for translation. Text file NGS-analysis-Workflow-PT.rtf contains sample command
lines to carry out NGS data treatment steps.
Reads were converted to FASTA format using script fastq to fasta (FASTX-Toolkit) to
produce the input file for transeq (EMBOSS v.6.6.0, (Rice et al., 2000)). C-terminal fixed
regions in loop sequences were removed by matching with the custom perl script Cter-
trim.pl, producing protein sequences corresponding only to the variable region of the W loop.
Reads were then counted using the custom perl script fasta-to-fastaCounts.pl, generating a
FASTA file with each unique read as a single sequence containing its number of ocurrences in
the dataset as part of the FASTA header. The custom perl script fastaCounts-toMatlab.pl
was then used to produce a .csv file as input for K-mer analysis in MATLAB.
2.6.6 Detection of enriched motifs by K-mer-based analysis
NGS-derived enrichment data was analysed with script TEM1 PoissonZscores csvOutput.m,
using .csv files of sequence counts generated for each library pre- and post-selection as
input. Hamming distances to selected sequences were calculated with script fastaCounts-
HammD.pl. Sequence logos were created with the weblogo tool (Crooks et al., 2004), using
scripts csv-to-fasta.pl and MakeLogos.sh to, respectively, reformat .csv sequence frequency
files into a simple FASTA file that retained frequency information and to automate gener-
ation of logo images.
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Development of a strategy for sequence-based functional residue
prediction in TOMM synthase proteins
3.1 Introduction
Protein sequence databases are useful tools for learning about the function of any given pro-
tein, by allowing the assignment of putative functions to uncharacterised proteins based on
homology to related sequences of known function. For TOMM synthases and their homo-
logues, these resources are unreliable, due their homologues being annotated with multiple
distinct functions (see Chapter 4 for the results of TOMM synthase homology searches),
such as nitroreductases among the TOMM dehydrogenase homologues and adenylases with
strong similarity to TOMM docking proteins. Since many predicted functions in sequence
databases are derived solely from homology-based transfer and this strategy is known to
be prone to mis-annotations (Friedberg, 2006), these are not always accurate indicators
of the true function of a given sequence. The lack of direct biochemical evidence for the
mechanisms of TOMM biosynthetic enzymes and the unreliable database annotations make
it impossible to create a “pure” dataset for functional prediction strategies, containing only
sequences predicted with a high degree of confidence to encode proteins involved in TOMM
biosynthesis. As the sequence similarity between homologues and known TOMM synthase
proteins increases, it becomes more likely that a homologue will possess a distinct function
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or even both functions at the same time — though such bifunctional proteins could also
have been lost along evolutionary time and the extant proteins all possess a single function.
The inability to generate clearly separated datasets containing homologous TOMM syn-
thase proteins and related proteins with divergent functions prevented the use of tools such
as SDPpred (Kalinina et al., 2004) for detecting functionally relevant residues within the
groups, since these require two or more clearly delimited groups of sequences as input.
Therefore, only datasets probably containing mixed functions could be produced and any
attempts at functional prediction with these sequences would have to explore the evolution-
ary information that can be extracted from a single MSA as input. Within such a dataset,
columns with high conservation and coevolution signals would be expected to contribute
to all or most of the functions contained in the MSA.
Any site that is only important for the function of a subset of the larger group would
be more di cult to detect due to a lack of signal from the other sequences in which that
site is not functionally-relevant. To circumvent this issue, a novel metric was developed to
compare conserved sites within the few validated TOMM synthase complexes to the wider
diversity found in the mixed datasets, with the aim of recovering information on sites which
contribute specifically towards functions related to TOMM biosynthesis.
3.1.1 Sequence-based metrics selected for functional residue prediction
Two complementary measures were selected from the literature for prediction of functional
residues from these mixed-function datasets: Jensen-Shannon Divergence (JSD, Capra and
Singh (2007)) and Cumulative Mutual Information (CMI, Marino Buslje et al. (2010)). JSD
was designed to detect conserved columns within alignments, which are likely to be relevant
to the function of all proteins in the dataset. On the other hand, CMI detects columns that
show strong covariation with other sites, suggesting coevolutionary interactions maintained
throughout the phylogenetic diversity contained in the input MSA.
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The conservation measure JSD of a column in a large MSA is a comparison of the
frequency distribution observed for that column to a background distribution, which is
the set of expected frequencies from the BLOSUM62 alignment scoring matrix (Capra
and Singh, 2007). Since this background distribution was computed from a large and
phylogenetically diverse set of protein sequences, a large deviation from this distribution
implies the existence of an evolutionary constraint maintained by purifying selection and,
therefore, a possible functional importance. JSD is calculated according to the following
equation:
JSDi =  
 
20X
a=1
Pi(a) ⇤ logPi(a)
r(a)
!
+ (1   )
 
20X
a=1
q(a) ⇤ log q(a)
r(a)
!
(3.1)
where pi(a) is the is the frequency of amino acid a in column i,   is a prior weight (the
default value of 0.5 was used), q(a) is the frequency of amino acid a in the background
distribution (derived from BLOSUM62), and r(a) =   pi(a) + (1   ) q(a). This score can
vary from 0 to 1, with 0 being the score when the distribution at the MSA column matches
the background distribution perfectly and the highest values occurring when the query
MSA has high frequencies for residues that are infrequent in the background distribution.
The mutual information between two frequency distributions is a measure of how de-
pendent one distribution is on another and is calculated according to the equation:
MI(i, j) =
20X
a,b=1
P (ai, bj) ⇤ log P (ai, bj)
P (ai) ⇤ P (bj) (3.2)
where (P (ai) is the frequency of amino acid a occurring at position i, P (bj) is the frequency
of amino acid b occurring at position j and P (ai, bj) is the frequency of amino acids a and b
occurring at positions i and j, respectively. Therefore, two columns in an MSA with a high
mutual information have a high likelihood of covarying. The coevolution measure CMI for
a column i within an MSA is calculated by adding all possible pairwise mutual information
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values between column i and the remaining positions in the MSA. A column i that has
a high CMI is simultaneously covarying with several other residues within the sequence,
which indicates that any mutation in that column tends be compensated by mutations at
other sites to maintain the function of the high CMI residue.
To compensate for the inability to generate validated TOMM synthase complex dataset
that is large enough for detection of functional residues, an alternative approach was devised
to extract information from the small set of representatives of this family that have been
characterised. If MSAs that can be constructed from homology searches of TOMM synthase
protein sequences contain divergent functions, any residues that are strongly conserved in
the known TOMM synthase proteins but are less evolutionarily constrained in the complete
MSAs are expected to be relevant to TOMM synthase-specific functions. Therefore, a
metric was developed to identify residues that have evolved following this pattern, as a
third strategy to employ the information contained in the diversity of TOMM synthases
and their homologues towards a greater understanding of the mechanisms for the production
of these peptide-derived natural products. Then, a search was carried out for a suitable
protein family to be used as a benchmark for the proposed metric together with the two
published strategies (JSD and CMI), followed by the construction of an input dataset and
validation of predictions by comparisons to published structural information and mutations
with known e↵ects.
3.2 Results and Discussion
3.2.1 Normalised Shannon Entropy
In a theoretical MSA containing only TOMM synthase complex proteins, any residue that is
strictly required for function in TOMM biosynthesis would be expected to be in a fully con-
served column. If the homologue of this residue is not important for the distinct functions
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of proteins that diverged from TOMM synthase proteins, it would be expected to contain
higher diversity due to relaxation of purifying selection at that position, representing a de-
terminant column as defined in Section 1.4.2.1. Therefore, in an extensive MSA produced
by alignment of sequences of mixed function recovered from homology searches (as depicted
in Fig. 1.6), this same column would be expected to contain diversity proportional to the
relative amount of TOMM synthase proteins — in which the residue is conserved — and
homologues with distinct functions — in which the residue is not constrained by purifying
selection — in the MSA. The diversity contained within a column can be estimated by a
simple metric such as Shannon Entropy(Shannon, 1948):
SEi =
 
 
20X
a=1
Pi(a) ⇤ logPi(a)
!
(3.3)
where Pi(a) is the frequency of residue a at column i of the MSA. However, this metric
alone would not be expected to recover the residues that are conserved in the subset of
proteins encoding for members of the TOMM synthase complex. The columns with the
highest Shannon Entropy values are poorly conserved for the entire alignment, likely to
be positions in the MSA which are not under selection pressure for any of the proteins
contained in the dataset.
Therefore, a hybrid metric was proposed to detect conserved residues within a smaller
MSA composed of validated TOMM synthase proteins — hereafter referred to as Validated
MSA — and use that information to modify the SE metric by penalising high diversity
columns int the larger MSA — hereafter referred to as Expanded MSA — that are not con-
served in the validated set. This metric was named Normalised Shannon Entropy (NoSE)
and is calculated according to the following equation:
NoSEi = PiC
 
 
20X
a=1
PiE(a) ⇤ log2PiE(a)
!
(3.4)
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where PiC is the frequency of the most common residue in the ith column of the Validated
MSA and PiE(a) is the frequency of residue a in the ith column of the Expanded MSA. This
score has a maximum value of approximately 4.3 (log220), when the ith site is invariable
in the Validated MSA, the Expanded MSA has all 20 aminoacids in the same frequency
(5%) and the relative frequency of TOMM synthases in the larger expanded set is very low.
However, this would also imply that any predictions obtained by the other two methods
were made on datasets containing mostly non-TOMM sequences, which was not the case
in the predictions made here, since no NoSE scores above 4 were observed in the datasets
that were explored.
Other example scenarios for the e↵ect varying degrees of conservation in both the Val-
idated and Expanded MSAs can be found in Table 3.1. The NoSE metric penalises all
scenarios except for the one where there is a high degree of conservation in the Validated
MSA and a high diversity in the Expanded MSA.
PiC P iE(a) NoSE
0.8 0.05a 3.5
0.8 0.2b 1.9
0.8 0.8c 0.6
0.2 0.05a 0.9
0.2 0.2b 0.5
0.2 0.8c 0.1
Table 3.1: Examples of NoSE scores for various conservation scenarios. a Equal frequency
of 0.05 for all residues in the Expanded MSA, representing no conservation. b Equal
frequency of 0.2 for five residues in the expanded MSA and 0 for all others, representing
an intermediate level of conservation. c 0.8 frequency for one residue and 0.2 frequency for
another, with 0 frequency for all others, representing a high level of conservation in the
Expanded MSA.
However, since the sequences from the Validated MSA are also contained in the Ex-
panded MSA, the relative size of the two alignments can also have a strong influence on
the NoSE score. If the Validated MSA is exactly half the size of the Expanded MSA and
has one fully conserved column, the maximum possible NoSE score for that column will
be approximately 0.32, when the Expanded MSA has the 19 residues not present in the
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Validated MSA in equal frequencies in its unique sequences. In this instance, the Shannon
Entropy component of the Expanded MSA would only be approximately 0.64, even though
the column is completely conserved outside the Validated MSA. Therefore, NoSE scores
will tend to reduce as the size of the Validated MSA is increased in proportion to the entire
Expanded MSA. In this work, this limitation of the method was not of large influence in
the calculated scores, since in all cases the Expanded MSA was at least 20 times larger
than the Validated MSA and a fully conserved column in the latter could not greatly a↵ect
the final residue frequencies of the former. Simulations with sampling of known datasets
could be carried out to more thoroughly explore the e↵ect of variations in relative size of
alignments and determine what range of relative alignment sizes can produce informative
predictions.
The intention for this metric was to extract additional information from the mixed-
function Expanded MSAs, that should be complementary to the predictions produced by
JSD and CMI, which respectively detect columns within the Expanded MSA that are con-
served or possess signs of coevolution with other columns. By extracting high-diversity
columns from the Expanded MSA that are conserved in the validated set, NoSE should
detect residues that became fixed or at least strongly conserved during the evolution of
TOMM synthases, but did not experience the same selective pressure in the set of homol-
ogous proteins that possess distinct functions.
Given the limited characterisation of the TOMM synthase complex proteins, these were
not ideal first targets to characterise NoSE. Instead, a functionally-diverse family of proteins
with extensive biochemical and structural characterisation was selected to validate the
proposed metric in comparison to the selected coevolution- and conservation-based metrics
3.2.2 Construction of a benchmark dataset
The main requirements sought in a benchmark dataset were the existence of published
structural and biochemical information on functionally-distinct but homologous protein
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subfamilies and a low enough level of sequence divergence between the two families to allow
the construction of MSAs. These MSAs would be used as input for functional residue pre-
diction using the JSD, CMI, and NoSE scores, to be validated by comparisons to published
information on the function of the families.
Initially, the CATH database of protein superfamilies classified on the basis of structural
similarity and subdivided into smaller groups likely to share similar functions named Func-
tional Families (FunFams), was used to search for a target family (Dawson et al., 2017),
along with associated functional annotation extracted from other resources, such as the
Catalytic Site Atlas (CSA, Porter et al. (2004)). A particularly well-annotated superfamily
— Aldolase class I (CATH Superfamily 3.20.20.70) — was selected for its abundance of
catalytic site information and preconstructed alignments were downloaded for two of its
FunFams. Attempts were made to merge the alignments from the two families by purely
sequence-based algorithms such as MUSCLE (Edgar, 2004), but this produced alignments
containing large tracts of gaps due to the high sequence divergence contained in these
families defined by structural similarity. Due to time constraints, no further improvement
was pursued for this superfamily and an alternative dataset was sought that could be con-
structed using only sequence-based alignment strategies.
The periplasmic Solute-Binding Proteins (SBP) of Gram-negative bacteria were selected
as another candidate for a benchmarking family for the TOMM synthase functional pre-
dictions. These proteins act as highly-specific receptors for substrates of the diverse group
of ABC importers and have been intensely studied. Structures are available for many of
these proteins — some crystallised in the presence and absence of their substrate (Oh et al.,
1994; Sun et al., 1998) — and their wide range of specificities has been exploited for biosens-
ing applications, including artificial variants with altered substrate specificity (de Lorimier
et al., 2002; Dattelbaum and Lakowicz, 2001; Gruenwald et al., 2012).
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The Glutamine-Binding Protein (GlnBP, UniProt P0AEQ3) from E. coli (Sun et al.,
1998) and the Lysine-, Arginine-, Ornithine-binding protein (LAO, UniProt P02911) from
Salmonella enterica (Oh et al., 1994) were selected as the starting points for dataset con-
struction. Crystal structures of both of these proteins are available in both apo and
substrate-bound forms, providing information on substrate-binding residues as well as con-
formational changes that occur upon binding. A separate set of homologous sequences were
constructed for each protein and these were combined into an Expanded MSA for calcula-
tion of the functional prediction scores, with the separate sets serving as Validated MSAs
for calculation of the conservation component of NoSE scores.
The sequences of both proteins were used as queries for BLASTP searches of the NCBI nr
database, producing tens of thousands of hits even at very stringent e-value cuto↵s (10-20).
These numbers are too large for alignment using computationally-intensive and accurate
methods such as T-Co↵ee, so clustering with USEARCH (http://www.drive5.com/usearch/)
was used to reduce the size of the sequence sets. In addition to the reduction in computa-
tional complexity, clustering removes duplicate sequences from strain genomes and reduces
the phylogenetic bias created by uneven distribution of genome sequencing e↵orts.
While the separate datasets were being constructed, sequences annotated as putative
GlnBP were detected in the set constructed with LAO as seed and vice-versa. The low se-
quence divergence between GlnBP and LAO that allowed them to be easily aligned to each
other also meant that homology searching by BLAST could e ciently recover members of
both functional groups from either query sequence. Since this would mean that the dataset
constructed for each function was “contaminated” by sequences annotated as coding for the
other function, the separate datasets could not be used as a Validated MSA for the NoSE
prediction which requires an alignment containing only a single function. Therefore, a single
Expanded MSA was constructed from the sequences obtained by the LAO BLAST searches
and a second, smaller, Validated MSA was constructed by manual curation containing only
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sequences annotated as GlnBP homologues from the NCBI Protein database and selecting
for a wide range of phylogenetic origins. This small set contained twelve sequences, with
at least one member of each of the following bacterial phyla: Alphaproteobacteria, Be-
taproteobacteria, Gammaproteobacteria, Deltaproteobacteria, Epsilonproteobacteria and
Firmicutes.
The larger dataset was constructed by taking sequences obtained by BLAST with the
LAO as query, with an e-value cuto↵ of 10-25 and a coverage cuto↵ of 90% to eliminate
partial alignments. Sequences with identity above 60% were clustered with USEARCH and
represented by only a single centroid sequence in the final alignment, to reduce the computa-
tional e↵ort required for alignment, producing a set of 741 sequences. The manually-curated
set of twelve GlnBP was concatenated into the larger set and all sequences were aligned
with T-Co↵ee, for a total of 753 sequences. The same Jalview Quality score cuto↵ of 50
was used initially to eliminate columns containing large proportions of gaps, but this still
left relatively large regions (>20 contiguous columns) containing >80% gaps. Therefore, all
columns with Jalview quality scores <300 were removed from this alignment to prevent the
scores being skewed by the small number of sequences that contained non-gap characters
at these sites.
3.2.3 Functional residue predictions in Solute-Binding Proteins
Since GlnBP from E. coli has had its structure determined both in the presence and absence
of glutamine (PDB IDs 1ggg and 1wdn, respectively), these structures were used here to
analyse the possible e↵ects of predicted functional residues (Fig. 3.1). The overall structure
of GlnBP and other SBPs is bilobed with a connecting hinge and a cavity formed between
the two lobes that forms the substrate-binding site. A large inter-domain movement occurs
upon substrate binding, with the ends of the lobes opposite the hinge coming closer upon
substrate binding (Fig. Fig. 3.1, bound glutamine in magenta).
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Figure 3.1: Structures of E. coli GlnBP. (a) GlnBP crystallised in the absence of sub-
strate (PDB ID 1ggg). (b) GlnBP crystallised in the presence of glutamine (PDB ID
1wdn).
The completed datasets were used as input for the selected functional prediction algo-
rigthms: JSD, CMI, and the NoSE score proposed in this work. JSD and CMI use only the
Expanded MSA containing more than one functional group and NoSE uses both the large
set and the manually-curated Validated MSA containing only GlnBP homologues. The top
5% of scores for each metric were selected, as an arbitrary cuto↵, for further analysis. These
residues were plotted onto the apo and substrate-bound forms of the GlnBP structure and
compared to previously published studies that characterised mutants or studied the func-
tion of this protein by other structural techniques such as NMR or molecular dynamics
(MD) simulations. As expected, the metrics selected columns within the Expanded MSA
with distinct evolutionary trajectories, which can be evidenced by the lack of any overlap
between the residues selected by each metric (Fig. 3.2).
The highest-scoring residues for the JSD metric in GlnBP were distributed throughout
the sequence, but all were located around the large domain of the bilobed structure of the
SBP proteins (Fig. 3.3). None of the top-scoring residues for JSD form direct contacts
with the substrate, but F16 and G26 are part of the hydrophobic core directly underlying
substrate-interacting F13 (Pistolesi and Tjandra, 2012) and could have indirect e↵ects on
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Figure 3.2: Venn diagram depicting the lack of overlaps between the top 5%-scoring
residues in GlnBP for JSD(yellow), CMI (red), and NoSE(blue)
activity through these contacts. The mobility of V14 has been demonstrated to be sig-
nificantly constrained upon substrate binding by MD simulations (Lv et al., 2017), which
could also suggest an indirect role in GlnBP activity. Residue W220 has previously been
assumed to be dispensable for glutamine binding and was mutated to cysteine to convert
GlnBP into a biosensor by labeling with a thiol-reactive dye (de Lorimier et al., 2002). How-
ever, characterisation of a W220A mutant showed reduced a nity to glutamine, confirming
a functional role in determining specificity for this residue (Gruenwald et al., 2012).
As was observed for JSD, the top-scoring residues for CMI (Fig. 3.4) were mostly located
in the large domain, but two residues (A182 and Q184) from this prediction were located
in the hinge region that connects the two domains. This region regulates the inter-domain
movement that occurs upon substrate binding and Q184 has been shown to form part of
a network of hydrogen bond contacts within this region that is though to stabilise the apo
form of the protein in the transport-incompetent open state (Sun et al., 1998). Residue
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Figure 3.3: Highest scoring residues for JSD in GlnBP. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of JSD scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in yellow on the structure of the apo form of
GlnBP (PDB: 1ggg). (d) Top 5% residues highlighted in yellow on the Glutamine-bound
structure of GlnBP (PDB: 1wdn). The bound glutamine is highlighted in magenta.
A56 is located along the putative interaction surface with the transmembrane portion of
the ABC transporter complex (Fig. 3.4 e), responsible for membrane transport of solutes.
The NoSE metric was calculated using the Validated and Expanded MSAs for GlnBP
and Shannon Entropy was also calculated for the Expanded MSA so the di↵erence between
the two metrics could be visualised (Fig. 3.5 a-b). Despite the existence of a correlation
between the two scores for each colum in the alignment (Fig. 3.5 c), the top 5% of scores
for each was distinct, with only two columns from the top 5% of Shannon Entropy values
also present in the selected columns for NoSE: Lys102 and a position that had a gap for the
GlnBP sequence in the Expanded MSA and was, therefore, not included in further analyses.
This comparison shows that the penalty towards non-conserved residues in the Validated
MSA allowed the detection of residues with potential function in GlnBP that would not
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Figure 3.4: Highest scoring residues for CMI in GlnBP. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of CMI scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in red on the structure of the apo form of GlnBP
(PDB: 1ggg). (d) Top 5% residues highlighted in red on the Glutamine-bound structure
of GlnBP (PDB: 1wdn). (e) Structure of a full ABC transporter complex (Vitamin B12
transporter from E. coli, PDB: 2qi9) in the same relative orientation as the models in
(c) and (d), with the solute-binding protein highlighted in red and the transmembrane
and nucleotide binding subunits in gold and cyan, respectively. The bound glutamine is
highlighted in magenta and the patch of residues on the surface mentioned in the text is
enclosed in a red dashed box.
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be selected by a strict diversity measurement in the Expanded MSA. The comparison
was extended by calculating the Shannon Entropy and ScoreCons metrics for the small
alignment, also showing no clear overlap between high-scoring residues in NoSE and these
other metrics ((Fig. 3.5, d-e)
Figure 3.5: Comparison between NoSE and other metrics scores. (a) Shannon entropy
values for each residue in the Expanded GlnBP dataset. (b) NoSE scores for each residue
in the GlnBP dataset. (c) Comparison between NoSE scores and Shannon entropy values
for each residue. The Pearson correlation coe cient between the two sets is 0.458. (d)
Shannon Entropy values for each residue in the Validated MSA. (e) ScoreCons values for
each residue in the Validated MSA.
Unlike in the published scores, among the top 5% of NoSE values for GlnBP were
residues in both domains of the protein (Fig. 3.6). One of the putative functional residues
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(Y185) was also in the hinge region, making hydrogen bond contacts to substrate-interacting
D157, and is a candidate trigger for the ligand-induced conformational change, mediating
the protein movements through its hydrogen bond contacts to the remaining hinge residues
(Sun et al., 1998). This residue was also one of the sites that produced a variant with
a nity towards lactate when mutated in an e↵ort to produce biosensors for non-cognate
small molecules using SBPs (Looger et al., 2003).
Similarly to residue F16 detected by JSD, F18 forms part of the hydrophobic core
directly interacting with F13 from the ligand site (Pistolesi and Tjandra, 2012), suggesting
a role in structuring the ligand-binding site for glutamine recognition. In addition, residues
K125 and G192 in the ligand-bound structure are located along the putative interaction
interface for the transmembrane subunits of the ABC transporter (Fig. 3.6 d), suggesting
a possible role in transporter function.
A summary of the predicted mutations compared to the results from the literature
described in the above paragraphs can be found in Table 3.2. Despite the prediction metrics
not identifying residues that interact directly with glutamine, at least three residues from
each prediction (out of a total of twelve, for a 25% hit rate) were found to have a known
contribution in the functional mechanism of GlnBP or were structurally modelled in a
position that suggests a role in ABC transporter function.
In addition to the residues discussed above and highlighted in Table 3.2 that have some
direct evidence for their possible function, other residues highlighted by the three methods
are positioned in the structure in ways that suggest a functional role.
For JSD, residues D63 and F81 (Fig. 3.3) are positioned on the surface of one of the
lobes, in a position that could also mediate interactions with the transmembrane transporter
subunit of the ABC transporter.
For CMI, residue E17 is a charged residue along the surface of the Gln-binding cavity
and can have interactions with the substrate during the binding process that were not
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Figure 3.6: Highest scoring residues for NoSE in GlnBP. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of JSD scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in blue on the structure of the apo form of GlnBP
(PDB: 1ggg). (d) Top 5% residues highlighted in blue on the Glutamine-bound structure
of GlnBP (PDB: 1wdn). The bound glutamine is highlighted in magenta and the patch of
residues on the surface mentioned in the text is enclosed in a blue dashed box.
captured by the crystallographic structure (Fig. 3.4). In addition, residues E34, A36, E38,
Y43, and L207 were highlighted by CMI and all lay along a large flat surface away from
the expected binding interface with the transmembrane subunits (Fig. 3.4, enclosed in
a red dashed box). GlnBP has known protein-protein interactions with binding partners
outside the glutamine ABC transporter complex, including components of ABC transporter
complexes for other amino acids (Szklarczyk et al., 2015), so this patch could represent a
region of the protein that coevolved to mediate interactions with diverse binding partners.
Among the residues highlighted by NoSE there was a group of residues similar to the
one described above for CMI, but on the other lobe of the structure, composed of residues
N99, K102, D106 and L180 (Fig. 3.6, enclosed in a blue dashed box). Since these residues
score highly in NoSE, they are well-conserved within the GlnBP proteins and variable in
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the larger set, which can indicate a role in an interaction that only occurs in the GlnBP
proteins.
Residue JSD CMI NoSE A nity Hinge Core Dynamics Interface
V14 X X
F16 X X
F18 X X
G26 X X
A56 X X
K125 X X
A182 X X
Q184 X X
Y185 X X X
G192 X X
W220 X X
Table 3.2: Summary of known function-a↵ecting mutations and structural information
for the sites selected by the three prediction metrics.
3.3 Conclusions
The results obtained from the benchmark functional predictions on GlnBP corroborate
the potential in employing the NoSE metric proposed here for sequence-based detection of
functional residues in diverse protein families. Using a dataset created by a simple analysis
pipeline, two residues known to contribute to the specificity of GlnBP towards glutamine
were detected, as well as two residues possibly involved in protein-protein interactions
essential for ABC transporter function. As expected from the distinct evolutionary signals
each metric was designed to detect, the residues selected by NoSE had no overlap with the
highest-scoring residues for the other two metrics used here, demonstrating their ability to
detect MSA columns with distinct evolutionary histories.
Among the residues detected by CMI, two distinct sets highlight the importance of
studying coevolving residues to detect functional constraints in protein evolution. The
A182-Q184 pair from the hinge region of GlnBP can represent a functional unit that is
maintained by purifying selection, eliminating variants at one site that are not compensated
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by a mutation at the other site. Similarly, the patch of residues highlighted at one end
of the protein not expected to participate in subunit interactions of the glutamine ABC
transporter complex (Fig. 3.4 c and d, enclosed in a red dashed box) could represent
a protein-protein interaction with component residues that must coevolve to produce a
functional binding interface to partners that vary as the protein family evolves.
Although known functional sites in GlnBP were successfully predicted, the benchmark
dataset used for these analyses was constructed using a simplified process that was chosen
due to the limited timeframe available for this process before completion of the thesis.
Therefore, subsequent work would necessarily include reconstruction of these benchmark
datasets to ensure a wider sampling of sequences and to reduce any phylogenetic bias,
following a strategy similar to what was used in the construction of datasets in Chapter 4.
Additionally, the number of sequences in the Expanded MSA used for GlnBP functional
predictions was reduced by aggressive clustering to enable construction of alignments on a
desktop computer with limited memory, which could be avoided by carrying out alignments
on dedicated servers. These improvements in the quality of the dataset should also make
predictions more informative, by decreasing the noise produced in the metrics by misaligned
sequences or spurious alignment due to phylogenetic biases. Another improvement that
could be made to the dataset generation step is the substitution of the Jalview Quality
score for another metric to estimate how reliable is each column of an alignment, possibly
as a strict cuto↵ based on the frequency of gap characters within a column. Since gaps
are ignored by the BLOSUM62 mutation scores that form the basis of the Jalview Quality
metric, this value in e↵ect is creating a bias towards more conserved columns while not
directly penalising columns with high proportions of gaps.
Application of these metrics to other protein families with deeper characterisation in
the literature could also be used to produce additional validation for the strategy proposed
here. Protein kinases could be an interesting candidate for a second benchmark family,
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due to their large diversity in eukaryotes and their relevance in cancer and other diseases
(Shchemelinin et al., 2006), which motivates the generation of large amounts of research
on their function and e↵ects of mutations (Lahiry et al., 2010; Patani et al., 2016). Intense
e↵orts are also dedicated towards the development of inhibitors for clinical use, due to the
di culties in producing specific inhibitors for members of this structurally-conserved class
of proteins (Arora and Scholar, 2005). Because of this di culty, predictions of specificity-
determining residues have been attempted for kinases with the aim of understanding the
structural basis for specificity and o↵-target e↵ects of inhibitor compounds (Ca↵rey et al.,
2008; Bradley et al., 2017). Since these studies have already constructed datasets for
functional prediction, the MSAs employed by the authors could be directly used as input
for JSD, CMI and NoSE, if they are already of su ciently high quality. The predictions
produced by these analyses could be validated by literature information and any uncharac-
terised residues — especially ones detected by NoSE analysis targeting specific kinases —
would be candidates for validation by experimental characterisation, to determine if any
represent previously undetected specificity determinants and, therefore, novel targets for
inhibitor development. In addition, comparisons against known benchmarks would allow a
deeper characterisation of the NoSE metric itself, producing information about the trade-
o↵ between prediction performance and false discovery rate in the method, to allow the
selection of thresholds for acceptance of prediction.
The NoSE metric itself could be also improved upon by changing its components that
calculate diversity of columns in the Expanded MSA and conservation in the Validated
MSA. As an example, the JSD metric could be used as the conservation measure to take
into account the di↵erent expected frequencies of each amino acid from a neutral background
distribution. This change could be beneficial because the JSD metric takes into account the
frequency of each residue at neutral columns, assigning higher scores to columns that diverge
strongly from these neutral frequencies. However, adopting this metric would also require
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larger Validated MSAs for reliable computation of frequency distributions for each column,
which can be di cult for proteins such as members of the TOMM synthase complex with
few validated homologues. The current components of NoSE were selected for producing
predictions with such limited datasets and any variations of the calculation will need to be
weighed against the available validated data.
The predictions generated here for GlnBP can contribute towards future characterisation
and engineering e↵orts for this protein. For instance, the residues putatively involved in
the interaction with the membrane subunit of the ABC transporter complex could be
validated by reconstitution of the entire ABC transporter complex encoded by the genes
glnH (GlnBP), GlnP (membrane subunit), and GlnQ (intracellular ATP-binding subunit)
and a method for detection of activity in GlnBP variants. This could be accomplished by
overexpression of the subunits and incorporation into lipid vesicles (Glavinas et al., 2008) or
deletion of the genomic copy of glnH in E. coli followed by overexpression of mutant variants
for cell-based assays. Activity detection can be carried out using radiolabeled glutamine
or recovery of cell/vesicle contents followed by HPLC quantitation (Glavinas et al., 2008).
Alternatively, a less cumbersome assay could be done by measureing ATP hydrolysis under
di↵erent conditions, since this process is activated upon GlnBP binding to the membrane
subunit and further increased by glutamine binding to GlnBP (Liu et al., 1997).
In addition to the residues highlighted in the comparisons to published functional and
structural information for the GlnBP protein, other residues with no obvious functional
relevance were also among the top 5% of all values for each metric. These can represent
false positive predictions that in reality have no relevance to the function of the protein,
but were selected by the predictions due to issues with data quality, sub-optimal choice of
thresholds for accepting predictions or even chance (Yu et al., 2018).
Among these residues, some could still have an uncharacterised function that could be
initially elucidated by high-throughput experiments with the aim of engineering the function
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of these solute binding proteins towards novel biosensors.These could be investigated by a
saturation mutagenesis (using small intelligent library construction (Tang et al., 2012) to
reduce screening e↵ort) screen in microplates of all individual candidate mutations using
the fluorescent assays previously employed for engineering of this protein as a biosensor
(Looger et al., 2003). Any residues identified by this screen as being important for glutamine
binding could be further investigated by complementary characterisation strategies and also
exploited for library generation in e↵orts to isolate biosensors for other small molecules.
Since the assays used for engineering of GlnBP and other SBPs for altered specificity
only require site-specific labeling of free cysteine residues and fluorescence intensity mea-
surements (de Lorimier et al., 2002; Looger et al., 2003), this strategy could also be adapted
into a higher-throughput screen using GlnBP libraries displayed and labeled on the surface
of E. coli, followed by FACS. Development of a FACS-based screen would allow libraries
of 106 or more clones to be screened in sorting runs shorter than 1 hour (Zinchenko et al.,
2014), which would enable screening of all possible single (20 residues at 27 sites = 540
variants) and double mutations (540 * 540 = 291600) at the sites picked by the prediction
metrics in a single experiment. A screening platform with this throughput would be a pow-
erful tool for engineering of SBPs for recognition of non-cognate small molecules, especially
when coupled to a prediction strategy that allows the construction of targeted libraries,
such as the one described in this chapter.
Despite the already-acknowledged limitations of the dataset constructed for these bench-
marks with GlnBP, the successful identification of residues relevant to the function of this
protein by all three prediction metrics demonstrated the validity of this prediction strategy
using mixed-function datasets constructed by homology searches. Therefore, the strategy
could also be applied for detection of candidate functional residues in the proteins of the
TOMM synthase complex.
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Prediction and validation of functional residues in the Mi-
crocin B17 TOMM synthase complex
4.1 Introduction
Before the functional prediction strategy described in the previous chapter could be ap-
plied towards characterisation of components of the TOMM synthase complex, two main
requirements needed to be met: a suitable dataset needed to be constructed for each pro-
tein in the complex and a robust assay system was needed to detect changes in activity
caused by the selected mutations. Dataset construction followed the strategy used for the
GlnBP benchmark (See Section 3.2.2), with modifications to exploit the known TOMM
synthases from phylogenetically distinct groups of organisms. However, experimental val-
idation of the candidate functional residues could not be done by in vitro assays used in
previously-published work on the TOMM synthases (Li et al., 1996; Melby et al., 2012) due
to inconsistent results in attempts to establish these assays in our group (See Chapter 5).
Therefore, an alternative activity detection method was needed.
The chosen strategy was a bioassay exploiting the toxic phenotype of the E. coli microcin
B17, on sensitive strains that do not possess the immunity mechanisms encoded in the
biosynthetic operon for this TOMM (Garrido et al., 1988; Tran et al., 2005). The plasmid
pCID909 (kindly donated by Syngulon SA, Belgium) contains the entire microcin B17
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(Mcb17) operon under the control of a constitutive promoter and turns strains carrying
it into producing strains resistant to toxic e↵ects of the DNA gyrase inhibitor (Fig. 4.1).
Mcb17 is made by the TOMM synthase complex McbBCD acting on the substrate peptide
McbA, while resistance to the e↵ects of Mcb17 is conferred by the ABC exporter McbEF
and the immunity protein McbG.
Figure 4.1: Construct for in vivo microcin B17 biosynthesis - All genes involved in
microcin B17 biosynthesis, extracellular export and immunity are under control of the
operon’s uncharacterised native promoter. McbA - substrate peptide. McbB - Docking
protein. McbC (in blue) - dehydrogenase. McbD - cyclodehydratase. McbE and McbF -
ABC transporter subunits. McbG - Immunity protein.
Since the mature Mcb17 product is exported to the extracellular medium, production of
this microcin can be detected by its toxic e↵ect on sensitive strains of E. coli not carrying
the pCID909 vector. The observed degree of cell death can be correlated to the amount
of mature Mcb17 produced (Herrero and Moreno, 1986) and the e↵ect of mutations on the
biosynthetic components of the operon can be inferred by changes in the toxicity phenotype.
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Both activities of the Mcb17 TOMM synthase complex — cyclodehydration to azolines
carried out by McbD cyclodehydratase with the McbB docking protein, as well as oxidation
to azoles carried out by McbC dehydrogenase — are required for production of mature
Mcb17. Therefore, mutations that alter the activities of the complex will have an e↵ect on
the rate production of active Mcb17 that can be detected. Any mutation that increases
the activity of an enzyme would only be expected to increase Mcb17 production if that
step was limiting for the whole pathway, including McbA substrate peptide translation
and export by McbEF. However, no information is available regarding the relative rates
of in vivo cyclodehydration and oxidation, so mutations with a positive e↵ect would not
necessarily be detected.
Dataset construction and functional prediction were carried out for all three proteins
in the Mcb17 TOMM synthase complex. However only the predictions for McbC dehy-
drogenase were experimentally validated with the bioassay as a proof-of-concept for the
sequence-based functional prediction strategy. Since no structure of a homologous dehy-
drogenase involved in TOMM biosynthesis has been published, information obtained in
these experiments could contribute to the understanding of the function of the TOMM de-
hydrogenases. In addition, overexpression of TOMM dehydrogenases always led to higher
yields than the other proteins in the complex (See Chapter 5) and binding of the FMN
cofactor represents an easily-detectable phenotype that could also be a↵ected by mutation,
making this protein into an attractive target for further characterisation attempts.
4.2 Results and Discussion
4.2.1 Dataset construction
In order to perform functional residue prediction, a large and diverse MSA was needed for
each protein to be studied. As mentioned in Section 1.3, currently, there are only a few
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TOMM synthase complexes that have been characterised by in vitro methods and structural
information is scarce. Therefore, purely sequence homology-based methods were employed
to construct the MSAs. The methods used in this process are summarised in Fig. 4.2.
Figure 4.2: Analysis pipeline implemented for the E. coli TOMM synthase complex
enzymes. The validated dataset was created by manual curation of BLAST hits from
the E. coli query sequences, to include only sequences found within a genomic cluster
that contained homologues for all three enzymes of the TOMM synthase complex. These
sequences were aligned by T-Co↵ee to produce the Validated MSA and also used as queries
for a larger BLAST search. The sequences obtained in the second BLAST search were
clustered to remove duplicate sequences and very close homologues, then an Expanded
MSA was created by realignment of the regions recovered from the BLAST searches and
removal of columns with low alignment quality. Both MSAs were then used as input into
prediction strategies.
A separate functional residue prediction dataset was created for each of the three en-
zymes in the E. coli TOMM synthase complex, using publicly available sequence databases.
The initial set — corresponding to the Validated MSA of Chapter 3 — was constructed by
performing blastp searches with the protein sequences from E. coli, B. amyloliquefaciens,
Bacillus sp. Al-Hakam, and Pyrococcus furiosus as queries against the NCBI nr database.
Since all of the currently characterised TOMM synthase complexes are coded by gene clus-
ters of no more than 20kbp, only hits that contained the genes for the other two enzymes
in the complex within a window of this size were included in the Validated set. Most of
the hits were uncharacterised proteins, but the degree of sequence similarity (>30% iden-
tity) and the presence of the two other putative genes in close proximity were considered
evidence of possible TOMM synthase activity.
This manual screen led to a set of 21 putative TOMM synthase clusters from Bacteria
and Archaea, with three sequences in each. The dehydrogenase, docking protein and cy-
clodehydratase sequences from each cluster were joined in three FASTA files to be submitted
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for alignment. A variety of alignment methods were tested (T-Co↵ee (Notredame et al.,
2000), M-Co↵ee (Moretti et al., 2007), MUSCLE (Edgar, 2004), Clustal Omega (Sievers
et al., 2011)) and their results visually inspected to determine which had the best perfor-
mance for these sequences. T-Co↵ee consistently produced the best alignments, with the
smallest gap insertions, across all three sequences and was used to generate the Validated
MSA for each dataset without any subsequent manual adjustment. In the dehydrogenase
(McbC in E. coli) and docking protein (McbB in E. coli MSAs, inclusion of one or more
of the sequences led to alignments containing excessive amounts of gaps — possibly due
to truncations in the annotated gene sequences or indels that occurred during evolution
— leading to poor alignment of homologous regions in the remaining proteins. These in-
dividual exceptions were eliminated from the sets and alignment was repeated, leading to
Validated MSAs containing 18 to 21 sequences.
However, these numbers of sequences were too small for reliable use of the functional
prediction methods, which recommend the use of MSAs containing at least 150 sequences
(Martin et al., 2005). To increase the size of the alignments, an expanded dataset was
constructed using each sequence in the Validated set as a query in a new round of blastp
searches. This second round of searching with phylogenetically distant queries produced
more divergent sequences, including proteins annotated as having a non-TOMM synthase
function — nitroreductases for the dehydrogenase queries, adenylases for the docking pro-
tein query, and the YcaO domain of unknown function for the cyclodehydratase. In total,
over 20000 hits were recovered for each of the three complex members with an e-value <10-5,
but these could not be used directly as inputs for MSA generation by global alignment due
to di↵erences in sequence length and greater sequence divergence than in the smaller set.
Therefore, a computational pipeline was implemented to produce the input MSAs for
functional prediction using the local pairwise alignments from the blastp output. Sequence
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analysis software tools were used (USEARCH (http://www.drive5.com/usearch/), exoner-
ate (https://www.ebi.ac.uk/about/vertebrate-genomics/software/exonerate)) and a set of
perl and MATLAB scripts for conversion of file formats and construction of the final align-
ments (see Fig. 4.2 for an overview of the workflow). The first step consisted of filtering
the blastp results using e-value (<10-6) and coverage (>50%) cuto↵s, to ensure that only
high-quality alignments remained in the dataset. Each column in the Validated MSAs
was also scored by the Quality values calculated by the Jalview alignment software (Wa-
terhouse et al., 2009) and any columns with Quality values below 50 were ignored in the
subsequent steps, to focus the analysis on regions that were not predominantly composed
of gaps. Then, the sequence IDs of each of the hits were extracted and used to recover the
individual target sequences from the nr database. These were clustered in groups of >95%
identity and a single representative sequence was kept in the dataset for each cluster, to
reduce any biases due to overrepresentation of certain taxonomic groups in the sequences
deposited in nr.
After clustering, the pairwise alignments containing the selected sequences from each
cluster were extracted from the blastp results. Some of these target sequences had signif-
icant alignments with more than one of the original queries, so these were compared and
only the highest-scoring alignment was retained. After this step, each dataset contained
at least 700 separate pairwise alignments of a filtered hit sequence to one of the original
queries from the Validated MSA.
To convert the separate blastp pairwise alignments into a single MSA, the aligned
residues in each pairwise alignment were mapped onto the original Validated MSA. This
was done by comparing the aligned query residue to its position in the Validated MSA and
adding the corresponding residue from the target sequence into the equivalent position of
a new Expanded MSA. These final datasets were then exported into a FASTA format that
could be submitted to functional prediction web servers and used for calculation of the
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NoSE metric, encompassing a Validated MSA and an Expanded MSA for each of the three
proteins in the TOMM synthase complex.
4.2.2 Functional residue predictions
All three prediction scores (JSD, CMI and NoSE) were applied to the datasets generated
in the previous section and analysis of results was carried out similarly to Section 3.2.3.
Residues with the top 5% values for each of the scoring methods were selected for analysis.
Since none of the proteins in the Microcin B17 synthase complex have had their structures
characterised, all structural comparisons were carried out with homology models built using
the Phyre2 server (Kelley and Sternberg, 2009). All of the homology models described below
had Phyre2 Confidence values of 100%, which indicates the probability that templates
used for modeling are true homologues of the query protein, Confidence values above 90%
correspond to 2-4 A˚ RMSD at the core of the structure, but surface loops are modelled at
lower accuracy (Kelley et al., 2015)
4.2.3 Cyclodehydratase functional residue prediction
Seventeen residues were selected from the highest-scoring sites in each prediction metric
for further analysis from the 332 scored sites in the McbD dataset. A small overlap was
observed between the residues selected by each metric, with one site shared by JSD and
CMI and another shared by CMI and NoSE (Fig. 4.3).
Homology modelling by Phyre2 produced a model (Fig. 4.4 a-b) using the cyanobacterial
bifunctional TruD heterocyclase (PDB ID: 4bs9) as template, with 15% identity and 87%
sequence coverage (Koehnke et al., 2013). This protein contains the cyclodehydratase
(“D”) and docking (“C”) domains in a single polypeptide and one of its domains aligned
structurally to the McbD homology model (Fig. 4.4 c-d) . Since TruD was crystallised in
the absence of any ligands, the structure of the YcaO protein with the co-crystallised ATP
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Figure 4.3: Venn diagram depicting overlaps between the top 5%-scoring residues in
McbD for JSD (yellow), CMI (red), and NoSE(blue).
analogue AMPCPP (PDB ID: 4q85, Dunbar et al. (2014)) was also structurally aligned
to the homology model and the position of AMPCPP in that structure was highlighted in
relation to the model (Fig. 4.4, in green). This E. coli protein of uncharacterised function is
homologous to the TOMM cyclodehydratases and names the superfamily in which they are
included (CDD cl19253, Marchler-Bauer et al. (2017)). Several residues homologous to the
ATP-binding site in YcaO were previously mutated and characterised in the Bacillus sp.
Al-Hakam BalhD cyclodehydratase, confirming that the YcaO structure is representative
of the TOMM cyclodehydratases (Dunbar et al., 2014). In the McbD model, the aligned
AMCPP molecule is located at the end of a cleft in the structure, which can possibly
represent the active site of the protein, away from the putative interaction surface with the
docking protein implied by the bifunctional TruD structure (Fig. 4.4 c)
The highest-scoring residues from the JSD prediction were distributed throughout the
primary sequence (Fig. 4.5a), but clustered spatially around the predicted ATP binding
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Figure 4.4: Phyre2 Homology model of McbD. (a) and (b) Views of McbD model with
structurally aligned AMCPP from YcaO (PDB ID 4q85) highlighted in green. (c) and (d)
Views of McbD model with the structure of TruD (PDB ID 4b29) overlaid in cyan. Views
are rotated 90 °around the y axis.
site, away from the putative binding interface to the docking protein suggested by the
bifunctional TruD structure (Fig. 4.5c-d). Three of these residues are in positions similar
to important sites from the YcaO structure. Glutamates 57 and 170 are in similar positions
to Glu75 and Glu202 in YcaO, which bind Mg2+ ions (Dunbar et al., 2014). Arg171 appears
homologous to R203 in YcaO, coordinating the g-phosphate of bound AMPCPP (Dunbar
et al., 2014). Since the remaining residues are in contact with these known functional sites,
their strong conservation detected by JSD could indicate a role in structuring the ATP
binding pocket and in catalytic function.
Similarly to JSD, the highest scoring residues for CMI were dispersed throughout the
protein sequence, but were physically located around the predicted position for ATP (Fig.
4.6). Gly56 is located on the distal side of this pocket compared with the other selected sites,
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Figure 4.5: Highest scoring residues for JSD in McbD. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of JSD scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in yellow on the McbD homology model. (d) Top
5% residues highlighted in yellow on the homology model, after structural alignment to
the TruD cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan.
The YcaO domain structure (PDB: 4q85) was also structurally aligned and its bound ATP
analog (non-hydrolysable AMPCPP) is highlighted in green in both panels.
and forms part of the hydrophobic surface along the ATP-binding pocket of YcaO (Dunbar
et al., 2014). The nearest apparent homologue to Lys257 is YcaO-Arg286, suggesting a
role for this lysine in interaction with the a-phosphate of AMPCPP. In addition to the
residues lining the ATP binding cavity, sites in the hydrophobic core of the domain could
be important for correct folding of the protein, requiring compensatory mutations at other
sites whenever they vary and producing the high CMI values observed.
Unlike the other two scores, NoSE-selected residues were dispersed throughout both the
sequence and structure of McbD (Fig. 4.7). Threonines 39 and 322 are located towards the
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Figure 4.6: Highest scoring residues for CMI in McbD. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of CMI scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in red on the McbD homology model. (d) Top 5%
residues highlighted in red on the homology model, after structural alignment to the TruD
cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan. The YcaO
domain structure (PDB: 4q85) was also structurally aligned and its bound ATP analog
(non-hydrolysable AMPCPP) is highlighted in green in both panels.
surface of the model in positions that suggest a possible function in the cyclodeydratase-
docking protein interaction, which has been shown to require the C-terminal region of
TOMM cyclodehydratases (Dunbar et al., 2014). The fact that none of the residues selected
by NoSE map to the AMPCPP binding pocket suggests that the proteins in the expanded
dataset share a conserved ATP-binding function, which would not be expected to have
enough sequence divergence to score highly in NoSE. The location of the selected residues
surrounding the ATP-binding site and the putative active site could indicate a more specific
role in catalysis, allosteric regulation or substrate specificity.
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Figure 4.7: Highest scoring residues for NoSE in McbD. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of NoSE scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in blue on the McbD homology model. (d) Top
5% residues highlighted in blue on the homology model, after structural alignment to
the TruD cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan.
The YcaO domain structure (PDB: 4q85) was also structurally aligned and its bound ATP
analog (non-hydrolysable AMPCPP) is highlighted in green in both panels.
4.2.3.1 Docking protein functional residue prediction
Phyre2 failed to produce a high-confidence model for the docking protein E. coli McbB,
so the analyses presented here were carried out using the homologous BamC from Bacillus
sp. Al-Hakam. The homologue used for modeling was also the cyanobacterial bifunctional
TruD heterocyclase (PDB ID:4bs9) (Koehnke et al., 2013), with 18% identity to BamC
and the aligned region covered 92% of the query sequence (Fig. 4.8). Although no ligands
for the cyclodehydratase domain were co-crystallised in this structure, the structural Zn2+
ion of the docking domain was present and structural alignment was used to predict its
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position relative to selected residues in BamC, which is near the putative binding interface
with the cyclodehydratase subunit (Fig. 4.8).
Figure 4.8: Phyre2 Homology model of BamC. (a) and (b) Views of BamC model. (c)
and (d) Views of BamC model with the structure of TruD (PDB ID 4b29) overlaid in cyan.
The zinc ion from the TruD structure is highlighted in green. Views are rotated 90 °around
the y axis.
Six out of 109 scored sites were further analysed for each scoring method in the docking
protein dataset. As was observed for McbD, a single high-scoring site was shared by JSD
and CMI and another site was shared by CMI and NoSE (Fig. 4.9).
The residues with the highest JSD values were dispersed throughout the sequence, but
the first thirty residues had distinctly lower values, indicating a low degree of sequence
conservation in the N-terminal region of this family (Fig. 4.10 a). The selected residues
clustered in one region of the structure and especially around the predicted Zn2+ binding
site (Fig. 4.10 c-d, Zn2+ obscured by highligted residues in c). Of note are three Cys residues
— 216, 308, and 311 — positioned around the predicted ion binding site, suggesting a role
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Figure 4.9: Venn diagram depicting overlaps between the top 5%-scoring residues in
BamC for JSD (yellow), CMI (red), and NoSE (blue).
in coordination of the metal ion that is carried out by cysteines in many known structures
(Pace and Weerapana, 2014).
Unlike the observed distribution along the sequence for JSD scores, all of the top 5%
of CMI scores corresponded to six contiguous resides in the BamC sequence (Fig. 4.11 a).
These were located near the Zn2+ binding site, with the positions of Cys216 (also high-
scoring in JSD) and Cys219 suggesting a role in ion coordination. The imidazole ring of
His218 is not oriented towards the zinc ion as is observed in structures that coordinate
zinc via this amino acid (Alberts et al., 1998), suggesting that the four identified cysteines
carry out this function in BamC and His218 could have an indirect function in shaping the
binding site.
As was observed for McbD (Section 4.2.3), the residues with the highest NoSE scores
were dispersed throughout the primary and tertiary structures of BamC (Fig. 4.12 a).
His218 was also selected in this prediction, indicating a high degree of conservation within
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Figure 4.10: Highest scoring residues for JSD in BamC. (a) Score for each residue in
the dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b)
Observed distribution of JSD scores, the red dotted line is the cuto↵ point for the top 5%
of all scores. (c) Top 5% residues highlighted in yellow on the BamC homology model.
(d) Top 5% residues highlighted in yellow on the model, after structural alignment to the
TruD cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan. The
bound Zn2+ from the TruD structure is highlighted in green in both panels. The structures
have been rotated 90°along the horizontal axis between panels for a clearer visualisation
of highlighted residues and the putative interface with the cyclodehydratase partner.
the set of TOMM-related proteins but more relaxed evolutionary constraint in the larger
dataset, leading to a high score in the CMI measure of coevolution (Fig. 4.12 c). In
addition, Asn227 is adjacent to an extended loop from the cyclodehydratase domain of the
TruD structure, suggesting a possible role in heterodimerisation (Fig. 4.12 d)
4.2.4 Dehydrogenase functional residue prediction
A homology model with a putative nitroreductase from Ralstonia eutropha as the closest
structural match (PDB ID: 3hj9) was produced, with 20% identity in an alignment covering
90% of the query sequence (Fig. 4.13). This protein was crystallised as a dimer, with
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Figure 4.11: Highest scoring residues for CMI in BamC. (a) Score for each residue
in the dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b)
Observed distribution of CMI scores, the red dotted line is the cuto↵ point for the top
5% of all scores. (c) Top 5% residues highlighted in red on the BamC homology model.
(d) Top 5% residues highlighted in red on the model, after structural alignment to the
TruD cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan. The
bound Zn2+ from the TruD structure is highlighted in green in both panels.The structures
have been rotated 90°along the horizontal axis between panels for a clearer visualisation
of highlighted residues and the putative interface with the cyclodehydratase partner.
two molecules of the FMN cofactor bound in distinct sites with contributions from both
subunits. The McbC homology model was structurally aligned to one of the subunits,
to identify potential roles for predicted functional residues in cofactor binding or subunit
interactions. The core of the protein monomers aligned well, but there was considerable
divergence between the Ralstonia structure and the McbC model (Fig. 4.13 c-d), which
can reflect real structural divergences between the homologues or modelling errors due to
the lower accuracy of the software for surface loops (Kelley et al., 2015).
All of the residues discussed in the text below were selected for mutation and validation
by in vivo Microcin B17 biosynthesis assays, due to proximity to the FMN binding and
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Figure 4.12: Highest scoring residues for NoSE in BamC. (a) Score for each residue
in the dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b)
Observed distribution of NoSE scores, the red dotted line is the cuto↵ point for the top
5% of all scores. (c) Top 5% residues highlighted in blue on the BamC homology model.
(d) Top 5% residues highlighted in blue on the model, after structural alignment to the
TruD cyanobacterial bifunctional heterocyclase/docking protein (PDB: 4ds9), in cyan. The
bound Zn2+ from the TruD structure is highlighted in green in both panels.The structures
have been rotated 90°along the horizontal axis between panels for a clearer visualisation
of highlighted residues and the putative interface with the cyclodehydratase partner.
putative active site, possible roles in protein-protein interaction, and structural integrity.
Twelve out of 225 high-quality sites from the McbC dehydrogenase alignment were selected
for further analysis and as candidates for validation by mutation and in vivo activity assays.
In this dataset, five high-scoring sites were found in both the JSD and CMI datasets and a
single site was present in both the NoSE and CMI sets (Fig. 4.14).
The highest-scoring residues from the JSD metric were located in the middle region of
the sequence, with distinctly lower scores at the N- and C-termini of the input alignment
(Fig. 4.15 a). Structurally, these predicted residues clustered mainly around one of the
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Figure 4.13: Phyre2 Homology model of McbC. (a) and (b) Views of BamC model. (c)
and (d) Views of McbC model with the structure of Ralstonia eutropha nitroreductase
(PDB ID:3hj9) (PDB ID 4b29) overlaid in cyan. The putative positions of the FMN
cofactors are highlighted in green. Views are rotated 90 °around the y axis.
FMN half-sites and also in a hydrophobic region away from the FMN sites and the dimer
interface (Fig. 4.15 c-d).
One of the residues within the top 5% JSD values — Tyr202 — has been previously
demonstrated to be required for azoline oxidation activity, but not for FMN binding, by
mutation of the homologous Tyr202 of BcerB dehydrogenase to Ala (Dunbar and Mitchell,
2013), so this site was selected for mutation as an expected negative control for McbC
activity. The position of Gly123 suggests its main chain could form a hydrogen bond to
one of the FMN hydroxyl groups and Gly215 is positioned along the long a-helix in the
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Figure 4.14: Venn diagram depicting overlaps between the top 5%-scoring residues in
McbC for JSD (yellow), CMI (red), and NoSE(blue).
dimer interface, indicating a possible role in dimerisation. Finally, a set of three contigu-
ous aromatic residues highlighted by JSD — Tyr150, His151, and Tyr152 — was selected
to determine whether these have a shared role in maintaining structural integrity of the
complex that is conserved in the larger family of homologues.
As was observed for JSD, the top 5% of CMI scores were located in the central re-
gion of the protein sequence, with markedly lower scores at the N- and C-termini of the
alignment (Fig. 4.16 a). However, the residues highlighted by CMI were more clustered
spatially, mostly around the FMN half-site that includes Tyr202 — present in the high-
scoring residues for both JSD and CMI (Fig. 4.16 c-d). Residues Tyr120, Ser122 and
Glu213 could form contacts with FMN or be part of the larger cavity which would be
needed to accomodate the azoline substrate. Ala198 and Ser216 are more distant from the
putative binding site and could contribute to interactions that shape the active site.
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Figure 4.15: Highest scoring residues for JSD in McbC. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of JSD scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in yellow on the McbC homology model. (d) Top
5% residues highlighted in yellow on the homology model, after structural alignment to A.
variabilis putative nitroreductase (PDB: 3eo7), with both subunits of the nitroreductase
dimer displayed in cyan. The FMN cofactors from the structurally aligned nitroreductase
(PDB: 3eo7) are highlighted in green in both panels and the views have been rotated for
clear display of highlighted residues and dimer subunits.
The NoSE scores were more evenly distributed throughout the sequence and the struc-
tural model than the previous two scores (Fig. 4.17). Lys201 is homologous to the other
known catalytically-important residue in the TOMM dehydrogenases, Lys201 of BcerB —
also leading to loss of activity but maintaining FMN binding upon mutation to Ala (Dun-
bar and Mitchell, 2013). Leu159, Arg204 and Phe132 were selected due to their proximity
to the long a-helix in the putative dimer interface. Finally, the isolated residues Ile72 and
Asp240 were selected for having no obvious function based on their predicted positions,
especially the the hydrophobic and apparently surface-exposed isoleucine.
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Figure 4.16: Highest scoring residues for CMI in McbC. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of CMI scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in red on the McbC homology model. (d) Top
5% residues highlighted in red on the homology model, after structural alignment to A.
variabilis putative nitroreductase (PDB: 3eo7), with both subunits of the nitroreductase
dimer displayed in cyan. The FMN cofactors from the structurally aligned nitroreductase
(PDB: 3eo7) are highlighted in green in both panels and the views have been rotated for
clear display of highlighted residues and dimer subunits.
The residues in McbC selected for mutation were: I72, Y120, S122, G123, F132, Y150,
H151, Y152, L159, A198, K201, Y202, R205, E213, G125, S215, and D240. Six sites were
picked for JSD and NoSE predictions and five from CMI, to produce a total of 18 variants
for assaying (when the WT is included).
4.2.5 Validation of predictions by in vivo microcin B17 synthesis assays
The selected putative functional residues in McbC dehydrogenase were mutated to cysteine
in vector pCID909 (See Section 2.2.8 for mutagenesis methods) to produce the panel of
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Figure 4.17: Highest scoring residues for NoSE in McbC. (a) Score for each residue in the
dataset, the red dotted line is the cuto↵ point for the top 5% of all scores. (b) Observed
distribution of NoSE scores, the red dotted line is the cuto↵ point for the top 5% of all
scores. (c) Top 5% residues highlighted in blue on the McbC homology model. (d) Top
5% residues highlighted in blue on the homology model, after structural alignment to A.
variabilis putative nitroreductase (PDB: 3eo7), with both subunits of the nitroreductase
dimer displayed in cyan. The FMN cofactors from the structurally aligned nitroreductase
(PDB: 3eo7) are highlighted in green in both panels and the views have been rotated for
clear display of highlighted residues and dimer subunits. Residue Asp240 is obscured by
the remainder of the structure in this view
mutants for validation. A cysteine scan was selected due to a general tolerance for cysteine
in non-essential sites in proteins revealed by deep mutational scan studies (Whitehead et al.,
2012) and for the possibility of labeling with thiol-reactive probes in future characterisation
e↵orts. Construction of the Y150C variant in pCID909 failed after multiple attempts and
characterisation was carried out with the remaining mutants.
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4.2.5.1 Microcin B17 bioassay development
Prior to validation of the mutant panel, a set of conditions for optimal detection of Mcb17
production needed to be established. These conditions include strain choice for both pro-
duction and activity detection, incubation temperatures and times, and the layout of the
experiment for exposure of sensitive strains to the microcins.
Initially, a small panel of three E. coli strains (BL21(DE3), NEB 10-b, NEB T7 Express
lysY/Iq) was tested in all nine possible combinations of producing (strain transformed
with the pCID909 vector) and sensitive (no plasmid) roles. Sensitive strains were added
to the plate to form a lawn, followed by spotting of producing strains onto the plate to
allow formation of a colony. Detection of a zone of growth inhibition was expected around
producing strain spots, where the local Mcb17 concentration became high enough for DNA
gyrase inhibition to lead to cell death of the sensitive lawn.
Sensitive and producing strains were grown for 16 h at 37°C in LB medium containing
chloramphenicol (producing strains) or no antibiotic (sensitive strains). Then, a lawn con-
taining 107 CFU of the sensitive strains was plated onto LB agar plates with no antibiotic,
10 µl of producing strains (containing approximately 106 CFU) was spotted in triplicate
onto the lawn, followed by overnight incubation at 37°C (Fig. 4.18). The BL21(DE3) strain
appeared to be the most e cient Mcb17 producer and also most susceptible to Mcb17 tox-
icity when not carrying the operon. Strains T7 Express lysY/Iq and NEB 10-b produced
smaller growth inhibition zones on sensitive strains and were also more resistant to the
e↵ects of the microcin.
Although growth inhibition was clearly visible in the tested plates, the cleared zones
and producing strain spots were irregularly-shaped (Fig. 4.18), which would represent a
source of noise during comparison of mutant strains by measurements of inhibition zones.
This e↵ect was probably caused by varying levels of moisture on each plate causing the
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producing strain spots to spread unevenly after pipetting, so alternative strategies were
sought to avoid this issue.
Figure 4.18: Test of producing and sensitive strains for Microcin B17 bioassay - Pro-
ducing strains spotted in triplicate over sensitive strain lawns to determine microcin B17
biopthetic capability and susceptibility. BL21 - BL21(DE3); 10-b - NEB 10-b; T7 - T7
Express lysY/Iq
The same experiment was repeated with an inverted order of addition of the strains,
in an attempt to create homogeneous circular inhibition zones. Producing strains were
spotted onto fresh culture plates, followed by addition of the sensitive strain. Sensitive
strains (107 CFU) were added to 3 ml 0.7% agar and spread onto plates containing dried
producing strain spots. The overall size and shape of the growth inhibition zones was
more consistent in this test, but producing strain spots could also be seen away from their
intended positions, carried by the agar overlay as it was spread (Fig. 4.19).
The same trend for more e cient production of Mcb17 and high susceptibility by the
BL21(DE3) strain was observed, so this strain was used for all subsequent experiments.
Contrary to the previous experiment, the sensitive 10-b strain showed inhibition by the
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producing strains in this test, which could be caused by susceptibility varying during growth
of this strain. Since the BL21(DE3) did not show such variation, it was also preferred for
this consistency. Coverage of the plate by the sensitive strain was also more consistent with
the overlay method, but the sensitive strain would need to be diluted into a higher volume
of agar solution to avoid gaps in the overlay caused by premature solidification (as seen in
the negative control of Fig. 4.19)
Figure 4.19: Use of an agar overlay of sensitive cells to detect microcin B17 production -
Producing strains spotted on blank plates, dried and covered with sensitive strains diluted
in agar solution. BL21 - BL21(DE3); 10-b - NEB 10-b; T7 - T7 Express lysY/Iq; Negative
control - Sensitive strain overlaid on a clean plate. Growth-free zones in the negative
control are due to insu cient volume of overlay suspension to cover the entire plate.
While the experimental layout was being optimised, the e↵ect of temperature on the
Mcb17 production was measured by repeating the experiment from Fig. 4.18 using strain
BL21(DE3) as the sole sensitive strain and incubating plates at 37°C, 30°C, and 25°C.
Incubations were carried out for up to 30 h to compensate for slower growth at lower tem-
peratures. Since no large di↵erences were observed in the size of the growth inhibition zones
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around the the producing spots (Fig. 4.20), a temperature of 37°C was used for subsequent
experiments due to faster cell growth at this temperature. The lower temperatures also led
to more uneven spreading of the producing spots, probably caused by slower evaporation
of liquid medium at lower temperatures.
Figure 4.20: E↵ect of temperature on microcin B17 biosynthesis assays - Producing
strains spotted over BL21(DE3) sensitive strain to determine the influence of temperature
on the observed phenotype. BL21 - BL21(DE3); 10-b - NEB 10-b; T7 - T7 Express lysY/Iq
To further reduce the experimental noise caused by uneven growth inhibition zones
and the formation of producing strain colonies within the growth inhibition zones, the well-
di↵usion assay was adopted (Balouiri et al., 2016). Briefly, an overlay of the sensitive strain
is added to culture plates, wells are created using a cork borer tool, and these are filled
with supernatant from overnight cultures of the producing strain (experimental details for
the optimised assay conditions are in Section 2.3.10). Mcb17 contained in producing strain
supernatants di↵uses from the wells into the surrounding medium, creating more uniform
growth inhibition zones (Fig. 4.21). The variability between biological replicates was also
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reduced by normalisation of cell concentrations in overnight cultures before centrifugation
to remove supernatant.
Each culture plate contained four wells spaced widely enough to prevent overlap of in-
hibition zones and the supernatant produced by a strain carrying one McbC mutant was
added to each well. To increase data collection throughput, plates were imaged and mea-
sured using ImageJ software (Schindelin et al., 2012). Each plate also contained a single
blank well filled with only sterile LB medium as a normalisation standard to account for
variations in zoom level of imaging equipment or plate positioning (Fig. 4.21). The ar-
eas of all inhibition zones were measured and estimated inhibition radii were calculated
by approximating to a circular area and subtracting the blank well radius from each mea-
surement. Each measurement was then normalised to the wild-type value as described in
Section 2.3.10.
Figure 4.21: Example of a Well-di↵usion assay for microcin B17 biosynthesis - Each plate
was used to measure microcin B17 biosynthesis by three McbC variants, with a blank well
containing LB medium for normalisation of measurements.
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4.2.5.2 Activity detection for McbC variants
The optimised conditions established for the Mcb17 bioassay were used to quantitate the ac-
tivity of McbC Cys mutants and validate functionally-relevant residues selected previously
(Section 4.2.4). Assays were carried out with a minimum of four biological replicates per
variant, with the wild-type present in every set of experiments as a normalisation control
to minimise any interference from uncontrolled changes in growing conditions and sensitive
strain overlays between days.
Visual inspection of plates and manual comparison of inhibition radius measurements
revealed clear drops in activity in some mutants when compared to the wild-type super-
natants (Fig. 4.22 a). However, some variants presented smaller trends towards reduced
(i.e. Phe132) and even increased (i.e. Ala198) biosynthetic activity that would require sta-
tistical testing to verify whether the observed divergences from phenotype were significant.
The activity measured in the bioassays is the result of variable amounts of Mcb17 con-
tained in the supernatants di↵using from wells into the surrounding medium, stopping the
growth of the sensitive strain wherever the local concentration of Mcb17 is high enough
to be toxic. Since the shape of the wells, height and volume of the liquid column, and
height of the culture medium are constant in all measurements, this leaves the amount
of active Mcb17 contained in each well and the size of the zone of growth inhibition as
the only two controllable variables. The inhibition zone is created by di↵usion of Mcb17
from the supernatant into the e↵ectively two-dimensional surrounding medium, thus the
inhibition radius measurement should not be linearly correlated with the concentration of
active Mcb17 contained in each well.
To verify the relation between Mcb17 concentration and the size of the growth inhibition
zone, dilution series of a wild-type supernatant and two mutants with apparently lower
activity (S122 and E213) were assayed and the observed inhibition radii were plotted against
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Figure 4.22: In vivo microcin B17 biosynthesis assays for McbC mutant panel. (a) Mcb17
biosynthesis activity of each McbC mutant relative to the wild-type. (b) Dilution curve of
wild-type and two mutants (Ser122 and Glu213) to estimate the relation between observed
inhibition radii and relative concentration of Mcb17 in supernatants. (c) Exponential
normalisation of data shown in (a). Two-tailed t-tests with Bonferroni multiple-testing
correction (p<0.05 was used as the significance cuto↵) were carried out using the data
show in (c) and mutants that di↵ered significantly from WT are labelled in red in all
panels. Wild-type in (c) had a value of exp(1) ⇡ 2.72. Error bars represent the standard
deviation of the measurements from the mean. n   4 for all mutants, in biological replicates
157
Chapter 4. In vivo validation of functional predictions
their relative concentrations. As expected, no linear correlation could be observed, but a
logarithmic fit was appropriate (R2   0.8 for all three plots), producing an apparently linear
behaviour on a plot with relative concentration on a log10 scale (Fig. 4.22b). Therefore,
activity measurements were transformed by the exponential of the inhibition radius as
an approximation of the Mcb17 concentration — and, therefore, McbC activity — before
significance testing.
All mutants were compared with the wild-type measurements by two-tailed t-tests with
Bonferroni correction for multiple testing (16 mutants). Six sites had complete activity
losses, including the known Lys200-Tyr201 motif (Dunbar and Mitchell, 2013). Of the
eight sites that significantly a↵ected McbC function (p < 0.05 after correction), six led
to complete loss of activity (Ile72, His151, Tyr152, Lys201, Tyr202, and Gly215) and the
remaining two (Gly123 and Glu213) were compromised but still able to produce su cient
Mcb17 for activity to be detectable. The results for the validation of the functional predic-
tions are summarised in Table 4.1.
Mutation JSD CMI NoSE Bioassay
I72C X -
Y120C X N
S122C X X N
G123C X X -
F132C X X N
H151C X -
L159C X X N
A198C X N
K201C X -
Y202C X X -
R205C X N
E213C X -
G215C X X -
S216C X X N
D240C X N
Table 4.1: E↵ect of mutations on McbC candidate functional residues. “-” indicates
reduced activity, “N” indicates no significant e↵ect on activity, and “X” indicates the
residue was among the top 5% of scores for that prediction.
158
Chapter 4. In vivo validation of functional predictions
Cysteine mutations at two of the residues predicted by the homology model to contact
the FMN cofactor, or form part of the active site region, led to negative impacts upon McbC
activity: Gly123 selected by JSD and CMI and Glu213 selected by CMI. However, these
mutations did not lead to full activity losses and two other residues selected by CMI within
that same region did not significantly reduce activity upon mutation: Tyr120 and Ser122.
Interestingly, both the latter mutations were conservative polar-to-polar substitutions of
residues that are solvent-exposed in the homology model — especially Ser122Cys, which
is only a replacement of a hydroxyl group with a thiol in the side chain. More disruptive
mutations, such as introducing a charged or hydrophobic residue could be used to determine
whether these positions have a functional role that was maintained when mutated to Cys
or the protein was una↵ected simply because they are solvent-esposed residues. These
results are consistent with the hypothesis that this set of positions has a role in substrate
interaction or positioning of active site residues and would, therefore, represent potential
candidates for diversification if engineering of McbC for changes in substrate specificity or
promiscuity were to be pursued.
The patch of buried aromatic residues detected by JSD led to complete loss of activity
when His151 and Tyr152 were mutated to cysteine, suggesting a role in McbC function or
maintenance of structural integrity. Attempts at producing the Tyr150Cys mutant failed,
but in light of the results obtained for the two subsequent residues in the sequence it would
be informative to obtain and measure the activity of this mutant. Due to their aromatic
nature and position within the McbC model, it is likely that these residues are involved in
maintaining the structure of the protein or in the folding process (Fukusaki et al., 2001), so
more conservative mutations to other aromatic or hydrophobic amino acids could assist in
elucidating their function. If conservative mutations lead to rescue of activity levels towards
values close to wild-type, the activity loss observed for cysteine mutations at positions 151
and 152 could be due to a structural e↵ect.
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Only one of the mutations at sites along the putative dimerisation interface in the ho-
mology model produced a complete loss of activity: Gly215. However, the cysteine variants
at positions 132 and 159 had slight non-significant trends towards activity reduction, sug-
gesting a smaller impact on protein function which would need to be verified by mutations
to other residues or a more sensitive assay method. The TOMM dehydrogenases have not
been shown to form homodimers in solution, but the position of the FMN cofactors in
the homology model between the two subunits and the results obtained here favour that
hypothesis. Since the only evidence for the subunit composition of a TOMM synthase
complex is the purification of the McbBCD complex in apparent unitary stoichiometry by
Li et al. (1996), this information together with the homodimeric structural homologues de-
tected by Phyre2 could indicate a trimer-of-dimers arrangement for the complex (2 McbB
: 2 McbC : 2 McbD molecules per complex). Another hypothesis would be that either
the docking protein or the cyclodehydratase acts as the binding partner for the dehydro-
genase in TOMM synthase complexes. However, the fact that two dehydrogenases from
phylogenetically divergent organisms (B. amyloliquefaciens and E. coli) were successfully
expressed in this work with bound FMN in the absence of other TOMM synthase complex
partners (Chapter 5) does not support this alternative model. In vitro homodimerisation
of McbC could be confirmed by methods such as SEC-MALS (Hong et al., 2012) or native
mass spectrometry (Heck, 2008).
Finally, the two isolated residues selected from the NoSE scores had opposite e↵ects. A
cysteine mutation at Asp240 had no detectable e↵ect on Mcb17 biosynthesis, while the same
mutation at Ile72 led to complete loss of activity. The mutation from Asp to Cys at position
240 removed the negative charge and decreased the length of the side chain, yet produced
no e↵ect on activity probably due to its position along the solvent-exposed surface of the
structure, which tends to be predominantly polar in soluble proteins (Moelbert et al., 2004).
Similarly, the Ile72Cys mutation would not be expected to cause a strong e↵ect even though
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it is a hydrophobic-to-polar change, because this site is in an extended surface loop distant
from the putative dimerisation interface in the Phyre2 homology model for McbC, which
would be expected to tolerate mutations to polar residues. However, structural modelling
of loops is known to be especially unreliable (Eswar et al., 2008), so the predicted location
for this residue could be incorrect and the Ile72 side chain could be facing the internal part
of the structure and in a close interaction with another hydrophobic residue.
4.3 Conclusions
The in vivo assay system established for microcin B17 biosynthesis enabled the quick valida-
tion of candidate functional residues obtained from predictions, demonstrating a significant
e↵ect on Mcb17 production for half of the mutations tested (eight out of the sixteen suc-
cessfully constructed mutants). While only negative e↵ects have been detected, it is not
clear whether increases in the activity of McbC would necessarily lead to increased export
of active Mcb17, which is the phenotype detected by the assay. Mutants with increased
activity are only expected to produce larger zones of inhibition if the azoline oxidation
step is limiting during in vivo production of Mcb17, but the relative velocities of each
pathway step (McbA translation, heterocyclisation, and export) are unknown and likely to
vary between strains and cultivation conditions. The relative velocities of each step could
be intentionally changed by altering relative expression levels — under- or overexpressing
individual pathway components by expression from separate higher copy number plasmids
or engineering of ribosomal binding sites (Reis and Salis, 2017). If the pathway could be
engineered to have oxidation by McbC as its rate-limiting step, it could be used as a bioas-
say capable of reliably detecting variants with higher activity than the wild-type, with the
Ala198Cys mutant as a candidate and other rationally selected mutations at sites found in
this work.
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Another caveat of the results produced by in vivo biosynthesis assays is that several
di↵erent phenotypes could be responsible for the di↵erences in activity observed for the
mutant panel, including phenotypes not directly relevant to the functional mechanisms of
TOMM dehydrogenases. A reduction in Mcb17 synthesis in a strain carrying a variant of
McbC could be explained by the targeted residue playing a role in processes such as catalytic
activity, FMN cofactor binding, substrate recognition, interaction with binding partners in
the TOMM synthase complex, enzyme folding, and thermostability. Therefore, additional
characterisation of isolated McbC would be needed to determine which mutations are di-
rectly related to McbC catalysis and specificity. One possibility would be to overexpress
and purify McbC, followed by characterisation with a simple assay such as Thermofluor
(Ericsson et al., 2006) to determine whether mutations caused negative impacts on protein
folding and stability, e↵ectively representing false positive functional residues. Constructs
have been prepared to overexpress the mutant panel following the optimised methods from
Chapter 5, but experiments were not carried out due to time constraints.
The fact that at least half of the predicted functional residues had some impact on McbC
function in the biosynthesis of Mcb17 demonstrates the power of coupling computationally-
simple information theory-based prediction strategies to robust bioassays in producing data
for characterisation of poorly-annotated protein families. The mutants validated by this
strategy can be further characterised to provide novel insight into the mechanism of TOMM
dehydrogenase activity and overall TOMM synthesis, avoiding laborious untargeted screen-
ing of variant repertoires to identify relevant residues. However, this combination can only
be applied if a simple bioassay can be established for the phenotype of interest, which limits
the range of biological systems that could be targeted to the ones that produce an easily-
detectable phenotype such as growth, gene expression or a marker metabolite. Recent
developments in directed evolution strategies to isolate biosensors for small molecules rep-
resent an alternative path towards generalisable assays and could greatly expand the range
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of possible molecules that could be targeted by a combination of computational predictions
and bioassays (Feng et al., 2015b; Skjoedt et al., 2016).
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In vitro exploration of TOMM synthase complexes
Previous in vitro reconstitutions of TOMM synthase complexes were carried out by het-
erologous expression of the complex proteins — frequently as fusions to Maltose Binding
Protein (MBP) to increase their solubility (Li et al., 1996; Melby et al., 2012), followed
by activity assays with incubation of purified complexes and substrate peptides. The most
commonly used method for detection of synthase activity is Mass Spectrometry (MS), due
to the loss of 20 Da associated with the full processing — heterocyclisation followed by
oxidation to azole — of each heterocycle in the substrate peptide. However, characterisa-
tion of a protein employing MS as the sole detection method in assays can become costly
and labour-intensive, especially if variants of the protein are made to study the function
of residues in its sequence. Alternative detection strategies employed previously include
polyclonal antibodies specific for Microcin B17 (Li et al., 1996) and detection of phosphate
released by ATP hydrolysis during the heterocyclisation step (Melby et al., 2012).
The aim of this section of the work was to establish a robust in vitro detection system
for the formation of heterocycles by TOMM synthase complexes, employing MS as the
main activity measurement strategy but also attempting to develop simpler methods to
assay complex function. The polyclonal antibodies used by Li et al. (1996) are no longer
available, but other commercially available antibodies could be employed in assays such as
ELISA to quantify TOMM production. Additionally, development of a negative assay based
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on labeling of unreacted cysteine residues — molecules with all cysteines fully converted
to thiazoles would not be labeled — was attempted, using fluorescent dyes coupled to
thiol-specific reagents.
5.1 Results and Discussion
5.1.1 In vitro reconstitution of the Bacillus amyloliquefaciens planta-
zolicin synthase complex
This section will describe experiments carried out with the aim of heterologously producing
the B. amyloliquefaciens TOMM synthase complex in E. coli and measuring its activity in
vitro.
5.1.1.1 Expression and purification of Bacillus amyloliquefaciens plantazolicin
synthase complex and substrates
Genes coding for the three enzymes of the TOMM synthase complex for plantazolicin
biosynthesis described by Scholz et al. (2011) were synthesised (GeneWiz Inc.) and cloned
by restriction-based cloning into fusion-free (pBAD30) and MBP-tagged (Fig. 5.1, in pMAL-
C2x, New England Biolabs) constructs for heterologous expression in E. coli. Constructs
were transformed into the protease-deficient E. coli K-12-derived strain ER2508 (NEB) for
expression. After optimisation of expression conditions, soluble expression was obtained for
all three enzymes fused to MBP, but not for the fusion free constructs (data not shown).
These proteins were partially purified by MBP-a nity chromatography on MBTrap
columns (GE Healthcare), reaching a purity of at least 80% for all constructs (Fig. 5.2a-c),
which was deemed su cient to carry out assay development. A yellow colour was clearly
visible in eluted fractions from BamB purification, indicating that the FMN cofactor needed
for activity was bound. Following previous literature reports (Li et al., 1996; Melby et al.,
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Figure 5.1: Constructs for expression and purification of B. amyloliquefaciens BamB,
BamC and BamD. (a) pMAL-C2x-derived vector for the expression of BamB with an N-
terminal MBP fusion. (b) pBAD30-derived vector for the expression of fusion-free BamB.
These constructs were also made for expression of the BamC and BamD proteins
2012) that showed full activity only for fusion-free proteins, cleavage with Factor Xa was
used to produce fusion-free enzymes. However, these cleavage reactions did not reach com-
pletion, even after optimisation attempts (Fig. 5.2d). Since the MBP fusion is known to
interfere with TOMM synthase function (Milne et al., 1999; Melby et al., 2012), alterna-
tive constructs were designed to obtain higher cleavage e ciencies by avoiding the use of
Factor Xa protease.
In order to obtain fusion-free enzyme preparations with a higher purity, a set of new con-
structs was designed and tested for the BamB dehydrogenase. These included three di↵erent
self-cleaving intein-Chitin Binding Domain (CBD) fusions (Mxe, Ssp and Sce intein-CBD
tags in pTWIN1 and pTYB21 vectors, New England Biolabs) as well as a Ssp intein-MBP
fusion (pMAL-C2x) and a fusion-free protein under the control of the tightly regulated
Rhamnose promoter (pD881 vector, DNA 2.0). All constructs were transformed into the
protease-deficient strain ER2566, derived from BL21(DE3), for transcription from the T7
promoter. The C-terminally-tagged construct BamB-Mxe led to the highest titres of soluble
BamB protein (Fig. 5.3), so constructs were made to implement this expression strategy
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Figure 5.2: MBP-tagged enzyme expression and purification. a-c) Fractions eluted from
amylose a nity chromatography column. In all images, there is significant enrichment
of the band corresponding to the target MBP-enzyme fusion. LYS - Lysate injected into
column. FT - Flow-through from injection. W - Material washed from the column before
elution. E - equate recovered after addition of Maltose. Numbers indicate mass of ladder
fragments in kDa. a) BamB purification. b) BamC purification. c) BamD purification.
d) Factor Xa-mediated cleavage of the MBP tag in BamB protein, in all conditions there
was still detectable uncleaved MBP-BamB. Lane 1 - no Factor Xa. Lanes 2-4 - varying
incubation times with Factor Xa, according to manufacturer’s instructions. Expected
masses for MBP-BamB = 72.7kDa, MBP-BamC = 80.3kDa MBP-BamD = 92.8kDa, free
MBP = 42.5kDa and free BamB = 30.2kDa. Bands enclosed in green boxes correspond to
desired purified or fusion-free protein. Bands enclosed in red boxes are fusions to MBP.
for the other two proteins in the plantazolicin heterocyclase complex. However, no sol-
uble expression could be obtained for BamC-Mxe and BamD-Mxe (data not shown), so
assay development continued with the pMAL-based N-terminal MBP fusions with Factor
Xa protease cleavage sites, using concentration by ultrafiltration to obtain enzyme stocks
for activity assays.
The native plantazolicin substrate peptide has 10 heterocyclisation sites which can
lead to complex mixtures of modification products in case of incomplete heterocyclisation.
Therefore, shorter sequences were designed to act as positive and negative controls for en-
zyme activity. Synthetic core region constructs were designed with the sequence XDGGK,
where X can be a non-cyclisable tyrosine (0C) or a number of consecutive cysteine residues
(1C, 2C, 3C). These core regions are preceded by the plantazolicin substrate peptide leader
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Figure 5.3: Solubility tests for alternative BamB constructs. MW - Molecular Weight
Marker. Every pair of subsequent lanes contains, respectively, the insoluble and soluble
fractions for one expression condition. Lanes 1-2 - fusion-free BamB under the control of
the arabinose promoter in pD881. Lanes 3-4 - MBP-Ssp intein-BamB fusion. Lanes 5-6
- BamB-Sce intein fusion induced with 1mM IPTG. Lanes 7-8 - BamB-Sce intein fusion
induced with 0.1mM IPTG. Lanes 9-10 BamB-Mxe intein fusion induced with 1mM IPTG.
Lanes 11-12 BamB-Mxe intein fusion induced with 0.1mM IPTG. Expected Molecular
weights: BamB = 30.2kDa, MBP-Ssp-BamB = 97kDa, BamB-Sce = 85.2.kDa, BamB-
Mxe = 58.1kDa
sequence (Scholz et al., 2011). In addition to the sequences required for TOMM synthase
complex recognition and activity, fusion tags were added to assist in assay development
and purification. A streptavidin-binding tag (Strep-tag, Wilson et al. (2001)) was fused
immediately to the C-terminal end of the artificial core sequence. This tag was used for
the immobilisation of peptides on streptavidin-coated microplates, which would be required
for the washing steps in the ELISA-based assays. Finally, the intein-CDB fusion tag from
pTWIN1 was at the C-terminus of the fusion peptide and was used for purification on chitin
resin (NEB) columns (Fig. 5.4). These constructs were named BXSIC (Bacillus leader - X
cysteines - Strep tag - Intein - CBD).
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Figure 5.4: Synthetic B. amyloliquefaciens TOMM synthase substrate construct. (a) De-
sign of the fusion protein, containing the native leader sequence, a synthetic core pep-
tide, a streptavidin binding tag for immobilisation and an Intein-CBD tag for purification.
(b) pTWIN1-derived vector for the expression of the synthetic substrate constructs. The
0C negative control substrate is shown here, but the remaining variants were made follow-
ing the same design.
The 0C and 1C substrate constructs were expressed and purified with high yields by
in-column cleavage, following manufacturer’s instructions (Fig. 5.5 for 0C, data not shown
for 1C). Significant amounts of contaminating uncleaved peptides could be detected in the
eluate. Therefore, the eluate from the first run was reloaded onto the re-equilibrated column
to capture the material still containing the intein CBD fusion and the flow-through fraction
of this second injection was used for assay development. After the second purification step,
the peptides were concentrated and bu↵er-exchanged using Amicon 3 kDa MW cuto↵ filters
(Millipore).
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Figure 5.5: Single step capture and cleavage of Intein-CBD-tagged 0C substrate peptide
by chitin column chromatography. LYS - lysate injected into column. W - Material
washed from the column before cleavage. E1A and E1B - Eluate fractions after cleavage.
E2 - Protein recovered after reloading E1A onto a reequilibrated column, showing a single
band near the 6.5kDa marker band. The bands corresponding to free substrate peptides
are enclosed in a red dashed box and the bands corresponding to Intein-CBD-substrate
fusions and free Intein-CBD are enclosed in a yellow dashed box. Expected mass for the
cleaved peptide is 6.7 kDa
5.1.1.2 Development of in vitro assays for the Bacillus amyloliquefaciens plan-
tazolicin synthase complex
Fusion-free substrate 0C (B0S, representing B0SIC after removal of the Intein-CBD tag)
peptides were analysed by MALDI-TOF (Matrix-Assisted Laser Desorption Ionization Time
of Flight) MS and single peaks were detected with mass/charge ratios almost 1000 units
smaller than the expected value for a singly-charged peptide (Fig 5.6). Initial cysteine
labelling tests were also conducted on the 0C and the 1C peptides, with the 0C peptide
acting as a negative control. These experiments resulted in strong background labelling,
which could interfere with future quantitation attempts. However, there was di↵erential
labelling of both peptides, with the stronger signal coming from the 1C peptide as expected
(Fig. 5.7).
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Figure 5.6: MALDI-TOF mass spectrum of purified 0C peptide, obtained in negative
linear mode. Expected mass for the peptide is 6731 Da
        5:1                     3:1                          1:1                              1:3    Label:Peptide 
 ‘           ratio
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Figure 5.7: Flourescence image of gel electrophoresis after Iodoacetamide-fluorescein
labelling reactions in di↵erent ratios of 0C/1C peptides to fluorescent label. As the La-
bel:Peptide ratio decreased, there was a reduction in background signal while the specific
1C band was still strongly labeled.
Once the peptide mass was confirmed by MS, TOMM synthase activity assays were at-
tempted by incubating Factor Xa-cleaved BamB/BamC/BamD with 0C and 1C peptides,
following conditions established for the Bacillus sp. Al-Hakam synthase complex (Melby
et al., 2012). After 72 hours, the reactions mixtures were loaded into Tricine SDS-PAGE
gels to detect any changes in migration of the peptides incubated with the enzymes. The
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expectation was that heterocycles installed in the peptide backbone would restrict con-
formational flexibility during electrophoretic migration, leading to altered migration of
modified peptides compared to unmodified controls.
Unexpectedly, both the 0C and 1C peptide bands shifted to a lower apparent molecular
weight when incubated with the enzymes, which could be evidence of activity of the TOMM
synthase even on the substrate that did not contain cysteines for modification (Fig. 5.8).
However, both peptides contain two threonine residues in the C-terminally fused Strep tag,
which could explain how the 0C negative control underwent modification by the enzyme
complex. Other forms of evidence, such as a shift in MS peaks or changes in iodoacetamide
labelling, would still be needed to confirm this result. Additionally, the shifts could be
caused by changes in bu↵er conditions and protein loading, which were not controlled
between positive and negative lanes.
Figure 5.8: TOMM Synthase activity assay electrophoretically separated on a polyacry-
lamide gel. When incubated for 72 hours in the presence of Factor Xa-cleaved BamB,
BamC and BamD, a mobility shift was observed for both 0C and 1C bands. Both peptides
had higher mobility after incubation with the BCD complex. “-” indicates the absence of
BCD enzymes in a reaction and “+” indicates the presence of BCD enzymes in a reaction.
The peptide bands prior to incubation with BCD enzymes are enclosed in a red dashed
box. The peptide bands observed after incubation with BCD enzymes are enclosed in a
yellow dashed box. Expected mass for the 0C and 1C peptides is 6.7 Da
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The unclear result from the initial assay developments tests led to a verification of all
construct designs to ensure the correct proteins were being used at all points. However, a
truncation was detected in the leader sequence inserted in the synthetic substrate peptides,
when compared to leader sequences used in previous studies (Scholz et al., 2011). This
error occurred due to a misidentification of the start codon in the BamA substrate pep-
tide gene from the B. amyloliquefaciens genomic sequences and required a redesign of the
substrate constructs (Fig. 5.9). In addition to the 0C,1C,2C and 3C peptides previously
mentioned, a peptide with the plantazolicin core region — RCTCTTIISSSSTF containing
10 heterocyclisation sites and named BPSIC — was also constructed as a positive control
for B. amyloliquefaciens complex activity. The peptides BPSIC, B0SIC and B2SIC were
the first to be successfully cloned with the new leader sequence, so these were used for assay
development while the remaining variants were being constructed.
Figure 5.9: Sequences of the truncated and corrected plantazolicin leader peptide, from
Scholz et al., 2011.
All three substrates were expressed in high soluble yields and purified by chitin a nity
chromatography followed by in-column cleavage of the intein-CBD tag (Fig. 5.10a, data
shown for BPS only). Free BPS was isolated by a two-step ultrafiltration protocol, removing
most of uncleaved BPSIC by filtering the eluted fraction through a 30 kDa cuto↵ filter.
This was followed by removal of remaining higher molecular weight proteins by filtration
through a 3 kDa cuto↵ filter that did not retain the free peptide of expected mass equal to
9.4 kDa, which was interpreted as normal variation in the mass cuto↵ of the filter device.
The migration of the BPS peptide in Tricine SDS-PAGE was faster than expected for its
mass, but this was interpreted as anomalous migration known to occur in Tricine SDS-
PAGE, especially with peptides containing high frequencies of hydrophobic amino acids
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(Schagger, 2006) — of which there are 21 out of 33 residues in the plantazolicin leader
peptide. To verify whether the two independent indications of lower molecular weight than
expected for the BPS peptide were correct, the purified peptides were submitted to MALDI-
TOF mass spectrometry, which identified a clear peak at 5543.3 Da and supporting the
anomalous migration and unexpected behaviour in filtration to indicate a likely truncation
in the purified peptide (Fig. 5.10 c).
Figure 5.10: BPSIC substrate peptide purification and MALDI-TOF detection. A -
Eluted fractions from the chitin resin column. MW - Molecular weight marker. Lanes
1-5 Eluted fractions, with the highest concentration of cleaved peptide in lanes 3 and
4. Expected MW for BPSIC = 8.6kDa. B - Removal of uncleaved fusion constructs by
ultrafiltration. Lane 1 - Retentate in 30kDa cuto↵ filter. Lane 2 - Filtrate collected from
30kDa cuto↵ filter. Lane 3 - Retentate in 3kDa cuto↵ filter. Lane 4 - Filtrate collected
from 3kDa cuto↵ filter and subsequently used as pure BPSIC peptide. C - MALDI-TOF
spectrum of purified BPSIC. Expected mass for the peptide is 9428 Da
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To verify whether this truncation was caused by the changes in the leader peptide portion
of the construct, B0S and B2S were isolated by the same procedure as BPS and analysed
by MALDI-TOF, along with TOMM synthase reactions using each substrate and the full
BCD complex (Fig. 5.11). As observed for the BPS substrate, the expected peak for each
free substrate peptide could not be observed and other unexpected peaks were also seen
in the lower regions of the spectra. Incubation with BCD enzymes for heterocyclisation
produced new peaks, but none corresponding to expected shifts of -20 Da or -40 Da for the
two-cysteine B2S peptide and no shift for the negative control B0S peptide (Fig. 5.11)
TOMM synthase activity assays were also attempted with the purified BPSIC pep-
tide and a similar electrophoretic mobility shift to the one observed in Fig. 5.8 could be
observed after BPSIC was incubated with Factor Xa-cleaved BamB, BamC and BamD
(Fig. 5.12a). The reaction mixtures were then analysed by MS and a shifted peak was
detected (Fig. 5.12c), but this peak did not match the peak observed after BPSIC purifi-
cation (Fig. 5.10c). Also, the observed shift was of approximately 332 m/z units, while
the expected shift from heterocyclisation of all 10 residues in the core peptide would be
only 200Da. Even if the two threonine residues in the Strep tag were also heterocyclised
to methyloxazoles, the expected shift would still only be 240Da, which indicates that the
observed shifts in MALDI-TOF spectra were not due to TOMM synthase activity.
The electrophoretic mobility shift after incubating substrate peptides with the TOMM
synthase complex was reproducible with all of the substrate peptides constructs used until
this point, initially interpreted as evidence of an active enzyme complex. However, since
the MS results were inconclusive and the direct detection methods (chemical labelling of
free cysteines or antibody detection of thiazoles) were not attempted for reaction products
of this complex, there still remained a possibility that the apparent mass change was a
technical artefact and not related to TOMM synthase activity.
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Figure 5.11: MALDI-TOF spectra of a TOMM synthase activity assay with corrected
leader peptide sequences. Spectra in green represent negative controls incubated in the
absence of TOMM synthase complexes and spectra in red were incubated in the presence
of purified and Factor Xa-cleaved BamB, BamC and BamD. (a) Spectra obtained for the
B0S non-cyclisable peptide. (b) Spectra obtained for the B2S substrate peptide containing
two cyclisable cysteines. Plots were zoomed into the region of the spectra that contained
peaks, no peaks were observed outside this region. B0S expected MW = 8454.2 Da. B2S
expected MW = 8497.1 Da. Each cyclisation event was expected to produce a loss of 20
Da, to a total of 40 Da if both Cys residues in B2S were cyclised.
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Figure 5.12: Synthase assay using BPSIC substrate. A - Gel shift assay of the reaction
products. MW - molecular weight marker. 1 - BPSIC peptide incubated in the absence of
enzymes. 2 - BPSIC peptide incubated in the presence of Factor Xa-cleaved BCD complex.
B - MALDI analysis of the reaction products from A. The top spectrum represents the
unreacted peptide and the bottom spectrum is the peptide fraction after incubation with
the active enzymes. Plots were zoomed into the region of the spectra that contained peaks,
no peaks were observed outside this region. Expected MW for BPSIC = 9428 Da. Each
cyclisation event was expected to produce a loss of 20 Da, to a total of 200 Da if all the
cyclisation sites in BPS were cyclised.
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One possible confounding factor would be a contaminant protease in the synthase en-
zyme preparations used in the assays. To eliminate this possible source of error, a synthase
reaction was set up with uncleaved MBP-fused BamB, BamC and BamD, which are likely
to be inactive (as described by Milne et al. (1999); Melby et al. (2012)). After a 72-hour
incubation, no shift was observed in the MBP fusion lane, while the Factor Xa-cleaved lane
had the same shift that was observed in previous experiments (Fig. 5.13), further indicat-
ing that the observed shift is due to TOMM synthase activity. Cleavage of the substrate
peptides by Factor Xa itself is unlikely as none of the substrate constructs have Factor Xa
sites and the assays are conducted in 5mM DTT, which would reduce the disulfide bonds
needed to maintain the Factor Xa subunits in their active form (Waugh, 2011).
Despite the indication of activity from the shift in electrophoretic mobility, no clear
evidence of heterocyclisation activity could be obtained for the B. amyloliquefaciens plan-
tazolicin synthase system. Commercially-synthesised peptides could be used to eliminate
the possibility of the anomalous masses being caused by intracellular degradation during
peptide expression in E. coli. Also, synthase reactions using the BamBCD complex could
be analysed with tandem MS/MS methods, fragmenting the peptides to confirm their se-
quence and also accurately detect locations of any heterocyclisation event that occurred,
as done by Melby et al. (2012) in the initial description of this enzyme complex. These
alternative approaches to confirm this evidence of activity were not pursued due to other
sets of TOMM synthase complexes and substrates becoming available for use, as described
in the following section.
5.1.2 In vitro reconstitution of the Bacillus sp. Al-Hakam TOMM syn-
thase
While e↵orts were being made to obtain a robust and consistent assay system for the
B. amyloliquefaciens TOMM synthase complex, contact was established with the group
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Figure 5.13: Control experiment for protease contamination in BamB, BamC and BamD
preparations. Lane 1 - NEB Broad Range marker. Lane 2 - 0C peptide incubated with
uncleaved TOMM synthase enzymes. Lane 3 - 0C peptide incubated with Factor Xa-
cleaved enzymes. Lane 4 - 0C peptide incubated with no enzymes. MW - Low Molecular
weight marker
of Prof. Douglas A. Mitchell (University of Illinois at Urbana-Champaign) for assistance
in method development. Prof. Mitchell advised the use of the Bacillus sp. Al-Hakam
(Balh) TOMM synthase system, due to its greater tolerance to mutations in the core
peptide (Melby et al., 2012; Deane et al., 2016) and higher in vitro activity (personal
communication). Expression constructs for all the proteins in the Balh system were kindly
donated, along with constructs for the E. coli microcin B17 system as a second backup
strategy.
5.1.2.1 Expression and purification of the Bacillus sp. Al-Hakam TOMM
synthase complex and substrates
All of the constructs for expression of the Balh TOMM synthase system contain TEV
protease-cleavable N-terminal MBP fusions under transcriptional control of the T7 pro-
moter, in pET-based vectors (Fig. 5.14). Among these were two substrate constructs:
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BalhA1-WT coding for the wild-type TOMM precursor and BalhA1-NC coding for a non-
cyclisable negative control variant, in which all Cys, Ser, and Thr residues after the leader
sequence were replaced with Ala (Fig. 5.14a-b). The cyclodehydratase BalhD and the
docking protein BalhC are encoded by the native sequence from Bacillus sp. Al-Hakam
(Fig. 5.14c-d). However, the dehydrogenase used in Melby et al. (2012) and subsequent
work in the Mitchell Group (Melby et al., 2014; Dunbar et al., 2014) is the cognate BcerB
from Bacillus cereus, since the FMN cofactor required for activity is not loaded when the
native BalhB is expressed in E. coli. All of the vectors were transformed into E. coli NEB
10-b for amplification, plasmids were extracted and confirmed by sequencing, followed by
transformation into T7 Express LysY/Iq for expression.
The first expression tests in 10 ml culture volumes were carried out using the conditions
previously established for the Bam system (Section 5.1.1.1) and also the conditions used by
the Mitchell group: induction of the enzyme constructs with 0.4 mM IPTG at 22°C for 16
h and induction of the substrate constructs with 1 mM IPTG at 22°C for 1 h (Fig. 5.15).
All of the proteins had higher soluble yields under the conditions established in this work
for the Bam system, so these conditions were scaled up to 200 mL cultures in shake flasks
for purification.
All cultures were lysed by sonication and purified by amylose-a nity chromatography
(Fig. 5.16) according to the methods in Section 2.4.5. Good yields were obtained for BcerB
and BalhC, but BalhD recovery was approximately 30-fold lower (Fig. 5.16a), reflecting
the lower soluble expression yield (Fig. 5.15). Multiple cultures of BalhD were carried out
and eluted fractions were pooled before concentration by ultrafiltration, to compensate for
this lower yield.
All three proteins of the TOMM synthase complex were concentrated in MBP storage
bu↵er to at least 1 mg/ml and stored at 4°C for up to two weeks. Unexpectedly, con-
centrated solutions containing BcerB dehydrogenase did not have the strong yellow colour
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Figure 5.14: Constructs used for the expression of the Bacillus sp. Al-Hakam TOMM
synthase complex and substrates - All constructs were fused to MBP at their N-termini
and a TEV Protease recognition site was included to allow the production of fusion-free
proteins. (a)BalhA1-WT wild-type substrate peptide. (b) BalhA1-NC negative control
peptide with no cyclisable residues. (c) BalhC docking protein. (d) BalhD cyclodehy-
dratase. (e) BcerB dehydrogenase from B. cereus. Constructs kindly donated by Prof.
Douglas A Mitchell.
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Figure 5.15: Induction tests for proteins from the Bacillus sp. Al-Hakam TOMM syn-
thase complex. All constructs were induced under the conditions optimised for the equiv-
alent proteins in the B. amyloliquefaciens complex and the conditions described in (Melby
et al., 2012). (a) Induction tests for TOMM synthase complex enzymes. (b) Confirma-
tion of selected conditions for TOMM synthase complex enzymes and induction tests for
substrate peptides. Bands that correspond to the proteins of interest are enclosed in red
dashed boxes. B - BcerB dehydrogenase (Expected MW = 75.8kDa). C - BalhC dock-
ing protein (Expected MW = 80.4 kDa). D - BalhD cyclodehydratase (Expected MW =
92.5 kDa). NC - BalhA1-NC negative control peptide (Expected MW = 53 kDa). WT
- BalhA1-WT wild-type substrate peptide (Expected MW = 53.3 kDa). M - NEB broad
range protein standard. I - Insoluble fraction. S - Soluble fraction. The induction times
after addition of IPTG were 3 hours for 37 °C, 1 hour for 22 °C for NC/WT, 16 hours for
22 °C for B/C/D, and 16 hours for 16°C.
characteristic of FMN-bound TOMM dehydrogenases (Melby et al., 2012; Gonzalez et al.,
2010b), despite being used by Melby et al. (2012) to correct this issue with the native BalhB
enzyme and being expressed in media supplemented with 50 µg/ml riboflavin. Repeated
inductions and purifications under the same conditions and exactly following the expression
conditions of Melby et al. (2012) did not yield di↵erent results (data not shown), so assay
development continued to determine whether there was any detectable residual activity in
these BcerB preparations, while expression of the E. coli microcin B17 system was started
as an alternative strategy (Section 5.1.3).
The substrate peptides were also recovered in high yield, but with strong free MBP bands
(of approximately the same intensity as the MBP-BalhA1 fusion bands) indicating possible
degradation of the core peptide region by proteases in vivo or after lysis (Fig. 5.16b).
Similar bands are also present in the enzyme purifications, but in lower relative proportion.
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Figure 5.16: Purification of proteins for the Bacillus sp. Al-Hakam TOMM synthase
complex - All constructs were purified by amylose a nity chromatography. (a) Purification
of TOMM synthase complex enzymes with a yield for the D protein at least 30-fold lower
than for B or C. (b) Purification of substrate peptides, with an apparent doublet band
visible for the WT substrate. Bands that correspond to the proteins of interest are enclosed
in red dashed boxes. B - BcerB dehydrogenase (Expected MW = 75.8kDa). C - BalhC
docking protein (Expected MW = 80.4 kDa). D - BalhD cyclodehydratase (Expected MW
= 92.5 kDa). NC - BalhA1-NC negative control peptide (Expected MW = 53 kDa). WT
- BalhA1-WT wild-type substrate peptide (Expected MW = 53.3 kDa). M - NEB broad
range protein standard. L - induced culture lysate. W - column wash fractions. E - Elution
fractions. The image in (b) has been cropped to remove intervening lanes unrelated to the
current experiment.
Subsequent induction experiments included a protease inhibitor cocktail in the lysis bu↵er
(cOmplete, EDTA-free Protease Inhibitor Cocktail, Roche) and produced lower levels of
degradation products (Section 5.1.3.1).
An apparent dimer band was also visible in the BalhA1-WT purifications (Fig. 5.16),
which would appear to be dimerisation induced by disulfide bridges between the Cys
residues in the WT peptide, absent in the NC variant. However, all samples were pre-
incubated in SDS-PAGE loading bu↵er containing 10 mM TCEP at 95°C, which should be
su cient to reduce all disulfides in proteins (Burns et al., 1991). Since this apparent dimer
is a relatively minor component (less than 20% of the intensity of the monomeric MBP
fusion) of the purified fractions, no e↵ort was made to isolate the monomeric band before
starting assay development.
At this point, all components needed for in vitro activity assays of the Bacillus sp.
Al-Hakam synthase complex were successfully expressed and purified, enabling assay de-
velopment to begin.
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5.1.2.2 Development of in vitro assays for the Bacillus sp. Al-Hakam TOMM
synthase complex
Initially, fluorescent labeling of free thiols in the peptide substrates and MALDI-TOF detec-
tion were carried out on TEV-protease-cleaved BalhA1 substrate variants to confirm these
peptides had the expected mass and free thiols. The iodoacetamide labeling reagent used
in previous experiments was substituted for Fluorescein-5-Maleimide, due to the higher
specifity for thiol groups over the undesired side reaction with amino groups (L.C. Cheah,
unpublished data). Free BalhA1-WT peptide has an expected MW of 6034.8 and six cys-
teines which should be labeled by the maleimide-fluorescein reaction. On the other hand,
free BalhA1-NC has an expected MW of 5807.0 Da and no free thiols to react with the
maleimide reagent. However, both peptides showed similar levels of labelling upon incuba-
tion with maleimide-fluorescein (Fig. 5.17), indicating similar reactivity of the free peptides
to the maleimide group in these conditions, corresponding to side reactions. Since TCEP
or other reducing agents were excluded from labeling mixtures to prevent scavenging of
the dye by these compounds (Shafer et al., 2000), it is possible that the thiols in the WT
peptide were not accessible due to intra- or intermolecular disulfide bonds and the observed
labelling was due to o↵-target reactions. This is corroborated by the continued presence of
the apparent dimer band of approximately 100 kDa only in the WT peptide lanes.
MALDI-TOF spectra of these two peptides contained peaks in the expected m/z region
for singly-charged species (Fig. 5.17), suggesting that the free peptides observed in tricine
SDS-PAGE corresponded to the expected sequences of the expressed constructs. Synthase
assays were carried out by incubating WT and NC peptides in the presence of TEV-cleaved
BcerB, BalhC and BalhD, followed by MALDI-TOF detection, which should show a shift
of -20 Da in the BalhA1-WT peak for every heterocyclisation event (-100 Da for conversion
into the final product containing 5 azole heterocycles). However, only the non-cyclised
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peak was ever observed in these experiments, meaning that no azoles were produced. This
could result from a complete lack of heterocyclisation activity on the BalhA1-WT purified
substrate or from acid hydrolysis of azolines (Melby et al., 2012), that were not oxidised
by the BcerB enzyme due to the lack of bound FMN cofactor. Azolines can be detected
by labeling free cysteines after incubation with the BCD enzymes, followed by incubation
in acidic conditions to hydrolyse azolines and MS/MS fragmentation. Any residues that
were not heterocyclised would be labeled, the oxidised thiazoles would remain intact and
thiazolines would be detected as free Cys residues after hydrolysis.
Due to the inability to express the BcerB enzyme with the FMN cofactor required for its
activity and the lack of specific cysteine labelling in the BalhA1-WT peptide, e↵orts were
shifted towards establishing the E. coli microcin B17 synthase complex for in vitro assay
development. Activity assays with the FMN-bound BamB enzyme from B. amyloliquefa-
ciens and the BalhCD proteins were not attempted since they were not described in any
reports from the Mitchell group and the microcin B17 system was deemed a safer option
to achieve successful activity detection.
Figure 5.17: Development of In vitro activity detection assays for the Balh TOMM syn-
thase complex - (a) Maleimide-fluorescein labeling of cysteines. Total protein was detected
by coomassie staining (left) and Maleimide-fluorescein-tagged proteins were detected by
fluorescence (right) No increase in fluorescent labeling was detected for the WT peptide
over the NC peptide (red box). M - Molecular weight marker. N - Non-Cyclisable pep-
tide. W - Wild-type peptide (b) MALDI-TOF spectra of NC (expected MW = 5807.0 Da)
and WT (expected MW = 6034.8 Da) peptides. Each cyclisation event was expected to
produce a loss of 20 Da, to a total of 100 Da all the modifiable sites in WT were cyclised.
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5.1.3 In vitro reconstitution of Escherichia coli microcin B17 biosyn-
thesis
This section will describe experiments carried out with the aim of overexpressing the E.
coli TOMM synthase complex and measuring its activity in vitro.
5.1.3.1 Expression and purification of the E. coli microcin B17 TOMM syn-
thase complex and substrates
The constructs kindly donated by the Mitchell group for expression of the E. coli microcin
B17 (Mcb17) system components have the same design used for the Bacillus sp. Al-Hakam
proteins. N-terminal MBP fusions are present in all the constructs, with a TEV protease
site to produce free proteins and under the control of the T7 promoter. (Fig. 5.18).
Only one substrate construct was used, coding for the full-length McbA precursor peptide.
All of the enzymes are the native versions from the microcin B17 biosynthesis operon:
McbB docking protein, McbC dehydrogenase and McbD cyclodehydratase. Vectors were
transformed into NEB 10-bcells for amplification, confirmed by sequencing and transformed
into the expression strain T7 Express LysY/Iq.
Initial induction tests were carried out using the conditions established for the Balh
proteins, producing satisfactory levels of soluble expression for all proteins but the McbD
cyclodehydratase (data not shown). To improve the soluble yield of McbD, a range of
culture conditions and media were screened (Fig. 5.19). The highest soluble yields were
obtained using both TB and 2xTY media, with 16 h inductions at 25°C. All cultures were
induced in shake flasks at 200 ml scale for purification.
All cultures were lysed in the presence of protease inhibitor cocktail and purified by
amylose-a nity chromatography (Fig. 5.20a), following the methods in Section 2.4.5. Dur-
ing the purification runs, expression of McbC dehydrogenase with its required FMN co-
factor was evident from the yellow colour of eluted fractions, becoming more intense after
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Figure 5.18: Constructs used for the expression of the E. coli microcin B17 synthase
complex and substrates - All constructs were fused to MBP at their N-termini and a
TEV Protease recognition site was included to allow the production of fusion-free proteins.
(a)McbA substrate peptide. (b) McbB docking protein (c) BalhC dehydrogease. (d) BalhD
cyclodehydratase. Constructs kindly donated by Prof. Douglas Mitchell.
concentration by ultracentrifugation. The relative proportion of free MBP from apparent
degradation of fusion products was less than 10% of the total protein in the McbA lane,
indicating that proteases did not cause significant degradation of fusion proteins. On the
other hand, an apparent dimer of the MBP-fused substrate was also observed in this sys-
tem — representing approximately 15% of the total protein in eluted lanes — but assay
development was continued in the presence of this additional band.
McbD expressed in optimised conditions was still recovered in approximately 50-fold
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Figure 5.19: Induction test for the E. coli McbD cyclodehydratase. Induction at 25°C
for 16h in 2xTY medium was used for subsequent cultures of this construct. Bands that
correspond to the protein of interest are enclosed in red dashed boxes. LBD - LB with 5%
glucose. TB - Terrific Broth
lower concentration than the other proteins in the system (Fig. 5.20). A possible cause
for these lower purification yields is reduced amylose-binding a nity of the MBP fused to
McbD compared to other fusion partners, caused by MBP-fusion partner interactions that
make the interaction between MBP and a nity resin less favourable (Park et al., 1998).
Previous experiments by other group members with the Pyrococcus furiosus TOMM syn-
thase complex suggested a capacity for heterodimerisation of the cyclodehydratase and the
docking protein by copurifying both proteins by a nity chromatography when only one of
the proteins was tagged with MBP (J. Ewan Coates, unpublished data). To test this pos-
sibility, the McbB docking protein and McbD cyclodehydratase were co-purified by mixing
their induced lysates in 1:2 volumetric ratio before injecting into the chromatography col-
umn (to account for the higher soluble yield of McbB) (Fig. 5.20b), yielding approximately
the a 2:1 McbB to McbD mass ratio in the eluted fraction, which was deemed acceptable
for assay development.
5.1.3.2 Development of in vitro assays for the microcin B17 TOMM synthase
complex
The purified proteins of the E. coli microcin B17 synthase system were used to start de-
velopment of MS and cysteine-labelling assays. Initially, the substrate alone was digested
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Figure 5.20: Purification of proteins for E. coli microcin B17 synthesis - All constructs
were purified by amylose a nity chromatography. (a) purification of McbA substrate
peptide, McbC dehydrogenase and McbD cyclodehydratase. The yield for McbD was at
least 50-fold lower than for the other proteins. (b) Copurification of McbB and McbD,
yielding both proteins in an approximate 2:1 mass ratio (B:D). Bands that correspond to
the proteins of interest are enclosed in red dashed boxes. A - McbA substrate peptide
(Expected MW = 49.6 kDa). C - McbC dehydrogenase (Expected MW = 74.4 kDa). D -
McbD cyclodehydratase (Expected MW= 86.5 kDa). B - McbB docking protein (Expected
MW = 77.6 kDa). M - NEB broad range protein standard. L - induced culture lysate. W
- column wash fractions. E - Elution fractions. LB - induced McbB culture lysate. LD -
induced McbD culture lysate. The image in (b) has been cropped to remove intervening
lanes unrelated to the current experiment.
with TEV protease to establish conditions for production of the free peptide. Overnight
digestion of 20 µg MBP-McbA with 8 U TEV Protease led to 30% cleavage of the fusion
protein detectable by SDS-PAGE (Fig. 5.21a) and the remaining material was split into
two equal fractions and precipitated by TCA-acetone for detection of free McbA peptide
by Tricine SDS-PAGE. Due to the known poor solubility of the McbA substrate (Yorgey
et al., 1993; Sinha Roy et al., 1998), pellets were resuspended in acetonitrile and MBP
storage bu↵er (Fig. 5.21 b). No clear band corresponding to the free McbA peptide could
be observed, but the lane containing acetonitrile-resuspended material had an amount of
total protein that was at least 5-fold higher than was obtained in the aqueous resuspension.
Precipitation followed by resuspension in acetonitrile coupled to a three-fold increase in the
TEV protease concentration (24 U TEV for 20 µg protein) were used to produce material
for establishment of conditions for MS detection of the McbA peptide and its heterocyclised
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products.
Figure 5.21: Production of free McbA substrate peptide by cleavage with TEV protease.
(a) MBP-McbA fusion cleaved with TEV protease. Only partial cleavage was observed, as
a lower band corresponding to free MBP (both bands enclosed in a red dashed box). The
free McbA peptite (expected MW = 6.2 kDa) is expected to migrate at the same rate as
the dye front in these conditions and, therefore, would not be detected. (b) Tricine SDS-
PAGE of cleaved McbA peptide after precipitation with TCA/Acetone and resuspension in
acetontrile (Acn) or MBP storage bu↵er (Tris). The expected position for the free McbA
peptide is enclosed in the green dashed box. M - NEB broad range protein standard.
Attempts at detecting the cleaved McbA peptide by MALDI-TOF, directly from TEV
cleavage reactions or after precipitation and resuspension in acetonitrile, failed to produce
any signal close to the expected mass value of 6239.8 Da (data not shown). This could be
caused by the low recovery of peptides by acetonitrile resuspensions, compounded by losses
of material during sample preparation, resulting in a final concentration of peptides in the
MALDI-TOF plates that is too low for detection.
To remedy this issue, detection by Liquid Chromatrography coupled to Mass Spectrom-
etry (LC/MS) was used to exploit the analyte concentration that occurs during chromatog-
raphy for improved detection. Two separate reactions were carried out, one repeating the
conditions used for MALDI-TOF detection of TEV-cleaved McbA and a separate reaction
containing all the components of the Mcb17 synthesis machinery and a threefold increase
in the MBP-McbA substrate concentration (60 µg MBP-McbA in 100 µl reaction volume)
to attempt detection of synthase complex activity. Both reactions were TCA-acetone pre-
cipitated and resuspended in 10 µl acetonitrile for LC/MS injection. A single peak was
detected for the TEV cleavage reaction at 6241 Da and multiple peaks consistent with
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multiple heterocyclised intermediates were visible in the TOMM synthase reaction, with a
single larger peak at 6242 Da, very close to the expected MW of 6239.8 Da (Fig. 5.22).
These spectra are the strongest indication of in vitro TOMM synthase activity that were
obtained in this work and they suggest the presence of species containing a maximum of
four heterocyclised residues (peak at approximately 6161 Da, mass 80 Da smaller than than
the unmodified peak) out of a total of eight sites that must be heterocyclised in mature
Mcb17. However, they are not su cient to conclude unequivocally that heterocyclisation
ocurred in these experiments and must be corroborated by other forms of evidence.
The commercial polyclonal antibody specific for the drug sulfathiazole (LSBio) was
tested for its ability detect thiazole moieties installed in the McbA peptide. TOMM syn-
thase reactions were carried out with the purified Mcb components, following the conditions
that led to detection of possible heterocyclic species by LC/MS and using two separate
batches of purified McbA peptide. To prevent loss of poorly-soluble material during sample
handling for Western blotting, dot blots were carried out with the entire volume of reaction
mixtures loaded onto the blotting membrane. However, no colorimetric signal specific to
the reactions expected to contain thiazole modifications could be detected (Fig. 5.23). The
di↵erence in signal intensity between reactions containing BCD enzymes and the negative
control was lower than 10%. The di↵erences observed between spots could be explained by
the higher substrate peptide concentration in purification batch 2 (approximately 2 µg/ml)
compared with batch 1 (approximately 1 µg/ml), suggesting that the signal observed was a
result of nonspecific binding to protein rather than specific recognition of thiazoles by the
primary antibody.
Due to the solubility issues encountered while carrying out experiments with the full-
length McbA substrate peptide, constructs were made by inverse PCR to express the trun-
cated variant McbA1-46 (Sinha Roy et al., 1998; Belshaw et al., 1998) with inserted residues
at the C-terminus to increase solubility. Two di↵erent variants were made, one with a
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Figure 5.22: LC-MS detection of McbA heterocyclisation. (a) Negative control spectrum
with free McbA peptide produced by TEV protease cleavage. (b) Heterocyclisation reaction
using free McbA and TOMM synthase complex enzymes. Peaks with approximately 20
Da spacing between them indicate the formation of multiple heterocyclised intermediates.
Expected MW of uncyclised McbA = 6370.9 Da. Plots were shifted to align the unmodified
peak. Each cyclisation event was expected to produce a loss of 20 Da, to a total of 160 Da
all the modifiable sites in McbA were cyclised.
KKD insertion (McbA1-46 KKD) and a second variant with a QMQ insertion (McbA1-46
QMQ). The length of the insertions was chosen arbitrarily and the sequences were selected
to produce one variant with a highly-charged insertion — KKD — that is expected to have
a strong impact on solubility and one variant with a mostly polar but uncharged insertion
— QMQ — that would be expected to have a smaller contribution to solubility (Trevino
et al., 2007). The McbA1-46 truncation reduces the number of Gly stretches — which are
likely to contribute strongly to the aggregation tendency of the peptide — and also contains
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Figure 5.23: Dot blot of Microcin B17 synthase reactions using a polyclonal sulfathiazole
primary antibody - Colorimetric signal was similar for reactions containing the synthase
complex and the negative controls
only a single SC bisheterocyclisation site, simplifying the interpretation of results during
assay development by MS detection of mass losses from heterocyclisation events or cysteine
labelling. Negative control variants were also made for each construct by mutating both
cyclisable residues to Gly.
After expression and purification, MBP-McbA1-46 variants were cleaved with TEV pro-
tease, labelled with maleimide-fluorescein and resolved by Tricine SDS-PAGE. Distinct
labeled bands corresponding to free McbA1-46 peptide were visible for both insertion vari-
ants (Fig. 5.24). Importantly, no fluorescein signal was detected for the negative variants,
indicating that maleimide labeling was specific for cysteines in the substrate peptides in
this experiment, unlike the results observed for the BalhA1 substrates (Fig. 5.17a). Faint
free peptide bands were also visible after staining for proteins, indicating an increase in
aqueous solubility of the new variants. These results suggest that mutations to increase
the hydrophilic character of substrate peptides are a viable strategy to produce material in
high quantities for higher-throughput assays. However, the activity of the heterocyclisation
machinery on these insertion variants was not measured and could be impaired especially
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by the charged insertions, since the WT sequence contains mostly hydrophobic residues
surrounding the heterocyclisation sites.
Figure 5.24: Maleimide-fluorescein labeling of McbA substrate variants for improved
solubility. Tricine SDS-PAGE of McbA substrate variants KKD and QMQ. Di↵erential
labeling was observed between variants containing cysteines and negative control variants.
Bands that correspond to the proteins of interest are enclosed in red dashed boxes. WT -
McbA 1-46 substrate. Neg - McbA 1-46 substrate with S40G and C41G substitutions.
5.2 Conclusions
Despite the e↵orts by multiple groups to characterise the function of distinct TOMM syn-
thase complexes and the range of products they are able to synthesise, only a few species
have had their biosynthetic machinery for this class of compounds reconstructed in vitro
(Li et al., 1996; Lee et al., 2008; Mitchell et al., 2009; Scholz et al., 2011; Melby et al.,
2012). The relatively low interest in the study and engineering of the TOMM biosynthetic
mechanism for the production of novel compounds can be at least partly attributed to the
di culties encountered here during attempts at establishing a robust in vitro system for
detection of TOMM synthase activity and also reported by other groups.
The enzymes of the B. amyloliquefaciens complex responsible for the production of plan-
tazolicin were solubly expressed and purified by a nity chromatography, but their activity
could not be detected due to apparent cleavage of the substrate peptides. Di culties in
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employing E. coli for the heterologous production of short peptides — especially those with
antimicrobial activity — are widely acknowledged, including a tendency towards degrada-
tion by intracellular proteases (Piers et al., 1993) and toxicity against the host if genes
related to immunity are not coexpressed (Li, 2009).
While the BalhA1 substrate peptides of the Bacillus sp. Al-Hakam complex were suc-
cessfully expressed and purified in this work with their expected molecular weights, the
dehydrogenase BcerB could not be produced with the bound FMN cofactor required for its
activity. Curiously, this orthologous enzyme from B. cereus was selected by Melby et al.
(2012) for its soluble expression with the bound cofactor to replace the BalhB enzyme,
which was never successfully expressed with FMN. The failure to produce active BcerB
protein illustrates the common issue of inconsistent expression of proteins across groups
and even at di↵erent times, often requiring meticulous experimentation to determine the
sets of conditions required for successful expression of a protein (Faiq et al., 2014).
A lack of bound FMN was also encountered by another member of the Pinheiro group,
when attempting to produce the TOMM synthase complex from Pyrococcus furiosus (J. Ewan
Coates, unpublished data). Milne et al. (1999) also attempted the coexpression of a chap-
erone shown to copurify with the complex, with the aim of increasing the concentration
of active enzymes. However, a decrease in TOMM synthase activity was observed (Milne
et al., 1999), suggesting that as-yet unidentified factors from native organisms could be
needed for e cient folding and activity of the complex. Another possible solution to this
issue is to extend the complementation approach used by Melby et al. (2012) and attempt to
substitute non-functional dehydrogenases with the proteins that were successfully expressed
with bound FMN such as McbC from E. coli and BamB from B. amyloliquefaciens.
The greatest degree of success in in vitro reconstruction was achieved here with the
Mcb17 synthase complex from E. coli. All the proteins involved in Mcb17 heterocyclisation
were successfully expressed and purified, including McbC dehydrogenase with bound FMN,
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and indications of azole formation were obtained by LC/MS detection of in vitro reactions.
However, the poor solubility of the free substrate peptide McbA made handling of these
activity assays di cult and also produced inconsistent results. The poor aqueous solubility
of free McbA was previously acknowledged (Yorgey et al., 1993; Sinha Roy et al., 1998)
and attempts in this work to produce substrate variants with additional polar residues for
increased solubility suggested a degree of success in producing variants that would be more
amenable to characterisation. Tolerance of the McbBCD complex toward these mutations
would still need to be tested, along with any cytotoxic activity against sensitive E. coli
retained by these variants.
An in vivo biosynthesis system could also be employed to characterise the plantazolicin
biosynthetic system from B. amyloliquefaciens. This compound has been identified as a
narrow-spectrum antimicrobial with a high specificity for B. anthracis and low activity
on the non-pathogenic closely-related species B. cereus (Molohon et al., 2016), making its
study relevant in the understanding of this pathogen and in drug development. While
virulent strains of B. anthracis are classified as biosafety level 3 and most groups involved
in protein engineering do not possess the facilities and training required to handle these
organisms, plantazolicin is still active on avirulent strains classified as biosafety level 2
(Molohon et al., 2016). Therefore, the functional prediction results obtained here could be
transferred to the plantazolicin biosynthetic complex for product and complex engineering
with the aim of creating tools for the study of B. anthracis pathogenicity and, eventually,
novel compounds for drug development.
Characterisation and engineering of TOMM synthase complexes and their products is
still an open challenge in the field. The work described here represents incremental steps
toward the aim of establishing a platform for the introduction of heterocycles into arbitrary
positions in synthetic peptides, which would enable the quick and e cient exploration of
the possible structures that exist in this class of compounds.
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InDel assembly as a framework for employing length and com-
positional variation in directed evolution
6.1 Introduction
This chapter covers the development of a strategy for the directed evolution of synthetic
TOMM products, which is comprised of (1) a novel library assembly method to produce
synthetic TOMM precursor peptides with targeted diversity in length and composition
and (2) an analysis framework to detect enrichment of motifs from selection experiments
employing these libraries. In the absence of a functional in vitro TOMM biosynthesis
platform, the strategy was employed to engineer a flexible substrate-recognition loop in
TEM-1 b-lactamase, generating seven novel variants of diverse lengths, with activity against
a non-cognate substate.
6.1.1 Development of a method to produce targeted length and compo-
sitional diversity
Given the limitations of current methods for the production of protein coding sequences
containing length and sequence diversity (Section 1.5.1.3), a novel DNA assembly strategy
was conceived as a tool to produce heterometric libraries of variants for screening novel
bioactive TOMMs. Significant structure-function analysis has not been reported for any
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already characterised TOMM. Therefore, such a method would ideally be able to produce
tunable distributions of length and composition. Using this flexibility, screening or selection
for novel compounds can start using broad diversity to identify candidate motifs, followed
by design of targeted libraries to explore the sequence space around hits and further rounds
of enrichment to obtain improved variants.
Here, an enzymatic method — called InDel Assembly — was established to produce tun-
able heterometric libraries based on enzymatic cycles of restriction and ligation in which
codon-length assembly blocks are added sequentially to template oligos (Fig. 6.1). Biotiny-
lated dsDNA oligonucleotides — named template oligos — are immobilised on paramag-
netic streptavidin beads, allowing for quick exchange of reaction components and washes
between steps. Assembly starts with digestion of bead-bound oligos (Fig. 6.1 Step i) by
a Type IIS restriction endonuclease, leaving a 50 overhang (Fig. 6.1 Step ii). Assembly
block oligos with three degenerate base (NNN) overhangs are then annealed to the exposed
template overhangs and ligated, increasing the length of the coding sequence by a single
codon (Fig. 6.1 Step iii). The assembly blocks added for ligation in the example extend
the sequence by a single codon (Fig. 6.1 Step iii), which ensures the lack of frameshifts in
protein coding sequences. Along with the single codon, each assembly block also contains
a recognition site for the same Type IIS endonuclease, allowing a new assembly cycle to
begin.
Mixtures of assembly blocks containing di↵erent codons can be added in Fig. 6.1 Step ii,
theoretically leading to incorporation of each codon according to its relative concentration
in the assembly mixture. At the end of the assembly process, a final cycle is carried out
with a capping block containing a primer binding site to enable amplification of the library
for cloning into a vector of choice.
The assembly pipeline proposed here is reminiscent of the steps used by Sloning (Van den
Brulle et al., 2008) and ProxiMAX (Ashraf et al., 2013) technologies, but these make use of
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Figure 6.1: Mechanism for proposed InDel Assembly strategy - An assembly cycle starts
with bead-bound template (i) oligos which are digested with a type IIS endonuclease (ii) to
produce overhangs for annealing and ligation of building block oligos (iii). Both enzymatic
steps have < 100% e ciencies, leading to a range of product sizes at the end of the
assembly. According to Tizei et al. (2017).
elution from beads or amplification to enrich for sequences that were successfully extended
in every assembly cycle, reducing the likelihood of any length variations.
The key di↵erence between the two methods cited above and the proposed workflow for
InDel Assembly is that digestion and ligation of bead-supported oligos in every cycle of the
assembly process are not carried out to completion, with only a fraction of all template
oligos being extended after each full assembly cycle. This is analogous to the strategy used
in the COBARDE technology (Osuna et al., 2004) for producing libraries containing length
diversity, but using partial enzymatic cycles in place of partial deprotection during solid-
phase synthesis of oligos. Once the assembly cycles are completed, the lengths of sequences
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produced should follow a binomial distribution determined by the number of assembly
cycles and the combined e ciency of the restriction and ligation enzymatic reactions.
6.1.2 Enrichment analysis of libraries containing heterometric diversity
In addition to the di culties involved in producing libraries containing targeted hetero-
metric diversity, the analysis of results obtained during directed evolution employing such
libraries also poses a challenge. The analysis strategies discussed in Section 1.5.3 for de-
tecting motifs enriched by selection using NGS data compare variants using sequence align-
ments, which are known to generate unreliable results when significant length variation
exists (Nuin et al., 2006). Even when length variation is acknowledged as an important
factor in determining function — such as the specificity-determining loops in antibodies —
sequences of equal length are grouped in analysis to ensure better quality for alignments,
discarding any information that could be gained by comparing motifs of similar sequence
that di↵er by indels (Ravn et al., 2013). The lack of available methods capable of e -
ciently detecting enriched sequences containing length variation is also acknowledged by
important groups in the field of protein engineering (Toth-Petroczy and Tawfik, 2014b)
and this gap motivated the development of an analysis strategy along with the library as-
sembly method, to create an integrated framework to accelerate directed evolution using
heterometric libraries.
Sequence comparisons on the basis of subdivisions of larger sequences into “words” or
k-mers have become widely adopted with the advent of large-scale sequencing datasets that
became accessible with NGS. Any sequence of characters can be represented as a list of all
its component k-mers, which are shorter strings of k characters. K-mer-based comparison
strategies been developed for phylogenetic reconstruction using large datasets (Gardner and
Hall, 2013) and de novo assembly of genomes from NGS data (Zerbino and Birney, 2008;
Bankevich et al., 2012), with the latter becoming the de facto standard tools of the field.
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Genome assembly from k-mers is a problem of reconstructing a sequence from its com-
ponent k-mers, obtained from subdivisions of the reads produced by NGS methods. Algo-
rithms such as de Bruijn graphs are used to perform this reconstruction, representing k-mers
as edges in a graph and generating a reconstructed sequence by finding paths connecting
overlapping k-mers (Compeau et al., 2011).
Since the component k-mers of any given sequence enriched by selection during directed
evolution also become enriched, a strategy capable of detecting sets of overlapping k-mers
that became enriched during selection could be used to reconstruct functional motifs in
a process that is analogous to the ones used in genome assembly. Such a method would
also recover shared motifs contained in enriched sequences of di↵erent lengths, since the
component k-mers of these motifs would also be shared — thereby avoiding the known
limitations of the commonly-used alignment-based enrichment analysis methods.
6.1.3 Selection of a model directed evolution target as a proof-of-concept
for InDel Assembly
Since a TOMM synthase in vitro modification system could not be established (see Chap-
ter 5), libraries produced with the system would need to be validated against a proof-of-
concept biological system. Ideally, the selected system would produce a phenotype that can
be easily screened in a high throughput assay or selected, that is already well-characterised,
and with known variants caused by indels. Among the phenotypes considered in this search
were the change in the activity of phosphotriesterase (PTE) when one of its loops is deleted
(Afriat-Jurnou et al., 2012), the shifts in kinetic parameters caused by truncation of an ac-
tive site loop in a cellulase (von Ossowski et al., 2003), the improved folding of a single
residue deletion within GFP (Arpino et al., 2014) or improved binding after loop extensions
in a nity maturation of certain antibodies (Krause et al., 2011). However, establishing a
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system to detect and enrich for a desired phenotype in these proteins were not compatible
with the timeframe available for the PhD project.
The b-lactamase TEM-1 is a widely-used model for directed evolution (Jones, 2005;
Kipnis et al., 2012; Palzkill et al., 1994a; Petrosino and Palzkill, 1996), due to the antibiotic
resistant phenotype that it confers upon E. coli cells when periplasmically expressed. The
wild-type enzyme confers resistance to penicillin-derived antibiotics such as ampicillin by
hydrolysing the b-lactam ring in their structure, rendering these molecules inactive. In
addition to the ease of selection, two other main factors contribute to making TEM-1
a versatile tool in directed evolution studies. First, there is a wide range of commercially
available cognate and non-cognate substrates, many of which are commonly-used antibiotics
in human or livestock therapeutic applications. Second, there is a repertoire of previously-
described variants from experimental and clinical work with varying substrate specificities.
TEM-1 belongs to class A b-lactamases, a-b-a sandwich enzymes with a structure that
is very similar to the peptidoglycan biosynthesis enzymes targeted by b-lactam antibiotics
(Kelly et al., 1986). TEM-1 hydrolytically inactivates its substrates employing a catalytic
mechanism that resembles the one found in serine proteases (Minasov et al., 2002). In
TEM-1, Glu166 and Lys73 act in concert to activate Ser70 to attack the amide bond in
the substrate, forming an acyl-enzyme intermediate (Meroueh et al., 2005). The same Glu
residue then acts in the deacylation reaction by activating a water molecule that attacks
the ester to regenerate the free enzyme (Adachi et al., 1991).
The level of resistance conferred by a given enzyme variant against an antibiotic is
commonly described by the Minimum Inhibitory Concentration (MIC) of a strain expressing
that variant, which is defined as the smallest concentration of the antibiotic that prevents
growth of the strain. This value — and consequently the ability of a strain to survive
selection under a given antibiotic concentration — is determined by two factors: the specific
activity of the enzyme on the antibiotic and the amount of active protein exported to the
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periplasm per cell. Therefore, it is important for selection systems to produce homogeneous
expression levels across a population, to minimise the influence of expression variance on
the resistance of cells and ensure a greater likelihood that enzyme variants with higher
specific activities are recovered.
Among the regions of TEM-1 that have been targeted in directed evolution studies,
the active-site W-loop is especially relevant because many known variants of this sequence
produce enzymes with activity on the non-cognate substrate ceftazidime (See Fig. 6.2 for
a comparison to the cognate substrate ampicillin), including mutations at the catalytic
Glu166 residue. Known ceftazidime-active variants of this loop di↵er from the wild-type
(WT) sequence in length as well as composition, including variants with long insertions of
up to 19 residues (Palzkill et al., 1994b; Petrosino and Palzkill, 1996; Hayes et al., 1997).
Circular permutation of the TEM-1 sequence has also been exploited to produce novel
functional enzymes and one variant which has its N- and C- termini at the W-loop was
found to be active on cefotaxime, an antibiotic that belongs to the same b-lactam class
as ceftazidime (Guntas et al., 2012). The highest activity mutant described for this loop
is a triple-mutant of residues 165-167, from the wild type WEP to YYG (Petrosino and
Palzkill, 1996).
Figure 6.2: Structures of the b-lactam antibiotics (a) ampicillin and (b) ceftazidime.
Public domain images obtained at www.wikipedia.org.
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The structure of the 165YYG167 mutant (hereafter referred to as 164RYYGE168 to include
the adjacent residues) was determined and the substantial shift (> 8 A˚) in the conformation
of the loop in the triple mutant suggests that the W-loop tolerates the large changes to
its main chain that are needed to accomodate the bulkier cephalosporin substrate, while
still producing a functional protein (Fig. 6.3, structures from Stojanoski et al. (2015)).
Interestingly, the mutated Glu 166 residue is important for both acylation and deacylation
steps in the WT enzyme and the structure of the triple-mutant suggests that Tyr 166 is
able, at least, to partially substitute for those functions in ceftazidime hydrolysis (Stojanoski
et al., 2015).
Figure 6.3: (a) Structure of the wild-type (highlighted residues in magenta and the re-
mainder of the structure in grey cartoon form; PDB structure 1XPB) and 164RYYGE168
(highlighted residues in red and the remainder of the structure in light pink cartoon form;
PDB structure 4RVA) TEM-1 W-loop. The three residues mutated in the 164RYYGE168
variant are highlighted along with the adjacent fixed residues and their side chains dis-
played. The region downstream of the mutations has a distinct shift in conformation when
compared to the wild-type structure.
Given the role of residues 165-167 of W-loop loop in determining TEM-1 substrate speci-
ficity and the known length and composition variants with selectable activity on ceftazidime,
this region was selected as a proof-of-concept for libraries produced by InDel assembly. The
initial goal was to produce a heterometric library with diversity centered around the known
164RYYGE168 variant — to validate the system by recovering this known positive variant
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and at the same time explore the sequence space around it for other variants active on cef-
tazidime that could not be easily produced by other diversification strategies. Two parallel
strategies were then pursued to refine the search of the W-loop sequence space: purifiying
selection with increasing stringency to isolate any superior variants and deep sequencing of
diversified libraries before and after selection steps — to identify motifs which contributed
to activity against ceftazidime and inform further rounds of diversification and selection.
The main requirement for establishing a selection system for TEM-1 function is periplas-
mic expression of the b-lactamase active protein, conferring resistance to b-lactam antibi-
otics in the culture medium by hydrolysing these molecules before they can act on cells and
employing whole cells as the genotype-phenotype linkage. Previous selection experiments
were carried out using high copy number vectors with the TEM-1 gene in a plasmid under
control of the native constitutive promoter (Palzkill and Botstein, 1992).
The initial design attempted here for the InDel proof-of-concept had the TEM-1 gene un-
der the control of the tunable arabinose-inducible pBAD promoter in the low-copy number
pBAD-30 plasmid (Guzman et al., 1995). This strategy was chosen to allow precise control
of b-lactamase expression levels for fine tuning of selection strengths (Guzman et al., 1995),
without producing the very high expression levels that can be obtained by other inducible
promoters such as the T7 promoter (Rosano and Ceccarelli, 2014). Low levels of induction
using L-arabinose would then be used to induce production of TEM-1 protein at levels sim-
ilar to the ones obtained from the constitutive promoter used in previous studies (Palzkill
and Botstein, 1992) and there should be no ampicillin resistance when cells are grown in
the absence of inducer. Diversified W-loop regions would be amplified from InDel-assembly
derived libraries with primers containing overhangs for the Type II restriction enzyme BsaI.
These fragments could then be inserted into the constant region of the TEM-1 coding se-
quence by inverse-PCR amplification of entire plasmids with the appropriate restriction
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sites and overhangs for the library fragments to be ligated and transformed into E. coli for
selection.
6.1.4 Residue numbering for length-variant sequences
To ensure consistent numbering of residues when comparing sequence variants of divergent
lengths, a numbering scheme inspired on the standards used for antibodies (Abhinandan
and Martin, 2008) was adopted here. In this scheme, residues outside the diversified region
maintain the same position numbers as the wild-type sequence and any changes in length
within the diversified region lead to the introduction of gaps or additional symbols in the
numbering. Since there is no information to reconstruct the full sequence of events that
generated any given sequence in an InDel library and assign a position to insertions or
deletions, all changes in length are defined to occur from the C-terminal end of the variable
region. This means that variants shorter than the wild-type length are represented as
deleted positions between the last residue in the variable region and the first residue of the
downstream invariant region. Inversely, in sequences longer than the wild-type length, the
inserted residues are given the same number as the last position of the variable region in
the wild-type sequence followed by a lower-case letter to continue the count in alphabetical
order. Examples of this numbering scheme applied to TEM-1 W-loop variants can be found
in Table 6.1.
Length Variable region Downstream invariant residue
= WT 164RYYGE168 169L
< WT 164RYGA167 169L
> WT 164RYYGEMG168b 169L
Table 6.1: Examples to illustrate the residue numbering scheme adopted for length
variants produced by InDel Assembly
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6.2 Results and Discussion
6.2.1 Simulation of libraries produced by InDel Assembly
A simulation tool written by Dr. Vitor Pinheiro in MATLAB was used to explore the
capabilities of the proposed method by generating hypothetical InDel Assembly libraries,
based on cycles of restriction and ligation with e ciencies lower than 100%. This model
uses a single per-cycle e ciency parameter to encompass the restriction and digestion steps,
being represented as the probability that a codon from the chosen assembly pool would be
incorporated into each sequence in the library. The identity of the inserted codons in
each step is determined randomly, with each codon having a likelihood of incorporation
proportional to its relative concentration within the pool used for that step. Overall,
the input parameters for the simulations are per-cycle e ciency, number of cycles in the
assembly, number of sequences in the simulated library, and relative concentrations of each
of the 20 codons in each assembly cycle.
Rounds of simulations were carried out to explore the parameter space for the model and
analyse the impact of varying parameters on the length and composition distributions in
the simulated libraries. For each run, the length distribution of the products is represented
in a histogram and the composition distribution is summarised by heatmaps showing how
composition is distributed along the length of sequences of each possible length. The
simulations shown here aimed to produce diversity in length and composition around an
arbitrarily-chosen target sequence: RYG.
A set of representative simulated library assemblies exploring the sequence space around
RYG was made, with the intention of reproducing this sequence and producing diversity
around it (Fig. 6.4). The per-cycle e ciency was varied between 25-75% in these runs, the
number of sequences in each library was set to 10,000, and six assembly cycles were simu-
lated for each run. The assembly block mixture used in each step was composed of 50% of
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the codon for the corresponding residue in the RYG target and 50% of the remaining 19
codons, with each position corresponding to two steps in the assembly (Fig. 6.4d). This li-
brary design strategy produces length diversity with a mean of three residues and frequency
peaks of three and four residues when the per-cycle e ciency is 50% (Fig. 6.4b). The higher
and lower e ciencies produce length distributions with peaks around two (Fig. 6.4a) and
five residues (Fig. 6.4c), with corresponding shifts in the composition distributions.
The shifts in the length distributions for e ciencies higher or lower than 50% can be
compensated by altering the library design. For e ciencies lower than 50%, a higher
number of assembly steps per position in the target are needed to produce a library centered
around the desired length (Fig. 6.5a). Similarly, decreasing the number of assembly steps
and simultaneously creating overlapped biases in the assembly block mixtures towards
adjacent residues in the target RYG sequence can produce similar results for e ciencies
higher than 50% (Fig. 6.5b). However, both of these strategies produce asymmetries in
the length distributions, with broadly-dispersed longer insertions (Fig. 6.5a) or a truncated
distribution containing only shorter insertions (Fig. 6.5b), along with lower frequencies for
any length that is not three or four in both runs.
The simulations using 50% insertion e ciency per cycle demonstrate a simple mapping
between number and composition of assembly cycles and the length and composition in
the final library: every two assembly cycles will contribute mostly to one position in the
final library, with indels and substitutions distributed symmetrically around the target
sequence length and composition. If prior knowledge about the functional sequence space is
available for a given target system, di↵erent e ciencies could also prove useful — especially
if functional sequences are known to be more frequent at shorter or longer ends of the
distribution. However, the complex mapping between assembly cycles and composition
distribution observed when the e ciency was higher than 50% makes library design less
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Figure 6.4: Simulation of InDel Assembly libraries with varying per-cycle e ciencies -
Length (histograms) and composition distributions (heatmaps) for simulated InDel As-
sembly products with 25% (a), 50% (b), or 75%(c) insertion e ciency per cycle. The
composition of the assembly block mixtures for each reaction cycle was kept constant for
all simulation runs (d).
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Figure 6.5: Simulation of InDel Assembly libraries with varying assembly block mixtures
- Four cycles biased towards each residue in the target sequence were used in the 25% per-
cycle insertion e ciency library (a). For the 75% e ciency simulation (b), only four cycles
in total were used and the codon biases for each cycle encompassed adjacent codons in the
RYG target sequence. Part of the composition heatmaps for 12-residue length in the 25%
e ciency simulation were truncated for clarity.
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tractable, requiring computational calculation of optimal assembly mixtures to e ciently
target libraries.
6.2.2 Development of a strategy for the detection of length-variable en-
riched motifs
The idea of employing k-mer based analysis in the reconstruction of sequence motifs en-
riched by rounds of selection was proposed by the author of this thesis and the analysis
framework was developed collaboratively in discussion with Dr. Vitor Pinheiro. MATLAB
scripts used in simulated selections and the k-mer-based analysis were written by Dr. Vitor
Pinheiro, with adaptations by the author to enable the analysis of data derived from NGS
datasets.
As stated in Section 6.1.2, an analysis strategy was developed to detect selected length-
variable motifs by analysis and reconstruction of enriched k-mers after rounds of selection in
directed evolution experiments. Due to the short length of the targeted region in the W-loop
of TEM-1 — only 5 residues in the wild-type and 164RYYGE168 variant — a size of three
residues was selected for subdivision of sequences in all the analyses described in this thesis.
This value was chosen as a compromise in discriminative power for sequence reconstruction.
For instance, repeats of length k or longer cannot be correctly reconstructed by k-mer based
analysis alone and the known ceftazidime-active variant 164RYYGE168 already has a Tyr
repeat of length 2, preventing the recovery of this sequence and similar variants by an
analysis based on 2-mers. On the other hand, longer k-mers can resolve longer repeats
and make reconstruction easier by requiring fewer overlapping k-mer comparisons, but also
reduce the number of k-mers that each sequence is subdivided into — a sequence of length
5 is only composed of two distinct 4-mers — and can make the analysis prone to failing to
account for indels like alignment-based strategies.
A masking strategy was also adopted in the k-mer decomposition (Vinga and Almeida,
2003), in which one position of each k-mer was represented as a wildcard character “ ”
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to reduce computational burden — there are 8000 possible 3-mers but only 800 possible
masked 3-mers — and also to detect positions within functional motifs that allow variation
— the enrichment of two 3-mers that only di↵er at one position would then be considered as
enrichment of a single 3-mer masked at that position. In the masked 3-mer representation
adopted here, the 3-mer X1X2X3 would be represented as X1X2 and X1 X3. Finally, the
first non-diversified residues surrounding the targeted region in each library were repre-
sented as “Z” characters to allow identification of enriched motifs that spanned the entire
region or at least reached one of its ends — also increasing the number of possible masked
3-mers to 882. The subdivision of an example sequence into its component masked 3-mers
is shown in Fig. 6.6 a.
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Figure 6.6: k-mer-based motif detection. (a) Sequences are subdivided into all possible
masked 3-mers, as shown for the variable sequence RGYMKER (underlined residues repre-
sent fixed ends). The counts for each residue form an 882-dimension vector (zero values not
shown for clarity). Vectors are normalised and multiplied by the enrichment score, then
PCA identifies enriched kmers, allowing reconstruction of sequences. (b) Demonstration of
sequence reconstruction from a set of enriched kmers. The sequence can be reconstructed
by the overlapping kmers from the initial fixed “Z” character until the terminal residue.
According to (Tizei et al., 2017)
Each sequence within a sequencing dataset (pre- or post-selection for each round of
selection) was then represented as a column vector of 882 dimensions — one for each of
the masked 3-mers, including the terminal “Z” characters — with masked 3-mer count as
the value in each dimension (Fig. 6.6 a). Vectors were normalised by transformation into
unit vectors and then multiplied by an enrichment score, calculated by subtracting the pre-
selection count of the sequence by its post-selection count. The vectors for all the sequences
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in a round of selection represent it in an 882-dimensional space, with the magnitude of each
vector as a proxy for its enrichment by selection and, consequently, its function.
Since an 882-dimensional dataset is too complex for direct analysis, principal component
analysis (PCA) was used to identify which of these dimensions representing the masked 3-
mers had the strongest contributions to the enrichment observed in a round of selection.
Deconvolution by PCA maps the observed variation in the dataset onto a new set of coor-
dinates in descending order of the fraction of total variance explained by each component
(or dimension).
The masked 3-mers with the strongest contributions to each component compose the
most highly enriched sequences that contributed to that component and, therefore, can be
used to reconstruct shared motifs in those sequences. Importantly, enriched sequences that
di↵er in length but contain a shared motif would cluster together in the 882-dimensional
space and contribute to the same components in the PCA. An arbitrary contribution thresh-
old of absolute value 0.1 (i.e. values higher than 0.1 or lower than -0.1 were considered)
was selected for inclusion of masked 3-mers in further analysis. Motif reconstruction for
each component was carried out by manual inspection of the masked 3-mers that met the
selected threshold value to identify 3-mers that are part of larger motifs by their overlaps.
The motif detection workflow was tested with simulated selections against ten-cycle
library assemblies biased towards the sequence “RYYGE” (as in Fig. 6.4 b). Selection was
represented by multiplication of the frequency of any variant that exactly matches a chosen
motif in any part of its sequence by a user-specified enrichment factor — with positive
factors for enrichment of functional variants and negative factors for simulated depletion
of deleterious mutations. Enrichment factors and the k-mer PCA were then calculated to
determine whether selected motifs could be reconstructed.
Initially, selection of the RYYGE motif targeted by the library synthesis was attempted,
by selecting this sequence with a 200-fold enrichment factor. As expected, the RYYGE
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sequence itself was the most highly enriched variant, followed by variations with one or
more N- or C- terminal insertions, that all had lower pre-selection frequencies than RYYGE
(data not shown). The first component of the PCA accounted for > 96% of all variation
in the selected dataset and the sequence RYYGE could be clearly reconstructed from the
3-mer contributions in that component (Fig. 6.7 a). This demonstrated the ability of the
motif detection strategy to detect enrichment of a sequence that was present in relatively
high frequency (> 1%) in the initial library.
Next, motif detection was attempted for a sequence that was not part of the RYYGE as-
sembly target, to determine whether lower frequency variants enriched out of a background
of higher frequency variants could still be recovered. The motif MGY was enriched 200-fold
in this test and it was represented by the masked 3-mers with the highest contributions of
the first principal component, but many other 3-mers not matching the selected motif were
also present (Fig. 6.7 b). Since this component only accounted for 44% of the variation
contained in this dataset, the selected 3-mers in the second and third components were
also inspected (82% of the total variation in the first three components). Similar patterns
were visible in these components, with the MGY motif (or parts of it) detectable and other
unrelated 3-mers.
The spurious 3-mers detected by the PCA in this selection could be a result of poor
sampling of the sequence space, due to all the enriched sequences having lower frequency
values in the initial dataset than in the previous example — the highest initial frequencies
among the enriched variants were 0.003% for variants MGYGE and MGY, which represent
only 3 counts for each. Repetition of the simulated assembly, selection and analysis cor-
roborated this obervation, producing a clear signal for enrichment of the 3-mers that make
up the MGY motif and disperse contributions from unrelated 3-mers.
A third simulated selection was carried out with two separate enrichment patterns: 200-
fold enrichment of GYY-containing sequences and 200-fold depletion of the motif GGE
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Figure 6.7: Motif detection in simulated InDel libraries. The plots show the contributions
of all k-mers to each principal component (PC1 in blue and PC2 in orange). The 0.1 cuto↵
for analysis of scores is indicated by the red dashed line. Contributions of the selected kmers
are listed in the tables, with reconstructed motifs for each principal component written
in bold under each table. (a) First principal component for the 200-fold enrichment of
RYYGE motif, accounting for 96% of the variation in the simulation. (b) First principal
component for the 200-fold enrichment of the MGY motif, accounting for 44% of the
variation in the simulation. (c) First (blue) and second (orange) principal components for
the 200-fold enrichment of GYY motif and 200-fold depletion of GGE motif, accounting
for 57% and 18% of the variation in the simulation, respectively. The Z character denotes
the fixed regions flanking the sequence diversified in the simulated library. 215
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(Fig. 6.7 c). The depleted motif was detected in the first component (accounting for 57%
of variation) and the presence of the C-terminal “Z” fixed region character associated with
it indicates it was mainly in the C-terminus of the enriched variants. Given the RYYGE
target sequence for the assembly, a GGE sequence would be expected to be more frequent
at the C-terminus of the variable region due to the biased GE positions, requiring only a
single additional insertion of a Gly codon to produce the depleted motif. On the other hand,
the enriched GYY motif could not be reconstructed in either of the next two components
of the PCA that accounted for > 85% of the variation (only first and second components
shown in Fig 6.7 c for clarity). The initial frequencies for the enriched sequences were
approximately 20% of the frequencies for the depleted variants, which could be the cause
for no clear enrichment signal being detected.
These simulations demonstrated that the masked 3-mer PCA can recover selected motifs
from enrichment patterns in libraries, but the results obtained are strongly a↵ected by
the initial composition of the library. Another confounding factor in these simulations
is the artificial nature of the enrichment criteria — variant counts were multiplied by a
fixed factor to represent enrichment or depletion and the context of the motif within the
remaining variant sequence was completely ignored. Therefore, further investigation into
the capabilities of the detection strategy were done once data from selections of TEM-1
variants for activity against ceftazidime became available (See Sections 6.2.6.2 and 6.2.6.3).
6.2.3 InDel Assembly protocol development and optimization
Initial versions of the InDel Assembly protocol will be described here as changes were made
to the method to improve its performance. The final, optimised version of the method was
described in Section 2.2.11.
Template oligos were synthesised with a biotin and (PEG)4 spacer at their 50 end and
also harboured a fluorescein label in a portion of the sequence that is not recognised by
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the restriction endonuclease — to ensure the labeled base did not interfere with restriction
enzyme recognition (Fig 6.8). The assembly blocks were single-stranded oligonucleotides
designed to fold into a hairpin with a degenerate NNN overhang at their 50 end, which
were heat-cool annealed to ensure formation of the correct secondary structure before 50
phosphorylation with T4 PNK. This design was preferred since an assembly block composed
of two separate single-stranded oligos would require additional handling steps to ensure
that only the the correct 50 end of the duplex is phosphorylated or costly custom synthesis
options, such as a 50 phosphorylated base in one strand or a blocked 50 in the complementary
strand.
Figure 6.8: Design of template block used for optimisation of InDel Assembly - 50 biotin
TEG group is represented as a red circle, the fluorescein label is represented as a green star,
the recognition site for SapI is highlighted in yellow and the region left as a 50 overhang
in the complementary strand after restriction is highlighted in cyan. The complementary
strand (bottom) contains no modifications.
The initial conditions tested in development of the InDel Assembly protocol were based
on prior experience of the Pinheiro group with analogous restriction and ligation reactions in
solution, as well as other protocols employing biotinylated oligos captured on paramagnetic
streptavidin-coated beads (Pinheiro et al., 2012b). A saturating amount of template oligos
(50 pmol) was added to 5 µl prewashed MyOneC1 beads (maximal binding capacity is
5 pmol oligos / µl resuspended bead slurry according to the manufacturer). Digestion
was carried out with 10U SapI for 10 minutes at 37°C and ligation was carried out with
400U T4 DNA Ligase for 5 minutes at 25°C. The reaction volume was 100 µl for both
steps and the bu↵ers supplied by the manufacturer were used. Assembly was carried out
for three full cycles of digestion, annealing, and ligation, removing a 1 µl aliquot from
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the bead suspension after every step. Reaction e ciency was measured by denaturing
electrophoresis in polyacrylamide gels (denaturing PAGE) coupled to fluorescence scanning
to detect extension of the fluorescein-labeled template strand.
The e ciency of both enzymatic steps in the assembly was very low under the initial
conditions (Fig. 6.9 a). A high gain setting in the fluorescence detector was needed for
visualisation of any ligated bands, which led to saturation of the unligated bands and made
accurate quantitation of the bands unreliable. However, it is clear that less than 50% of
the initial template was digested in each cycle and only a very small portion of the digested
templates were ligated in each cycle (Fig. 6.9 a). Since these conditions produced insertion
yields very far below the desired 50% value, conditions for the assembly reactions were
optimised, starting with the restriction reaction.
Figure 6.9: Optimisation of the digestion step in InDel Assembly. (a) Three full cycles
of InDel Assembly carried out using the initially proposed reaction conditions. Lane T
contains only the template oligo. DX and LX represent the output of the digestion and
ligation steps, respectively, of each assembly cycle. Saturated bands in the image prevented
accurate quantitation of reaction products (b) SapI digestion of the template oligo under
varying reaction conditions. Digestion e ciencies are under each lane and were calculated
as the ratio between the intensity of the digested band and the sum of the digested and
undigested bands. The template oligo was loaded in the first lane on the left. The template
oligo is 50 nt, the first digestion product is expected to be 36 nt and the first ligation product
is expected to be 69 nt.
The hairpin design for the assembly block oligos was abandoned before this experiment
and replaced by two annealed oligos with an overlap of twenty base pairs after the SapI
recognition site (represented in Fig. 6.1), to ensure e cient binding of the enzyme to
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extended oligos. Changes in reaction time, enzyme concentration and concentration of the
crowding agent PEG-8000 were evaluated for their e↵ect on the SapI reaction step. Aliquots
from each reaction were loaded on a denaturing PAGE and e ciency was measured by band
densitometry using ImageJ. Both the increase in reaction time and enzyme concentration
had an e↵ect on the e ciency of digestion (Fig. 6.9 b), so these conditions were combined
and subsequent development of the assembly used 2-hour digestions with 20U SapI / µl
in a reaction volume of 100 µl. The e ciency obtained in these conditions was deemed
su cient to start the optimisation of the ligation step.
Digestion was carried out as described above to produce the overhang needed for the
ligation step, with the exception of a digestion time of 2 hours aiming to increase the
digestion e ciency further, since a longer reaction time increased e ciency in the digestion
test. Unlike the observed inhibition of SapI digestion by PEG-8000, this crowding agent
is known to increase the activity of T4 DNA ligase (Sambrook and Russell, 2001), so it
was added to a final concentration of 3% in the ligation mixture. A time course reaction
was carried out by periodically removing aliquots from the same reaction tube incubated
at 25°C. As expected the intensity of the ligated band increased over time, with a peak of
approximately 40% ligation e ciency after 20.5 hours of reaction time (Fig. 6.10). Since
more than 20% of the template had been ligated after only one hour of reaction time, this
time point was selected for further development as a compromise between ligation e ciency
and the number of InDel cycles that could be carried out within a single day. An unexpected
doublet band was observed for the ligated product in this reaction (Fig. 6.10 a), with both
bands in the doublet increasing simultaneously in intensity. This was interpreted as blunt
ligation of a second assembly block oligo at the 30 end of the growing chain, which would
be removed by the restriction enzyme digestion.
As shown in Fig. 6.4, a ligation e ciency of only 20% (close to 25% shown in the
simulation) would require four three-hour long assembly cycles to be carried out for every
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Figure 6.10: Optimisation of the ligation step in InDel Assembly. (a) Denaturing PAGE
of a ligation timecourse. The intensity of both bands within the red box were added
together for ligation e ciency measurements for each time point. (b) Plot of ligation
e ciencies at each time point.
unit increase in mean sequence length and would also create asymetric length distributions.
Therefore, the published and patent literature were searched for additional conditions that
could enhance ligation activity and obtain e ciencies closer to the 50% target. Patents
from New England Biolabs report increased e ciency for T4 DNA ligase in the presence
of the small molecule 1,2-propanediol (Kucera and Evans, 2014) and the accessory enzyme
50 deadenylase, which removes adenylated side products of T4 DNA ligase activity that
inhibit ligation (Lohman and Nichols, 2015). A full cycle of InDel Assembly was carried
out using the previous conditions, 12% 1,2-propanediol and 0.5 U/µl 50 deadenylase. These
conditions led to approximately 50% insertion yield after one full assembly cycle (Fig. 6.11).
Therefore, these conditions were used for the production of the first sequence libraries for
directed evolution of the TEM-1 W-loop.
6.2.4 Establishing the selection system for TEM-1 variants
Since pBAD-30 already has a copy of TEM-1 as its transformation marker, this was replaced
by the CAT (chloramphenicol acetyltransferase) chloramphenicol resistance cassette and a
new copy of TEM-1 was inserted downstream of the pBAD promoter by Type IIS restriction
enzyme-based cloning, producing vector pBT1-WT 6.12. The 165-YYG-167 variant from
the Palzkill group (Petrosino and Palzkill, 1996) was made by inverse PCR of pBT1 with
oligos containing the mutations from the wild-type sequence WEP to YYG, which was
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Figure 6.11: InDel assembly reaction in optimised conditions. (i) Starting template oligo.
(ii)Products of digestion step. (iii) Products of Ligation step. According to (Tizei et al.,
2017).
blunt-ligated to produce pBT1-RYYGE. In addition, the M182T stabilising mutation was
added by the same procedure to all mutant versions of the TEM-1 protein, since it is
established in the literature that mutations that increase activity in non-cognate substrates
tend to be destabilising and M182T can compensate for some of this e↵ect (Sideraki et al.,
2001). This stabilisation would lead to higher levels of folded and active enzyme per cell
and, therefore, the 164RYYGE168 variant expressed by this construct would be expected to
have a MIC towards ceftazidime higher than 64 µg/ml that was observed by Petrosino and
Palzkill (1996).
These vectors should confer cells with constitutive resistance to chloramphenicol and
arabinose-inducible resistance to AMP (pBT1-WT) or ceftazidime (pBT1-RYYGE). Since
a standardised method for measurement of MICs had not yet been established in this work,
comparative tests were carried out between WT and 164RYYGE168 variants to establish
culture conditions that would di↵erentiate variants active on CAZ from those with activity
against this drug similar to WT. Images were not recorded for display of these results, so
only growth comparisons will be described here.
Plating both constructs on media containing the corresponding antibiotic (100 µg/ml
AMP for WT and 10 µg/ml CAZ for 164RYYGE168) in presence or absence of 0.1% (w/v)
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L-arabinose inducer produced robust growth when the construct was induced but growth
was also visible in the absence of the inducer, albeit with reduced numbers of colonies.
No growth was observed when the WT construct was plated on CAZ plates or when the
164RYYGE168 construct was plated on AMP plates, repeating the respective sensitivity
towards ampicillin and ceftazidime of the 164RYYGE168 variant and WT, observed by
Petrosino and Palzkill (1996). However, variability in colony sizes was visible when cells
were plated under inducing conditions (data not shown), suggesting the existence of cell-
to-cell expression heterogeneity of the pBAD promoter in these constructs, which has been
previously characterised (Siegele and Hu, 1997).
Therefore, a new construct was made replacing the resistance marker of pUC19 with
CAT and inserting the TEM-1 coding sequence under control of its own promoter by Type
IIS restriction enzyme-based cloning (Fig. 6.12). As expected, strains carrying these vec-
tors with the WT (pTEM1-WT) and 164RYYGE168 (pTEM1-RYYGE) variants were con-
stitutively resistant to their corresponding antibiotics, but sensitive to ceftazidime (for the
WT construct) or ampicillin (for the 164RYYGE168 construct). Since the construct and
strain used were distinct from the system constructed by Petrosino and Palzkill (1996),
the 164RYYGE168 construct was plated on media containing increasing concentrations of
ceftazidime up to 500 µg/ml ceftazidime and growth was observed at 100 µg/ml ceftazidime
but not at 200 µg/ml ceftazidime, indicating that the MIC of this variant for ceftazidime
was between these two values and much higher than the value reported by Petrosino and
Palzkill (1996). These results demonstrated that the pTEM1 constructs are robust for se-
lection of variants and, therefore, these vectors were used as templates for library assembly,
and as negative (WT) and positive (164RYYGE168) controls for ceftazidime resistance.
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Figure 6.12: Vectors used for expression of TEM-1 during development of InDel assembly
and rounds of selection. (a) First design of the TEM-1 expression vector with the TEM-
1 gene under control of the pBAD arabinose-inducible promoter. (b) TEM-1 expression
vector used for all selection experiments, with TEM-1 under the control of its own promoter.
Both vectors also carry the chloramphenicol resistance marker that was used for cloning.
6.2.5 Directed evolution of TEM-1 using libraries generated by InDel
Assembly
6.2.5.1 First round of diversification and selection
The goal for the first round TEM-1 directed evolution was to demonstrate that libraries
produced by InDel could e↵ectively explore the sequence space around a target sequence,
with simultaneous variation in length and composition. The library for this round was
designed to contain the 164RYYGE168 variant at a frequency of approximately 0.1% and
ensure its recovery as a known positive variant, while at the same time exploring the
sequence space — in both length and composition — around this peak. This strategy
also aimed to determine whether 164RYYGE168 is an isolated fitness peak in its sequence
neighbourhood or whether other similar sequences could produce similar or even higher
levels of activity on ceftazidime. The targeted region was expanded to contain residues
Arg164 and Glu168, since deletions and mutations at these residues had also been previously
shown to produce strains with higher MIC than WT on ceftazidime (Palzkill et al., 1994a;
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Sowek et al., 1991). To achieve this, the library was assembled in ten InDel cycles with the
optimised reaction conditions (from Section 6.2.3) to produce a distribution of sequence
lengths centred around the wild-type length of five residues. In each cycle, a mixture of
codon building blocks composed of 50% of the codon present in the equivalent position in
the 164RYYGE168 variant and 50% of the remaining 19 codons was added in the annealing
step.
Once the library was assembled and transformed into E. coli NEB 10-b (see Sec-
tion 2.2.6), cells were plated into agar plates containing 34 µg/ml chloramphenicol as a
transformation control and 10-200 µg/ml CAZ. Colony density was visually estimated,
with near-confluent growth at 10 µg/ml CAZ, fewer than 20 colonies at 50 µg/ml CAZ
and none on the higher concentrations — suggesting that the assembled library had a high
proportion of low-activity mutants. The variants from three arbitrarily selected colonies
from the 50 µg/ml plate were sequenced and all three showed no insertions in the targeted
loop, indicating that only the final cap block had been ligated onto these variants after ten
cycles of assembly. These results suggested that the measured per-cycle assembly e ciency
from the method optimisation (Fig. 6.4 b) was overestimated since — according to sim-
ulations (see Section 6.2.1) — the majority of the assembled sequences were expected to
contain five or more residues and the 164RYYGE168 variant should have been recovered in
the plates containing 50 µg/ml ceftazidime, as it was expected to represent approximately
0.1% of all assembled sequences. A possible explanation for this large discrepancy is that
test assemblies during optimisation were only carried out for a single cycle and did not
account for factors that could reduce reaction e ciencies over multiple assembly rounds,
such as carryover of enzymes and digested oligo fragments into subsequent reaction steps
or loss of enzyme activity after being reused for multiple cycles within a day. Another pos-
sibility is that saturating concentrations of oligos bound to the bead surface can hinder the
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accessibility to enzymes and assembly block fragments, reducing the maximum e ciency
that can be obtained per step.
The three identical variants are e↵ectively full-deletions of the five targeted residues in
the W-loop and were more resistant to ceftazidime than the WT. Since this variant was not
isolated in previous publications of TEM-1 variants, one of the clones was named D5 and
stored for later characterisation along with other variants isolated in later selection steps.
A new assembly was made following the strategy described above, while reducing the
template oligo bound to the streptavidin beads to 10 pmol. This parameter was changed as
an attempt to reduce the proportion of oligos that were not ligated to any codon building
blocks during all the assembly cycles (i.e. increase the overall per-cycle e ciency) and,
ultimately, obtain a library of higher quality with a length distribution closer to what was
predicted in simulations (Fig. 6.4). Once this new library was assembled, it was transformed
into NEB 10-b, cells were plated into 24.5 cm x 24.5 cm LB agar plates containing 50 µg/ml
ceftazidime for selection and incubated overnight at 37°C.
This selection yielded more than one thousand colonies, which were harvested and grown
in liquid media containing the same concentration of ceftazidime until visibly turbid (OD600
of approximately 1), to amplify the selected transformants and further enrich for the most
highly active variants. Plasmids were extracted from this culture for later deep sequencing
and an aliquot was frozen in glycerol at -80°C. Approximately 104 CFU of this culture
were plated onto LB agar plates containing increasing concentrations of ceftazidime up to
500 µg/ml. The ceftazidime concentrations above the estimated MIC for 164RYYGE168
(between 100 and 200 µg/ml) represent a selection step of su cient stringency to remove
this variant from the selected pool, allowing only variants that confer higher MICs to be
recovered.
A single transformant was isolated in the plate containing 300 µg/ml ceftazidime and
sequenced, which showed that its W-loop had the sequence 164RGYMKER168b (named
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PTX7) replacing the target 164RYYGE168 sequence. In a single InDel diversification and
high-stringency selection cycle, a variant with apparently higher fitness on ceftazidime was
obtained that is two residues longer than the length of the wild-type sequence and the
164RYYGE168 variant.
6.2.5.2 Control library
In the same assembly round that produced the succesful 164RYYGE168 diversification li-
brary (see Section 6.2.5.1), a small control library was generated in parallel to detect possible
assembly biases — the assembly simulations in section 6.2.1 all assumed unbiased selection
of codons for incorporation — and also obtain an independent measure of assembly e -
ciency. To achieve this, five assembly cycles were carried out with no overlap between the
building blocks used in each cycle. The building blocks in each cycle were always mixed in
equimolar amounts and the mixtures had the composition shown in Table 6.2. At the end
of the process, the assembly products were amplified and stored for later deep sequencing
along with the selection libraries, to characterise the population of assembled products in
detail.
Cycle Residue Codon
1 Ala GCA
2 Cys TGC
Asp GAC
3 Glu GAG
Phe TTC
Gly GGT
4 His CAC
Leu CTG
Pro CCA
5 Gln CAG
Table 6.2: Composition of assembly block mixtures in the control library
An aliquot of the amplified products were cloned in a small-scale transformation and
isolated in the absence of selection for TEM-1 function — by plating on media containing
chloramphenicol. Three colonies were arbitrarily selected from this transformation and
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sequenced to determine the number of successful building block insertions in each assembly
product. Two of the products had sequences corresponding to two insertions and the other
sequence contained no building blocks inserted between the template and cap blocks. While
a q2 goodness-of-fit test for this small sample did not reject the null hypothesis that the
observed values came from a population with the expected mean of 2.5 insertions for a five-
cycle assembly, further improvement to the assembly e ciency was sought in the assembly
step for the second round of directed evolution targeting the W-loop.
6.2.5.3 Second round of diversification and selection
Since the PTX7 variant is divergent from 164RYYGE168 in sequence and length, another
round of directed evolution was carried out to explore the sequence neighbourhood around
the PTX7 variant isolated in the first round and determine whether there are more undiscov-
ered peaks of activity against ceftazidime in the W-loop sequence space. A more aggressive
diversification strategy was used to maximise the breadth of the sequence space covered by
this new library around the apparent peak obtained after selecting the first-round library.
Since the sequence of PTX7 (164RGYMKER168b) had an N-terminal Arg residue and the
variants with the highest activity against ceftazidime from Palzkill et al. (1994b) and Pet-
rosino and Palzkill (1996) all had an N-terminal Arg, this residue was kept constant in the
second round libraries.
The remaining six residues were targeted for variation in the form of insertions, dele-
tions and substitutions at each position in the PTX7 sequence. The volume of streptavidin
bead slurry used to capture template oligos in the beginning of the assembly was increased
from 5 µl to 60µl, in an attempt to further increase the e ciency of restriction and liga-
tion reactions by reducing crowding e↵ects that could have occurred at bead surfaces in
the conditions used for the previous assembly rounds. The assembly strategy was com-
posed of thirteen cycles with the following sequence of building block mixture additions
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XG*XY*XM*XK*XE*XR*X, where X represents codons for all 20 aminoacids in equal
frequencies (100%X) and letters followed by asterisks represent the corresponding codon at
50% frequency and the remaining 19 codons in equal frequencies (X*). Assembly simula-
tions (assuming that per-cycle e ciency reaches 50% with the change in reaction conditions)
carried out for this strategy in comparison to the one used previously show that the fully-
degenerate cycles increase the coverage for residues not present in PTX7, which was the
objective for this round of diversification (Fig. 6.13). The PTX7 variant should represent
approximately 0.1% of all assembly products when the diversification strategy of the first
round is used in simulation (Fig. 6.13 a) and only around 0.01% of all sequences produced
under the more aggressive assembly strategy (Fig. 6.13 b).
This library was transformed into NEB 10-b and selected on 200 µg/ml ceftazidime,
yielding approximately 80 colonies, which were grown in LB containing 200 µg/ml cef-
tazidime for plasmid extraction and selection at higher stringencies to isolate any highly-
active clones. At 500 µg/ml ceftazidime, a single colony was obtained and its W-loop was
sequenced. This variant had the sequence 164RGYKEERD168c (the underlined residue is
the N-terminal Arg that was removed from the diversified region in this round) and was
named PTX8.
This novel variant was longer than both 164RYYGE168 and the best clone obtained from
the previous library (PTX7), but it also diverged from both sequences in composition.
Increasing selection stringency revealed the existence of another fitness peak — apparently
with even higher activity on ceftazidime than 164RYYGE168 and PTX7, since neither of
these variants have been observed to form colonies at 500 µg/ml ceftazidime. The only
sequences longer than PTX8 that have been explored in TEM-1 directed evolution were
produced in a pentapeptide insertion experiment, yielding variants with higher activity
than WT on ceftazidime, but much lower than the activity shown by 164RYYGE168 (Hayes
et al., 1997).
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Figure 6.13: Simulation of two strategies for assembly libraries for the second of selec-
tion - The sequence distributions of library simulations using two di↵erent diversification
strategies for thirteen assembly cycles are shown. (a) Pairs of consecutive assembly cycles
with 50% of their building blocks represented by each position in PTX7, followed by a final
cycle 100% X. (b) Alternating cycles of 100%X and X*. The composition heatmaps for
lengths of eleven and twelve residues were removed for clarity.
To obtain PTX8 (164RGYKEERD168c) from PTX7 (164RGYMKER168b) without a li-
brary made by InDel Assembly — using single steps of indels or substitutions — would re-
quire: deletion of the Met residue from PTX7, followed by insertion of a second Glu residue
following the one already present and finally insertion of the C-terminal Asp residue for a
total of 3 mutational events separating these two variants with high activity on ceftazidime.
6.2.6 Deep sequencing of libraries produced by InDel Assembly
Samples from the control library and both rounds of TEM-1 directed evolution (before and
after selection) were sequenced on an Illumina MiSeq instrument at the UCL Institute of
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Child Health genomics facility and the resulting datasets were processed according to the
steps described in Section 2.6.5. The analysis for each dataset will be described in the
following sections.
6.2.6.1 Control library
Quantification of the assembled sequences from the control library clearly show that the
per-cycle e ciency estimated by band densitometry analysis was overestimated (Fig. 6.14).
Over the five assembly cycles of the control library, an average e ciency of only 3.7% was
obtained, producing the length distribution in Fig. 6.14. This result corroborates the non-
significant trend towards insertion frequencies lower than the expected 50% value that was
observed by Sanger sequencing of three clones from this library, prior to deep sequencing
(Section 6.2.5.2)
Some insertion bias was detectable in this dataset (Table 6.3), but it cannot be solely
attributed to di↵erences in GC content producing variable binding a nities in the 3-base
overhangs using the available data. In the only cycle which had a mixture of codons of
varying GC content (third cycle), there was a near threefold excess of the codon with two
GC bases (GAG for glutamate), but similar variations were also observed in the fourth
cycle which only had codons with two GC bases. The codons from the second cycle in
the control library had markedly lower counts than all others, possibly due to improper
resuspension of beads or other manipulation error during the assembly. Since this dataset
is derived from a single assembly run, its results are su cient to show that di↵erent codons
do get incorporated with varying e ciencies, but it is not possible to quantitate these
biases reliably. More accurate quantitation of incorporation bias could be obtained by
sequencing of multiple independent assembly reactions containing all twenty codons in equal
proportions, to determine their relative incorporation e ciencies and whether there are any
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Figure 6.14: Length distribution of the control library assembled products
Cycle Codon (residue) GC bases Count Fraction Bias1
1 GCA (A) 2 4758 1 -
2 TGC (C) 2 193 0.29 -
GAC (D) 2 472 0.71 2.4
3 GAG (E) 2 3158 0.74 2.9
TTC (F) 1 1083 0.26 -
CGT (G) 2 899 0.11 -
4 CAC (H) 2 1596 0.20 1.8
CTG (L) 2 2656 0.34 3.0
CCA (P) 2 2687 0.34 3.0
5 CAG (Q) 2 4547 1 -
1Bias was defined as the ratio of counts of a given codon to the codon
with the lowest frequency in the same assembly step
Table 6.3: Estimates of insertion bias from the control library
e↵ects between adjacent codons caused by the annealing of degenerate NNN overhangs to
the previous codon in each step.
The pre-selection datasets from the first and second directed evolution rounds could
also be used to estimate insertion biases for di↵erent codon assembly blocks. The expected
frequencies of each residue in both TEM-1 libraries were calculated from the frequencies of
codon blocks in each assembly step and compared with the frequencies observed in the NGS
data. It is clear that there was divergence between these values, with some residues being
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over-represented in one library while others seemed to be incorporated at a lower e ciency
(Fig. 6.15 a, c). However, when these divergences are compared between libraries, it is
evident that several of the trends observed in one round are inverted in the other round,
which would indicate random variation around around a mean value. This is more evident
when the data is analysed in the form of the observed bias for each residue, defined as
(observed predicted)/predicted (Fig. 6.15 b, e). These values show that all of the strongest
positive or negative biases present in the first-round library are inverted to the opposite
signal or greatly reduced (i.e. Serine maintains a positive bias of approximately 0.5, while
Glutamate changes from a negative bias to a strong positive bias). While more replicate
experiments would be needed to estimate the bias toward any specific residue accurately,
the data shown here indicate systematic insertion bias does not occur.
Figure 6.15: Estimates of insertion bias in pre-selection (a,b) first- and (c,d) second-
round libraries. (a,c) Predicted and observed counts for each residue. Residues added only
in equimolar proportions as part of degeneracies at each site are labeled in cyan, while
residues targeted in each assembly are shown in orange. Observed counts for each residue
are shown in black. (b,d) Incorporation bias for each amino acid.
6.2.6.2 First round of selection
DNA amplified directly from the paramagnetic beads used in the first round assembly and
the plasmids extracted from the selected clones of the same library were submitted for high-
throughput sequencing, to characterise the initial library and to obtain information from
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the enrichment of sequences to help direct further rounds of directed evolution. Reads were
trimmed, selected for high quality, translated and counted. This yielded 73,084 unique
sequences out of 3.3x106 reads for the pre-selection library and 9,840 unique sequences
from 3.3x105 reads in the post-selection library. This number of unique sequences in the
post-selection dataset is much higher than the estimated 1,000 colonies recovered from the
selection plate, which could be caused by sequencing errors that persist after the filtering
steps in the analysis.
The average e ciency per cycle of assembly was approximately 8%, slightly higher than
observed for the control library (produced using the same reaction conditions), and this
yielded a length distribution with a strong bias towards very short sequences (Fig. 6.16).
The sequence length of the wild-type and 164RYYGE168 variants was only represented by
0.2% of this library and the only 0.005% of the reads recovered in this dataset had a length
equal to PTX7.
Figure 6.16: Length distribution of assembled sequences in the first round library for
TEM-1. Frequencies for each class observed in the NGS dataset (bars) compared with the
expected frequencies from a binomial distribution using the per-cycle e ciency derived
from the dataset.
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The exploration of sequence space around the target 164RYYGE168 sequence was char-
acterised by examining the compositional diversity and also the coverage of the possible
sequences for each length category, before and after selection (Fig. 6.17). The compositional
diversity was evenly distributed throughout the libraries, with only a small bias towards
arginine codons in the first position, which was intentional in the library design. The se-
quence landscapes shorter than 164RYYGE168 were relatively well-covered, with almost all
possible 3-mers and around 10% of all 4-mers present in the pre-selection library. How-
ever, 5-mers had under 1% coverage because of the lower-than-expected e ciency from the
assembly and the higher number of possible variants of this length. The high number of
enriched sequences with Hamming distance greather than or equal to one shows that the
sequence space around the 164RYYGE168 target is populated with functional sequences,
that were recovered by selection. This is also corroborated by the logo plots, which show
a preference for Arg at the first position, Tyr at the third position and Gly at the fourth
position. This data also confirmed that the sequence space around the seven-residue PTX7
variant was sparsely sampled and similar activities with high activities could still be found
by a second round of diversification and selection.
The k-mer based motif detection analysis was used to probe the enriched sequences from
this round of selection. The linear enrichment score was replaced by a Z-score derived from
comparison between pre- and post-selection libraries as Poisson distributions, which was
expected to provide accurate representation of enrichment than was observed in some of
the simulated selections (Section 6.2.2). The score was defined as follows:
Z =
(cX   Y )  (c✓x   ✓y)p
C2✓X + ✓Y
(6.1)
here c is the ratio in size between post- and pre-selection libraries as a correction for
sampling, X is the number of counts for a sequence post-selection, Y is the number of
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Figure 6.17: Exploration of the sequence space around 164RYYGE168 before and after
selection. (a) The possible sequence space is divided into fixed lengths and the most
frequent variant derived from 164RYYGE168 at that length was used as origin for Hamming
distance calculation. (b) The sequence space around 164RYYGE168 was e ciently covered
at the shorter sequence lengths. (c) Sequence logos show minor biases in the pre-selection
library for arginine residues at the N-terminal end of the variable region. (d) Selection
produced strong enrichment of sequences at the higher lengths. (e) Sequence diversity
recovered post-selection at each length.
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counts for that sequence pre-selection, ✓X and ✓Y are estimated Poisson parameters defined
as X and Y counts as a fraction of the total number of reads for the respective libraries.
The Z-score indicates divergence between the post- and pre-selection distributions, with
very high positive values indicating the most highly enriched sequences.
Comparisons between the PCA-derived motifs and the most frequent sequences directly
from the post-selection NGS dataset are in Table 6.4. While the first dimension of the
PCA was covered by the three most frequent sequences, the second dimension recovered
the 164RYYGE168 sequence along with shorter variants RYYG and RYY. Other slightly
more divergent motifs were also picked out by the PCA, such as GGW (PCA6), RGYH
(PCA8), and SYHZ (PCA9).
Component PCA-derived motif Most frequent match Ranking
ZDZ 1
1 Z(D/T/P)Z ZTZ 2
ZPZ 3
ZR(Y/G)YGZ ZRYYGZ 14
2 ZR(Y/G)YGXZ ZRYYGEZ 16
ZR(Y/G)YZ ZRYYZ 324
3 ZDZ ZDZ 1
Z(D/S)Z ZDZ 1
4 ZSZ 4
ZYSZ ZYSZ 5
5 ZPZ ZPZ 3
ZSZ ZSZ 4
6 ZG(G/S)Z ZGGZ 12
ZGGXZ ZGGWZ 45
ZSZ 4
Z(S/Q)Z ZQZ 7
7 Z(R/S)YYG ZRYYGEZ 16
ZYYG ZSYYGZ 225
ZYYGHZ 4568
ZSZ ZSZ 4
8 ZRGYXZ ZRGYHZ 10
ZXHZ ZPHZ 18
Z(S/G/N)(Y/H/G)Z ZGGZ 12
9 ZXYY(G/H)Z ZRYYGZ 14
Z(S/G/N)YHZ ZSYHZ 31
10 Z(Q/M)Z ZQZ 6
ZRGYXZ ZRGYHZ 10
Table 6.4: Enriched motifs detected by k-mer based PCA of the first selection round
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6.2.6.3 Second round of selection
The pre-selection library and the plasmids extracted from the selected clones of the second
round library were also submitted for high-throughput sequencing, to characterise the ini-
tial library and to identify motifs that were enriched in this round of selection. Reads were
trimmed, selected for high quality, translated and counted. This yielded 731,711 unique
sequences out of 7.9x106 reads for the pre-selection library and 765 unique sequences from
6.5x104 reads in the post-selection library. Similarly to what was observed in the first round
dataset, 765 unique sequences were recovered in the post-selection NGS data, out of ap-
proximately 80 colonies recovered from the selection. This near tenfold excess of sequences
over the number of colonies could be due to sequencing errors, mutations accumulated dur-
ing outgrowth or degradation of ceftazidime during outgrowth in liquid media leading to a
lower selection stringency and recovery of inferior clones.
The average e ciency per cycle of InDel assembly was approximately 20% for this
library, higher than was observed in the control and first-round libraries (Fig. 6.18). The
wild-type and 164RYYGE168 sequence length of 5 residues constituted 7.5% of the total
sequences in the library and the length of PTX8 — 8 residues in total, but the N-terminal
Arg was kept constant in this assembly and is not counted in the plot — was approximately
0.8% of the total sequences.
It is interesting to note that the proposed single-mutation path from PTX7 to PTX8
(Section 6.2.5.3) was fully represented in the pre-selection library. The initial Met deletion
(164RGYKER168a) had 26 reads, the Glu insertion (164RGYKEER168b) had 6 reads and
the final selected variant (164RGYKEERD168c) had a single read. However, none of the
intermediates were detected in the post-selection dataset and initial PTX7 sequence was
also not represented in the selected variants. This is only one of the many possible single-
mutation paths that can bridge these two sequences (including di↵erent orders of these
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Figure 6.18: Length distribution of assembled sequences in the second round library for
TEM-1. Frequencies for each class observed in the NGS dataset (bars) compared with the
expected frequencies from a binomial distribution using the per-cycle e ciency derived
from the dataset.
steps and also other mutations followed by reversals), but it is a demonstration of the
potential inherent in using InDel Assembly-derived libraries for protein engineering. Since
none of the proposed intermediates was enriched in the second round, it is likely that they
did not confer su cient resistance to survive the higher selection stringency and, therefore,
could not be obtained by consecutive single mutations while being selected at 200 µg/ml
ceftazidime.
As was done for the first-round library, the exploration of sequence space was char-
acterised by the compositional diversity and fraction of possible sequences in each length
category (Fig. 6.19). In this round, there was some bias towards glutamate and arginine
residues in the last two positions, as well as a weaker bias for glycine in the first position.
The higher assembly e ciency and higher number of cycles in this round led to a higher
degree of coverage of sequence space. Nearly 50% of all possible four-residue sequences
were detected before selection, compared with less than 10% in the first library. The longer
landscapes have greatly increased numbers of possible sequences and, therefore, were more
238
Chapter 6. InDel Assembly
sparsely covered. However, as in the previous round, the clone isolated at the highest se-
lection stringencies belongs to a length category that had less than 0.1% of its possible
sequences sampled. The higher per-cycle insertion e ciency enabled this library to cover
the wild-type and 164RYYGE168 sequence length (four diversified residues in this assembly)
much more e ciently than the first round, which did not reach 1% coverage for this length
category.
Since this round of selection was carried out at a higher stringency, the post-selection
diversity was greatly reduced and the sequence logos show one or two motifs being clearly
dominant in each landscape. The number of unique sequences post selection was also
smaller, with less than 100 sequences recovered post-selection in each landscape. The
di↵erence between the number of colonies obtained in the library selection plate and the
number of unique sequences recovered by sequencing is likely a result of sequencing artifacts
generated in library preparation or the sequencing process itself, due to the existence of
multiple low-frequency sequences diverging from the highly-enriched variants by only a
single residue.
The clear trends in selection visible in the broad view of library exploration were com-
pared with the results produced by the k-mer based PCA for motif detection (Table 6.5).
The first four PCA dimensions match the most-frequent sequences exactly, but there are
changes in ranking starting from the fifth dimension and some sequences with lower read
counts appear higher in the PCA motifs due to similarity to other more strongly-enriched se-
quences. Sequences 164RMHKKRH168b, 164REYGEQ168a, 164RRYGT168 and 164RGERQ168
were selected for further characterization, along with other variants isolated during selection
rounds and controls.
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Figure 6.19: Exploration of the sequence space around PTX7 before and after selection.
(a) The possible sequence space is divided into fixed lengths and the most frequent variant
derived from PTX7 at that length was used as origin for Hamming distance calculation. (b)
The sequence space around PTX7 was e ciently covered at the shorter sequence lengths.
(c) Sequence logos show minor biases in the pre-selection library for glutamate residues
towards the C-terminal end of the variable region. (d) Selection produced strong enrich-
ment of sequences at each length. (e) Sequence diversity recovered post-selection at each
length.
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Component PCA-derived motif Most frequent match Ranking
1 ZMHKKRHZ ZMHKKRHZ 1
2 ZEYGEQZ ZEYGEQZ 2
3 ZRYGT Z ZRYGEZ 3
4 ZGERQZ ZGERQZ 4
ZGEZ
5 ZGVYGGFZ ZGVYGGVZ 7
ZGVYZ ZGVYZ 8
ZAKERHZ ZAKERHZ 5
6 GVY ZGVYZ 8
Z E(V/K/R)XZ ZEKERHZ 108
7 ZAKEXH ZAKERHZ 5
Z(A/G)YVZ ZGYVZ 6
8 ZEEVHZ ZEEHVZ 9
Z(A/W)(E/Y)EHRZ ZWEGRQZ 10
9 ZWEGR(Q)Z ZAYEHRZ 12
VEGRQ
VXZ
10 ZGVYZ ZGVYZ 8
Z(A/G)Y(Y/E)HRZ ZAYEHRZ 12
ZGAYEHRZ
Table 6.5: Enriched motifs detected by k-mer based PCA of the second selection round
6.2.7 Phenotypic measurements and comparisons between selected vari-
ants
A small number of candidates from the PCA analysis was selected for characterisation by
measurement of the levels of resistance conferred to di↵erent classes of antibiotics. Among
these were WT and 164RYYGE168 as controls, PTX7, PTX8, D5 and the set of four variants
extracted from the top four dimensions of the second round library PCA to validate the func-
tional motif detection based on sequence enrichment: 164RMHKKRH168b, 164REYGEQ168a,
164RRYGT168, and 164RGERQ168. Only sequences from the second round were selected for
this characterisation with the goal of identifying variants with the highest levels of resis-
tance to ceftazidime, which these were expected to possess due to being selected at higher
stringency.
Two simple measurements from clinical microbiology assays (Balouiri et al., 2016) were
chosen to compare the phenotypes of variants isolated from selection and observed in the
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second-round sequencing dataset to WT and 164RYYGE168, requiring development of pro-
tocols in the group to produce these measurements. Minimal Inhibitory Concentrations
(MICs) were estimated by the broth microdilution assay, in which cultures are grown in
the presence of dilutions of antibiotics in 96-well plates and growth is measured by OD600,
defining MIC as the lowest concentration of a specific antibiotic at which no growth was
observed for a given strain. Disc Di↵usion Assays were also carried out, by measuring the
diameter of the zones of inhibition created around filter paper discs containing di↵erent
antibiotics.
Initial attempts at measuring MICs by growth in 96-well plates resulted in noisy data
due to evaporation from wells on the edges of the plate and cell clumps in sub-MIC concen-
trations reducing the accuracy of absorbance measurements (Fig. 6.20). The evaporation
issue was solved by not carrying out cultures in the outer rows and columns of the plates
and filling those wells with 200 µl sterile H2O. The e↵ect of cell clumping was reduced by
mixing all cultures using a multichannel pipette prior to reading on the spectrophotometer.
Figure 6.20: Initial conditions for MIC measurements in 96-well plates - Growth of TEM-
1 WT (a and b) and 164RYYGE168 (c and d) variants grown in varying concentrations of
ampicillin (a and c) or ceftazidime (b and d) were measured by absorbance measurements
at 600 nm. Each condition was grown as two independent biological replicates.
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The variants chosen for these phenotypic comparisons were all recloned to ensure that
the measured phenotypes were solely a consequence of changes in the W-loop rather than any
undetected mutations which could have occurred elsewhere in the TEM-1 coding sequence,
in the vector backbone or in the genome of isolated clones. These new clones were produced
by commercial synthesis of the variable regions for each construct as separate single strands
containing BsaI sites. Pairs of single stranded oligos coding for each variant were annealed,
digested and inserted into pTEM1 vector amplified by iPCR with primers containing BsaI
sites with compatible overhangs.
Characterisation of the substrate spectrum of isolated TEM-1 variants was carried out
by MRes student Emma Harris and the results are in Fig. 6.21. In the disc-based assay,
PTX7 and 164RYYGE168 did not have their growth inhibited by the ceftazidime discs, while
the WT was strongly inhibited and all other variants (including PTX8) had intermediate
levels of resistance. A similar pattern was seen for cefotaxime, which is also a non-cognate
cephalosporin. The cognate substrates ampicillin and carbenicillin did not a↵ect the growth
of the WT, with the remaining clones showing varying degrees of resistance to these antibi-
otics. Interestingly, the 164RGERQ168 variant was more resistant to these antibiotics than
all other selected motifs, while having similar or lower activity on the cephalosporins. As
expected, the stabilised 164RYYGE168 variant characterised here had a MIC of 150 µg/ml,
apparently higher than 64 µg/ml that was described by Petrosino and Palzkill (1996), but
direct in vitro activity comparisons of the two proteins would be needed to eliminate the
confounding e↵ects of strain di↵erences and changes in expression constructs on the relative
amount of active enzyme produced by each strain.
Imipenem, belonging to the carbapenem class, was also included in the panel but, as
expected, none of the variants conferred resistance to this drug which is clinically used
to treat resistant infections, due to the very ine cient hydrolysis of this compound by
many TEM-1 variants. The results obtained in the microplate-based assay mirrored the
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disc-based assay closely, with the main di↵erence being the slightly higher MIC of the
164RYYGE168 variant in ceftazidime (150 µg/ml) compared to PTX7 (100 µg/ml). Since
both variants had null values for growth inhibition in the single-dose disc assay, the range of
concentrations used in the microplate assay allowed these two variants to be distinguished
and demonstrated that the original 164RYYGE168 variant confers higher levels of resistance
onto E. coli than the novel variants selected at higher ceftazidime concentrations.
Significance tests were carried out for the disc-based assays, employing t-tests with
Bonferroni corrections for multiple testing. All the variants were significantly more resistant
to ceftazidime and cefotaxime than WT, except for 164RGERQ168 against cefotaxime, and
all were significantly less resistant to ampicillin and carbenicillin than WT. None of the
variants had statistically-significant di↵erences in resistance to imipenem when compared
to WT. The 164RGERQ168 variant was also significantly more resistant to carbenicillin than
PTX7, the variant with the second lowest inhibition radius for this antibiotic.
As expected, the results for drugs of the same class — penems (ampicillin and car-
benicillin) and cephalosporins (ceftazidime and cefotaxime) — were very similar, reflecting
the structural di↵erences between classes. The results obtained for this panel of variants
corroborates the previous observation of the E166Y mutation in the active site leading to
higher activity on ceftazidime (Sowek et al., 1991). It is interesting to note that of the
variants tested in this panel, only 164RGERQ168 has a Glu residue in the same position as
WT. This is the selected variant with the highest resistance to penems and lowest resistance
to cefotaxime, suggesting a role for the glutamate residue in favouring activity in penems.
All the other variants have a Tyr residue in the same position as 164RYYGE168, except for
164RMHKKRH168b which has His166 or Lys167/168 as possible candidates for the general
base in the catalytic mechanism of this mutant.
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Figure 6.21: Resistance spectrum of selected TEM-1 variants produced by selection of
InDel-derived libraries. Resistance of all clones to (a) penem, (b) cephalosporin, and (c)
carbapenem antibiotics was measured by growth inhibition around antibiotic-soaked paper
discs. Lower values in this assay indicate higher resistance. Resistance of selected clones to
ampicillin and ceftazidime: (d) WT, (e) 164RYYGE168, (f) PTX7 , (g) 164RMHKKRH168b
and (h) PTX8. Results produced by MRes student Emma Harris, using the assay method-
ology developed in this work.
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6.2.8 Selection parasites
Since the recloned PTX7 and PTX8 variants were unable to grow at the ceftazidime concen-
trations used for high stringency selection of the libraries (300 µg/ml ceftazidime for PTX7
and 500 µg/ml ceftazidime for PTX8) and that allowed the original clones — hereafter
named PTX7S and PTX8S — to be isolated, they possibly represent selection parasites
(Tizei et al., 2016). These are variants that are enriched by selection, but possess a dis-
tinct phenotype from what selection was intended to enrich, due to secondary e↵ects that
increase their chance of survival in the selection system. In the specific case of selecting W-
loop libraries for increased ceftazidime hydrolysis by TEM-1, a parasite can be a mutation
in an untargeted region of the TEM-1 sequence, a mutation in the plasmid that increases
the concentration of active b-lactamase or a genomic mutation that synergistically increases
resistance to ceftazidime through another mechanism.
The plasmid backbones of clones PTX7S and PTX8S were fully sequenced to identify
any secondary mutations which could explain the di↵erences in phenotype. Each clone
had a single substitution in the entire plasmid sequence, in addition to the targeted TEM-1
W-loop region, and both mutations were outside the TEM-1 coding sequence. This suggests
that the higher tolerance of PTX7S and PTX8S when compared to the recloned variants
could be a consequence of more e cient expression of the TEM-1 gene, rather than an
increase in specific activity of the enzyme.
PTX7S had a G to T substitution 49 base pairs upstream of the N-terminal Met codon
of TEM-1, between the AmpR promoter and TAAGGAG Ribosome Binding Site (RBS).
The Salis lab RBS calculator (Salis et al., 2009) did not predict any new Ribosome Binding
Sites in the mutated region, which could produce higher levels of protein. Therefore, the
isolation of PTX7S at concentrations higher than the MIC of PTX7 could be explained by
another undetected regulatory e↵ect or bu↵ering of ceftazidime concentrations by increased
production of Penicillin Binding Proteins (Sauvage and Terrak, 2016).
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PTX8S had a C to T substitution in position 89 of the ColE1 origin of replication. This
site is transcribed from both strands to produce the RNAI and RNAII regulators of ColE1
replication initiation. Stable base-pairing interactions between these loops in these RNA
molecules prevents the initiation of replication because the 30 end of RNAII is the primer
that starts replication, so a mutation in this region could have an impact on plasmid copy
number. This substitution has been previously reported as responsible for runaway plasmid
replication, by disturbing the interaction between the second loop of RNAI and RNAII
(Lacatena and Cesareni, 1981; Camps, 2010). This was corroborated by the observation
that plasmid extractions from PTX8S cultures yielded approximately threefold more DNA
than was routinely obtained from all other clones in the pTEM1 vector. An increased
plasmid copy number could lead to an increase in production of PTX8 mRNA and protein,
increasing the total ceftazidime-hydrolysing activity of carrier cells.
These secondary mutations could also be part of the reason why the 164RYYGE168
variant — which confers levels of resistance against ceftazidime similar to PTX7 and PTX8
— was not isolated in either round of high-stringency selection, while at least being present
in both pre-selection libraries. Since the stringent selection steps in both rounds were
carried out at concentrations far higher than the MIC of 164RYYGE168 (300µg/ml and 500
µg/ml CAZ in the selections, while its MIC was 150 µg/ml), mutations of similar e↵ect
as the ones found in PTX7S and PTX8S would need to occur in the strain carrying a
164RYYGE168 copy to increase the likelihood of this variant being isolated under high-
stringency conditions.
Alternatively, the high-stringency plates could have contained lower e↵ective concentra-
tions of the antibiotic due to degradation by TEM-1 variants secreted during growth of
selection pools in liquid culture, allowing growth of strains with MICs lower than the in-
tended ceftazidime concentration. In this situation, any changes in relative number of cells
of each variant in the pool placed into liquid cultures could be amplified during growth and
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the sample of only 104 cells in the high-stringency plates could not be su cient to recover
all the functional variants from the pool after growth. This e↵ect could be reduced by
washing the colonies harvested from the initial selection plates in fresh medium to ensure
no residual TEM-1 is carried over and eliminating the liquid growth step before plating into
high-stringency conditions, to ensure a more even representation of the harvested variants.
6.3 Conclusions
The results obtained from the two rounds of selection for TEM-1 using libraries made with
InDel assembly demonstrate the power of this novel approach to quickly obtain functional
variants from unexplored regions of sequence space. Despite the per-cycle insertion e cien-
cies being lower than desired — even after additional rounds of protocol improvement —
libraries produced by this strategy allowed for e cient exploration of the sequence neigh-
bourhood around known positive variants of TEM-1 while at the same time producing novel
functional variants that are highly divergent in length and composition. Producing similar
diversity by other strategies would require the construction of multiple libraries to cover
all possible insertions and deletions from target sequences (16 separate libraries to cover
just 1 residue longer or shorter than PTX7), which can become costly and experimentally
intractable. Due to the ease of producing customisable libraries that cover length-variant
regions of sequence space, InDel Assembly has potential for use in discovery of binders such
as antibodies or ones based on di↵erent protein sca↵olds (e.g, bicyclic peptides (Heinis
et al., 2009)).
The fact that both clones isolated from the high-stringency selection steps were selection
parasites illustrates one of the main pitfalls in employing selection in directed evolution.
As selective pressures are increased to isolate a small number of variants — or even a
single variant — from a large initial population, the likelihood of obtaining such a false
positive result also tends to increase, especially when selection is carried out in vivo by
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di↵erential growth of cells that are adaptable and can spontaneously generate variants
that circumvent the artificial selection system constructed for directed evolution. The
appearance of these parasites is a possibility that must always be evaluated when designing
selection strategies for directed evolution and, if possible, researchers should aim to predict
which possible phenotypes could represent parasites within the selection, to implement
strategies to mitigate their e↵ect (Tizei et al., 2016).
In this context, the enrichment analysis framework presented here can also be a powerful
strategy to avoid such parasites, since neither PTX7 nor PTX8 were identified in the motifs
from the top ten dimensions of the PCAs (see Sections 6.2.6.2 and 6.2.6.3). The fact that
more than one variant in the post-selection library can contribute to the enrichment detected
in the PCA reduces the likelihood of a parasite receiving a high score, since a secondary
beneficial mutation would have to occur simultaneously in all the variants that contributed
to the predicted motif.
Libraries produced with InDel Assembly coupled to the k-mer based enrichment analysis
can help accelerate the engineering of biological systems, reducing the selection or screening
e↵ort require to obtain the desire phenotype by using information from previous rounds of
selection to inform the design of subsequent libraries. Previous strategies to analyse the
output of antibody selections stratified the enriched variants into discrete length categories,
discarding valuable information about functional motifs that could be exploited to direct
further improvements more robustly to the obtained binders (Ravn et al., 2013). In addi-
tion to the strategy described here for loop engineering of TEM-1, considerable e↵ort has
been directed towards obtaining methods to intelligently restrict search space in directed
evolution, producing libraries enriched for the desired functions and — consequently —
reducing screening or selection e↵ort (Currin et al., 2015; Woldring et al., 2017).
So far, InDel assembly has only been tested for codon-by-codon assembly, but the
method design can accommodate di↵erently-sized building blocks, which also opens the
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possibility of producing libraries to engineer phenotypes on di↵erent scales. Short struc-
tural elements can be combinatorially assembled to produce protein domains, domains can
be shu✏ed in large modular proteins, and even metabolic pathway engineering could be
done with longer elements encompassing coding sequences and regulatory regions.
The framework presented in this chapter, though validated by engineering an enzyme
as a proof-of-principle, can be directly employed for the engineering of TOMMs and other
classes of compounds derived from ribosomal peptides. As long as a robust selection or
screen is available to represent the test stage of the synthetic biology cycle (Baldwin et al.,
2015), InDel Assembly can be used to produce a library — targeted if starting candidates
are known, or with no bias — and the k-mer based analysis strategy can detect functional
motifs to inform further rounds of diversification and selection.
Due to the cycle time of over three hours and the fact that multiple cycles need to be
carried for every unit increase in average length of the library, the current codon-by-codon
assembly strategy would only be adequate for relatively short stretches of residues in a
hypothetical TOMM precursor library. However, longer fragments can be built up using
longer assembly blocks as mentioned above and by designing library amplification primers
to allow multiple copies of the library to be cloned in tandem, even up to the 69-residue
length of the McbA precursor of Microcin B17.
Even in the absence of a robust in vitro platform for the heterocyclisation of modified
TOMM precursors, it would be possible to employ InDel libraries to further probe the
requirements for function in the Microcin B17 system. By cloning a low diversity library
built using fragments containing heterocyclisable residues flanked by glycines (most of the
cyclised positions in Mcb17 are in G(S/C)(S/C)G and G(S/C)G motifs) and linker frag-
ments into the biosynthetic operon, it would be possible to carry out medium throughput
screening on 96-well plates to obtain more information on the functional e↵ects of the order
and number of the heterocyclic moieties within the compound.
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The inconsistency between results obtained for DNA gyrase inhibition and antibacterial
activity for truncated Microcin B17 variants (Shkundina et al., 2014; Thompson et al.,
2014) suggests an as-yet-uncharacterised target for this molecule. In this regard, if a screen
of InDel-derived variant precursors heterocyclised in vivo produces novel Microcin B17
analogs, these could be employed as tools to elucidate further the structure-function rela-
tionship of this microcin. One possible strategy to determine whether there is a second
target of Microcin B17 that is unknown would be to screen microcin variants against a
panel of E. coli gene deletion mutants and any mutant that presents a response di↵erent
to the WT to microcin variants would indicate a candidate gene for a gyrase-independent
e↵ect. The proteins encoded by these candidate mutants could then be identified and the
e↵ect of microcin variants on their function measured by appropriate assays.
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Conclusion and Perspectives
7.1 Conclusions
The work presented here contributed in distinct aspects to the mechanistic understanding
of TOMM synthases and their products, representing foundational work towards the estab-
lishment of this biosynthetic pathway as a tool for the discovery of novel azole-containing
bioactive compounds and also with broader applicability in many other biological systems.
A sequence-based functional prediction was developed and tested for a well-characterised
protein family, the bacterial solute binding proteins involved in the transport of amino acids
and other small molecules from the external medium. The three metrics employed in the
prediction detected residues known to be relevant to function of the glutamine binding
protein GlnBP, including ones that have been targeted by previous work to alter the sub-
strate specificity of this protein (Looger et al., 2003). The NoSE metric proposed here is
of special interest, being designed to detect determinant residues, conserved only within
a subset of sequences within a mixed-function alignment that are known to share a single
function. Previous methods to detect residues with this evolutionary signature relied on
the construction of alignments with clearly delimited functional subgroups (Kalinina et al.,
2004), which is often not possible if insu cient functional annotation is available for the
family of interest.
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The prediction strategy was then applied to the TOMM synthases and predictions were
validated for the dehydrogenase McbC in the biosynthetic complex for Microcin B17 of
E. coli. A simple bioassay was established for validation, showing an impact on the in
vivo production of this TOMM for eight out of the sixteen McbC mutants constructed.
Among the putative functions for the mutants with a negative phenotype inferred from the
literature and homology modeling are candidate FMN cofactor-interacting residues, sites
with apparent structural roles, and others along a putative homodimerisation surface. The
functional results obtained for McbC and the predictions made for the remaining proteins
in the complex can assist in producing novel insight into the functioning of the TOMM
synthase complex, by targeting experimental characterisation e↵ort at sites already known
to posses a functional role, or at least predicted to have a role.
Three distinct TOMM synthase complexes — from B. amyloliquefaciens, Bacillus sp.
Al-Hakam, and E. coli — were heterologously expressed and purified for in vitro recon-
stitution and deeper characterisation of their activity. Activity detection was attempted
by mass spectrometry, fluorescent labeling of free cysteines, and employing a commercial
polyclonal antibody. Unequivocal and consistent detection of in vitro TOMM synthase
activity could not be obtained for any of the three complexes due to di culties with the
expression and purification of proteins in the complex and the substrate peptides. However,
evidence of activity was found for the complex from E. coli by MS detection and substrate
peptide variants with increased solubility were obtained that avoid the peptide solubility
issues encountered in attempts to detect the activity of this complex. Further investigation
into these substrate variants can yield a more robust assay system for TOMM synthases,
producing consistently reproducible results.
Finally a novel integrated framework was developed for the directed evolution of flexible
regions of proteins, employing sequence libraries containing diversity in both composition
and length. The assembly method produces customisable high-quality libraries containing
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heterometric diversity and the analysis strategy detects motifs enriched among sequences of
variable lengths after rounds of selection. Validation of this system by two rounds of directed
evolution of the b-lactamase TEM-1 led to the isolation of seven novel variants active on
the non-cognate substrate ceftazidime spanning a range of lengths — the diversified region
of these variants had sequences of zero to eight residues in length — that could not be
easily obtained by previous methods. This framework also has immediate applicability in
the engineering of proteins such as antibodies (Ravn et al., 2013) and enzymes with active
sites composed of loops (Afriat-Jurnou et al., 2012).
7.2 Perspectives
Each of the avenues of research explored in this thesis raised relevant new questions that
could be pursued by future members of the Pinheiro group and could also be taken up by
other research groups working in related fields. The tools developed in this work with the
aim of furthering the understanding of TOMM synthases and establishing their engineering
can also be applied to other biological systems.
The functional prediction strategy proposed here — including the NoSE metric for
detection of determinant residues — was able to recover sites known to be important in the
solute binding protein GlnBP along with additional candidate residues that have not yet
been investigated and could be relevant to its native function, as well as for engineering of
novel phenotypes. Other families of proteins that maintain enough sequence conservation
for construction of alignments but diverge in phenotype could be targeted by this strategy
for prediction of functionally relevant sites. Among these possible targets are the highly
diverse families of proteins involved in eukaryotic signaling pathways such as protein kinases
with their wide range of phosphorylation substrates (Bradley et al., 2017) and families of
G-Protein Coupled Receptors that include members acting as receptors for small molecules
and light receptors (Wolf and Grunewald, 2015).
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The initial characterisation obtained here for the dehydrogenase McbC from the E. coli
TOMM synthase complex can be expanded to the remaining proteins in the complex for
identification of more candidate residues for complex engineering. In parallel, the mutants
confirmed to a↵ect dehydrogenase function in the in vivo assays can be further characterised
to determine the nature of their e↵ect on McbC function. Overexpression and purification
of the mutants can quickly reveal whether FMN binding was a↵ected, by the visible lack
of yellow colour in solutions of proteins that not contain this cofactor. Structural integrity
can be assayed by denaturation-based assays such as thermofluor (Ericsson et al., 2006)
or circular dichroism — the latter also yielding information on any changes in secondary
structure content caused by mutations.
In addition, the microcin B17 bioassay system can be employed to investigate interac-
tions between components of the TOMM synthase complex by varying relative expression
levels of genes within the operon to identify rate-limiting steps in overall TOMM biosyn-
thesis and how these are a↵ected by the mutations obtained here. The approach employed
by Melby et al. (2012) to reconstruct a functional Bacillus sp. Al-Hakam TOMM synthase
complex with the addition of a functional dehydrogenase from a di↵erent species can be
mirrored in the in vivo system, enabling the identification of putative enzymes from related
organisms that can rescue TOMM biosynthesis.
In vivo engineering of TOMM production can be further expanded by the development
of a biosensor for heterocyclised moieties in peptides, analogously to so,e of the recently-
developed small-molecule biosensors (Feng et al., 2015b; Skjoedt et al., 2016). Such biosen-
sors could be used in logic circuits linking intracellular presence of heterocyclised peptides
to growth or expression of a selectable marker, enabling the exploration of the sequence
space for substrates and synthase complexes with the aim of obtaining promiscuous systems
capable of delivering diverse libraries of synthetic TOMMs for activity screening.
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Finally, the e cient exploration — at a low cost — of length-variable sequence space
that was enabled by InDel Assembly coupled to the motif detection framework can be
employed to shift protein engineering e↵orts away from their almost-exclusive focus on
constant sequence lengths (Toth-Petroczy and Tawfik, 2014a), more faithfully reflecting the
sampling of indels by biological processes (Tenaillon et al., 2016; Toprak et al., 2011). The
assembly method itself can also be made even more accessible by optimising the amount of
time and reagents required for library construction, as well as translation into an automated
format with computer-guided library design and automated liquid handling for the assembly
steps. Changes in the size of the sequence inserted with each assembly cycle can also be
explored to enable the assembly of combinatory libraries of secondary structure elements,
domains, and even non-coding elements such as regulatory regions.
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Appendix A - List of Reagents
Table 8.1: Reagents used in this work.
Reagent (Abbreviations or stock solution used
in this work)
Manufacturer
a-Cyano-4-hydroxycinnamic acid (CHCA matrix, 10
mg/mL solution in Methanol / 0.1% Formic acid)
Sigma-Aldrich, USA
1kb DNA ladder N3232L New England Biolabs,
USA
100 bp DNA ladder N3231L New England Biolabs,
USA
20% Sodium Dodecyl Sulfate solution (SDS) Fisher Scientific, USA
2-Butanol Sigma-Aldrich, USA
37% Hydrochloric Acid (HCl) VWR International,
USA
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES)
Sigma-Aldrich, USA
5-(Iodoacetamido)fluorescein (IAA-FITC, 10 mM
stock solution in DMF)
Santa Cruz Biotechnol-
ogy, USA
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Reagent (Abbreviations or stock solution used
in this work)
Manufacturer
Maleimide-5-Fluorescein (Mal-FITC) Thermo Scientific, USA
50% Sodium Hydroxide solution (NaOH) Sigma-Aldrich, USA
Absolute Ethanol (Ethanol) VWR, USA
Acetone VWR International,
USA
Acrylamide/Bisacrylamide 37.5:1, 40% solution Alfa Aesar, USA
Adenosine triphosphate (ATP) Roche Diagnostics
GmbH, Germany
Agarose Fisher Scientific, USA
Amicon Ultra-0.5 Centrifugal Filter Unit with Ultracel
membrane
Merck Millipore, Ger-
many
Ammonium acetate (4M solution in dH2O) AppliChem GmbH,
Germany
Ammonium persulfate (10% (w/v) solution in dH2O) Acros Organics, USA
Ampicillin, sodium salt (100 mg/mL solution in
dH2O)
AppliChem GmbH,
Germany
Anti-sulfathiazole polyclonal serum LSBio, USA
Bacto Tryptone (Tryptone) Becton Dickinson, USA
Bacto Yeast Extract (Yeast Extract) Becton Dickinson, USA
Betaine Sigma-Aldrich, USA
Boric acid Fisher Scientific, USA
Bovine Serum Albumin (BSA) Sigma-Aldrich, USA
Bromophenol Blue Alfa Aesar, USA
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Reagent (Abbreviations or stock solution used
in this work)
Manufacturer
Chitin Resin New England Biolabs,
USA
Color Protein Standard, Broad Range P7712L New England Biolabs,
USA
cOmplete Mini EDTA-Free Protease Inhibitor Cock-
tail
Roche Diagnostics
GmbH, Germany
D-Glucose Sigma-Aldrich, USA
Diethyl Ether Sigma-Aldrich, USA
Difco Agar (Agar) Becton Dickinson, USA
Dithiothreitol (DTT) Thermo Scientific, USA
Dimethylformamide (DMF) Sigma-Aldrich, USA
Dimethylsulfoxide (DMSO) Thermo Scientific, USA
Ethylenediaminetetraacetic acid (EDTA), trisodium
salt
Sigma-Aldrich, USA
Factor Xa protease New England Biolabs,
USA
Formic acid Sigma-Aldrich, USA
GeneJET Plasmid Miniprep Kit Thermo Scientific, USA
GeneJET PCR Purification Kit Thermo Scientific, USA
Glycerol Fisher Scientific, USA
Glycine Sigma-Aldrich, USA
Glycogen Azure Sigma-Aldrich, USA
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Reagent (Abbreviations or stock solution used
in this work)
Manufacturer
Immobilon-P transfer membrane Merck Millipore, Ger-
many
InstantBlue Expedeon Ltd, UK
Isopropyl b-D-1-thiogalacto-pyranoside (IPTG) Glycon Bioch. GmbH,
Germany
L-Cysteine Acros Organics, USA
MBPTrap HP 1mL chromatography columns GE Healthcare, Sweden
MBPTrap HP 5mL chromatography columns GE Healthcare, Sweden
Methanol Merck KGaA, Germany
Monarch DNA Gel Extraction Kit New England Biolabs,
USA
Orange G TCS Biosciences, UK
Phenol-Chloroform-Isoamyl Alcohol (25:24:1) Acros Organics, USA
Phenylmethanesulfonylfluoride (PMSF) AppliChem GmbH,
Germany
Pierce 660 nm Protein Assay Reagent Thermo Scientific, USA
Pierce TBM HRP substrate Thermo Scientific, USA
Potassium Chloride (KCl) Fisher Scientific, USA
ProTEV Plus protease Promega, USA
Rabbit anti-goat IgG, HRP Thermo Scientific, USA
Sequazyme Peptide Mass Standards Kit LIfe Technologies, USA
Sodium Chloride (NaCl) Fisher Scientific, USA
SYBR Safe DNA Gel Stain Life Technologies, USA
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Reagent (Abbreviations or stock solution used
in this work)
Manufacturer
Tetramethylethylenediamine (TEMED) Sigma-Aldrich, USA
Triethylammonium bicarbonate bu↵er (TEAB, 1M so-
lution in H2O, pH 8.5)
Sigma-Aldrich, USA
Trichloroacetic acid (TCA) Fisher Scientific, USA
Tricine Acros Organics, USA
Tris (2-carboxyethyl) phosphine (TCEP) Sigma-Aldrich, USA
Triton X-100 Sigma-Aldrich, USA
Trizma Base (tris(hydroxymethyl) aminomethane)
(Tris)
Sigma-Aldrich, USA
Ultra Low Range Molecular Weight Marker M3546 Sigma-Aldrich, USA
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Appendix B - List of Oligonucleotides used in this work
The list of oligos referred to in the text is contained in the AppendixB.xls file of the enclosed
disc.
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Appendix C - Scripts written for data analysis
The scripts written for data analysis in this work, including dataset construction, functional
score prediction, NGS data treatment and k-mer based motif detection, are in the “scripts”
folder of the attached disc.
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